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ABSTRACT 
This thesis is concerned with the hyperlipidaemias which occur 
during pregnancy and in infancy. It is presented in the form of
 6 
chapters, 5 of which contain a relevant introduction and section 
of 
methodology, preceded by a general introduction and review of re
levant 
literature. 
The hyperlipidaemia of pregnancy was manifested by mid-gestation
. 
Using ultracentrifugation, the pattern of cholesterol and trigly
ceride 
distribution among the major lipoprotein fractions most closely 
conformed to the phenotype of primary (genetic) combined 
hyperlipoproteinaemia. Hypertension and pre-eclampsia exaggerat
e the 
triglyceride component, whilst pre-existing hypercholesterolaemi
a and 
renal disease also modify the pattern. 
The hyperlipidaemia of pregnancy was further investigated using 
sterol balance techniques. The size of early plasma cholesterol
 
increases was related to maternal weight gain. Bile acid excret
ion in 
the second trimester was related to plasma cholesterol and trigly
ceride 
concentrations, and may be increased compared to the first and t
hird 
trimesters. 
The next sections concern changes in the perinatal and infantile
 
periods, with consideration of possible influences and their mod
e of 
action. Foeto-maternal stress was an important determinant of p
lasma 
triglyceride concentration in the infant at birth, whilst plasma
 
cholesterol was related to maternal LDL-cholesterol concentratio
n. 
Changes in plasma cholesterol and triglyceride were monitored du
ring 
the first few days of life. The magnitude of the hyperlipidaemi
a was 
partly determined by the loss of weight during this early period
. 
A prospective study measured plasma lipid concentrations in 230 
children at birth and at 12-22 months of age. The aim was to de
termine 
V 
the value of the measurement of umbilical cord plasma during infancy . 
The plasma lipid concentrations during infancy were influenced by the 
child's sex, weight and diet, and plasma cholesterol was related to 
his birth level. An hype rcholesterolaemic child at birth was more 
vi 
likely to be hypercholesterolaemic during infancy, than one who was 
norrnocholesterolaemic at birth. However, the majority of hyperlipidaemic 
infants at 12-22 months were norrnocholesterolaernic at birth, but were 
more likely to have a family history of arteriosclerotic disease or 
hypercholesterolaernia. 
Cholesterol metabolism was studied in the neonate and young infant 
using sterol balance techniques. Bile acid and neutral sterol excretion
 
doubled during the first 3 weeks of life, becoming comparable to adult 
values (on a weight basis). Dietary cholesterol and the fatty acid 
composition profoundly affected the rates of excretion. 
The final chapter is an applied problem concerning modification 
of the lipid composition of human milk. Milk linoleate content was 
doubled by substitution of polyunsaturated margarine and oils for butter
 
and some of the saturated animal fat in the diet of mothers who were 
breast-feeding. The changes in milk fatty acid were correlated with 
maternal plasma changes, and the effect upon the infants' plasma 
cholesterol concentrations was monitored. The results are discussed 
in relation to the secretion of milk as well as changes in infant 
cholesterol metabolism. 
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CHAPTER 1 
INTRODUCTION 
A. CHA GES IN PLASMA LIPIDS IN PREGNA CY AND THE PUERPER
IUM 
Historically the hyperlipidaemia of pregnancy has been know
n for 
many years, having been described by John Hunter in the ei
ghteenth 
century, and by Rodier and Becquerel (1845) and Virchow (1847) (Boyd, 
1934). Numerous studies have been carried out during the last 50 years
, 
with increasing sophistication of techniques and better de
finition of 
the lipid fractions being investigated. 
1. Normal Human Pregnancy 
Cholesterol . The plasma cholesterol level has been reported to increas
e 
progressively during pregnancy and then either decrease be
fore delivery 
(Oliver and Boyd, 1955; Watson, 1957; Hashmi and Afroze, 1972), remain
 
elevated during the last trimester (de Alvarez et al, 1959; Pantelakis
 
et al, 1964a,b) or continue to increase right up to term (Peters et al, 
1951; Moses et al, 1952; von Studnitz, 1955; Vernet and Smith, 1961;
 
Svanborg and Vikrot, 1965a). It has been suggested that the plasma 
cholesterol level may actually decrease during the first t
rimester of 
pregnancy (e.g., de Alvarez et al, 1959; Green, 1966). The level 
remains within the limits for the normal non-pregnant pop
ulation, and 
if studies are not commenced early, in anticipation of pre
gnancy, such 
a decrease would be missed. 
The change in plasma cholesterol in the post parturn perio
d has 
been variously described. Most authors have reported a sl
ow, steady 
decrease in plasma cholesterol concentration following del
ivery (Watson, 
1957; Konttinen et al, 1964; Svanborg and Vikrot, 1965b), but blood 
lipids have been reported as above normal limits several m
onths post 
partum (Peters et al, 1951; Oliver and Boyd, 1955; Watson, 1957; de 
Alvarez et al, 1959). In one report, however, there was an initial 
decrease in plasma cholesterol, and then a rebound by the 
end of the 
first week (Oliver and Boyd, 1955). 
2 
Triglycerides . Mos t a uthor s r eport a 2-3 f old i ncr ease by the third 
trimeste r or at de live ry c ompa r e d t o the n on-p r egna n t or ea r ly pregnancy
 
values (Cra me r et al, 1 964/5 ; Konttine n et al , 1 964; Renkonen , 1966 ; 
Svanborg and Vikrot, 1 96 5a; Damiani et al , 19 72; Knopp et al , 1973) . 
The mode of incre a s e is d escribe d a s bein g s t e ady throughout p r egnancy 
(Peters et al, 1951; Knopp et al , 1973) with Svanborg a n d Vi k r ot (1965a) 
demonstrating a p ositive line ar r e lationship b e tween the l og v a l ue of 
the plasma triglyce ride s and stage of gestation. 
Plasma triglyce ride concentration de cre ases rapidly following 
delive ry. By day 5 post p arturn the concentration had halved (Sv a nborg 
and Vikrot, 1965b; Konttinen et al , 1964). 
Phospholipi ds. Many of the studies mentioned above have included 
measurements of the plasma phospholipids. Total phospholip ids increase 
during pregnancy , but Svanborg and Vikrot (1965a) have found differences 
in composition, the level of lysolecithin showing a marked decreas e. 
Several authors have found a continuous increase until term or delivery 
(Peters et al, 1951; von Studnitz, 1955; de Alvarez et al, 1959; 
Svanborg and Vik rot, 1965a) whilst a decrease prior to term has been 
described by Oliver and Boyd (1955), Pantelakis et al (1964b) and 
Hashmi and Afroze (1972). The latter authors found that the level close 
to term was lower than at any other time during pregnancy. 
The decrease in total phospholipids in the puerperiurn parallels 
that of cholesterol showing a slow steady fall following delivery 
(Konttinen et al, 1964; Svanborg and Vikrot, 1965b) or little immediate 
change (Oliver and Boyd, 1955; de Alvarez et al, 1959). The lysolecithin 
component abruptly increased during the first 4 days post parturn 
(Svanborg and Vikrot, 1965b). 
Fatty Acids. Free fatty acid concentration is increased during pregnancy . 
Fairweather (1971) found the levels to be higher than normal as early as 
the ninth week of gestation. There are other rep orts of elevate d fre e 
3 
fatty acid l evels in the third trimester and at delivery (Bleicher e t al , 
1964). The level of free fatty acid has been r eported to decrease 
almost imme diately after delive ry of the placenta (Fairweather , 1965) , 
with a continuing decrease ove r the first week afte r delivery (Becker 
et al, 1971; Bleicher et al, 1964). 
Lipoproteins . In · the 1950's, electrophoresis showed the changes in total 
plasma lipids to be equated with changes in the ratio of S and a 
lipoproteins during pregnancy, there being an increasing density of the 
S band coupled with an apparent change in migratory properties (Watson, 
1957). The S/a ratio was uniformly increased (Russ et al, 1954; Oliver 
and Boyd, 1955; van Studnitz, 1955). Watson (1957) found that the 
mean S/a lipoprotein ratio had fallen towards normal by 6-8 weeks post 
partum, though was still above normal, supporting the finding by Oliver 
and Boyd (1955) that the cholesterol concentration and the ratio of S to 
a was still raised 20 weeks postpartum. 
Pantelakis et al (1964a,b) correlated lipoprotein changes during 
pregnancy derived by electrophoresis and ultracentrifugation. The pre-S 
band equated with lipoproteins of Sf 15-100 (having a density greater 
than 1.020). It was not increased in a normal pregnancy until after the 
sixteenth week, but in a diabetic pregnancy often earlier than this. The 
low density fractions, Sf 10-15 and Sf 3-9, increased later in gestation. 
Lipoprotein separation and measurement of the cholesterol and triglyceride 
components has recently been carried out by Knopp et al (1973) in 
conjunction with electrophoresis . They found all 3 major fractions (very 
low density lipoprotein, VLDL, low density lipoprotein, LDL, and high 
density lipoprotein, HDL) to be increased in the third trimester of 
pregnancy. Triglyceride was significantly increased in all fractions, 
whilst cholesterol increased only in VLDL and LDL. 
Post Heparin Lipolytic Activity {PHLA) . Since the triglyceride increase 
in pregnancy is of such magnitude, mechanisms which may affect triglyceride 
metabolism have been investigated. PHLA has been considered to
 be an 
expression of the rate or efficiency of removal of triglyceride
 from the 
circulation. Meng and McGanity (1958) and Fabian et aZ (1958) found 
PHLA to be decreased in pregnancy, recovering during the puerpe
rium. 
However, Knopp and Arky (1972) comparing pregnant normal and diabetic 
subjects were unable to demonstrate diminished PHLA in the third 
trimester of normal pregnancy, when a correction for its dilutio
n in the 
larger plasma volume of pregnancy was made. The PHLA in diabet
ics was 
however significantly lower (diabetes, 3.96 ± 0.63; normal, 7.13 ± 1.05 
m Eq ml FFA/µg heparin/hour), and coincided with differences in plasma 
triglyceride levels (271 and 169 mg/100 ml respectively). 
2. Possible Effects of Diet, Race and Disease Studie
s conducted 
4 
amongst pregnant women have generally shown that the hyperlipae
mia of 
pregnancy is not affected by diet. Hansen et aZ (1964), in a group of 30 
women, showed that the "degree of lipaemia in the last trimeste
r of 
pregnancy" was independent of the maternal intake of calories, 
protein, 
carbohydrate, total fat, and saturated and unsaturated fatty ac
ids. 
Vegetarians and non-vegetarians amongst a population studied in
 New Delhi 
showed similar increases in plasma lipids in the third trimeste
r, but 
socio-economic differences were noted (Mullick et aZ, 1964). Similarly, 
use of a polyunsaturateddietdid not influence the changes duri
ng 
pregnancy in either norrno- or hyper-cholesterolaemic women (Green, 1966) 
and Moses et al (1952) were unable to influence plasma lipids by daily 
supplementation of the diet with 2 grams of cholesterol. 
The socio-economic difference noted above by Mullick et al (1964) 
amongst the women in New Delhi bears further consideration. Da
miani et 
aZ (1972) in Uganda compared African women with Asian and European women, 
the latter having a much higher social status than the former. 
Among 
non-pregnant controls the European and Asian women had signific
antly 
higher plasma cholesterol and phospholipid levels than the Afri
can women. 
Whilst the Asian- European women showed an inc
rease in plasma choleste rol 
during pregnancy, from 196 ± 35 mg/100 ml (mean± S.D.)
 to 244 ± 42 in 
late pregnancy, the African women did not chan
ge ( 166 ± 2 7 and 15 7 ± 4 7 
mg/100 ml r espectively) . Both qroups showed an increas
e in plasma 
triglyceride (109 ± 59 to 241 ± 64 mg/100 ml, i.e. 221%
 amongst the 
Asian-European women, and 87 ± 8 to 177 ± 54 
mg/100 ml, 204%, amongst 
the Asian women ). A group of women from a low-income g
roup in Nigeria 
had a plasma cholesterol level during pregnan
cy of 174 ± 6.9 mg/100 ml 
(mean± S.E.M.) maximal at 24 weeks gestation, compared
 with 162 ± 2.6 
mg/100 ml in the non-pregnant women. The pla
sma triglyceride levels in 
the same group we re 97 ± 11.1 mg/100 ml at 24
 weeks and 120 ± 5.9 at 36 
weeks, compared with 47 ± 6.5 mg/100 ml in th
e controls. No data was 
available from either of these two studies r
egarding weight gain, skin-
fold thickness, or nutritional status, althou
gh Taylor (1972) suggests 
that one of the major reasons for the absence of a rise in
 plasma 
cholesterol levels is inadequate caloric inta
ke. 
A further cultural group which shows little 
rise in plasma 
cholesterol during pregnancy is the Massai p
eople. Mann and Shaffer 
(1966) studied 17 women at various stages of pregnancy,
 and found that 
there were no differences between their plasm
a cholesterol levels and 
that of age-matched non-pregnant women and th
e levels were all 
significantly lower than among American wom
en. No data are available 
regarding diet, (though it was assumed to be similar to
 the remainder of 
the Massai, rich in animal fat and protein), apart from
 the statement 
that the women "were sleek and plump and show
ed every evidence of good 
nutrition". The skin-folds and weights "allo
wing for pregnancy gain" 
were similar to those in the non-pregnant wo
men. Hormonal differences 
between these populations and others develop
ing hypercholesterolaemia 
have been proposed as a cause (Taylor, 1972). 
5 
The occurrence of severe anaemia (a haemoglobin concentration 
less than 8 grn/100 ml) in pregnancy results in low plasma cholesterol 
levels throughout pregnancy when compared with non-anaemic pregnant 
women; but the level does increase during gestation, being maximal in 
the second trimester (Hashmi and Afroze, 1972). The numbers in this 
study were small, and no cause for the anaemias was documented. 
6 
Whilst there has been considerable interest in changes in metabolism 
which may accompany pre-eclampsia and eclampsia in pregnancy, there has 
been little agreement among reports concerning plasma lipids. The 
presence of higher plasma cholesterol, phospholipid and triglyceride 
levels has been reported (Boyd, 1934a,b; de Alvarez and Bratvold, 1961; 
Konttinen et aZ, 1964; Nelson et aZ, 1966), though not always reaching 
statistical significance. The triglyceride content of placentae from 
toxaemic and normal pregnancies may be different (136 mq/100 g and 89 
mg/100 g respectively) (Nelson et aZ, 1966). Diabetics, not unexpectedly 
may show a marked increase in plasma lipids in pregnancy. Recently, total 
plasma triglyceride and cholesterol concentrations were shown to be 
higher in the third trimester in a group of diabetic women (plasma 
triglyceride - diabetic, 258 ± 11.4 mg/100 ml, n=21; normal, 186 ± 20.7, 
n=l4; mean± S.E.M.; p <0.02). In a group of gestational diabetics 
the triglyceride level was higher than in normal pregnancies, but not 
statistically so, being 228 ± 16.1 mg/100 ml (Knopp et aZ, 1973). The 
plasma cholesterol was apparently lower in the latter group (193 ± 8.7 
mg/100 ml) than in the normals (228 ± 9.0, p <0.02), but higher in the 
diabetic group (245 ± 8.0, n.s.). Previous studies had shown no difference 
in plasma cholesterol levels between normal and diabetic pregnancies in 
the third trimester or at term (Vernet and Smith, 1961; Pantelakis et aZ , 
1964a,b). Lipoprotein studies during diabetic pregnancy have indicated 
an increased pre-B concentration, both on electrophoresis (Vernet and 
Smith, 1961; Pantelakis et aZ, 1964a) and ultracentrifugation 
(Pantelakis et al , 1964b). Furthermore , it is the more complicated 
diabetic pregnancies that show gross elevation of the pre-S band, which 
may remain raised for some time postpartum (Vernet and Smith, 1961). 
3. Animal Studies The effect of pregnancy upon plasma lipid 
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concentrations has been studied in several animal species. Some of the 
results are shown in Table 1.1. There is a resultant hypocholesterolaemia 
in the subhuman primates (the baboon and the rhesus monkey) and in the 
rabbit, whilst a hypercholesterolaemia occurs in the dog and the rat. 
Plasma triglyceride concentration fluctuated widely in the studies in 
the rhesus monkey, but did increase towards term. Zilversmit et al 
(1972a) l..zere unable to demonstrate a change in triglyceride levels in the 
rabbit. 
In the puerperium, in the baboon plasma cholesterol l evels increase 
following delivery and are elevated during lactation (169 mg/100 ml 
compared with 138 in the non-pregnant animal). In the rhesus monkey, 
the plasma cholesterol and triglyceride levels return to nor~a l within 
2 weeks of delivery, whilst the rats' plasma lipids return to control 
values on the third day postpartum. The rabbit undergoes a rapid 
increase in plasma cholesterol level immediately after parturition, with 
a slight secondary decrease during lactation. 
Triton WR 1339 , a detergent which blocks the clearance of plasma 
triglyceride, has been used to study the mechanisms responsible for the 
changes in plasma lipids during pregnancy. Zilversmit et al (1972a) found 
the rate of secretion of cholesterol into rabbits' plasma to be 10.l ± 1 
mg/100 ml/hour in pregnant animals compared with 7.9 ± 0.6 mg/100 ml/hour 
in non-pregnant rabbits. Otway and Robinson (1968), in the rat, shmved 
a progressive increase in entry of triglyceride-fatty acid into plasma 
as body weight increased wi t..h pregnancy coupled with a low adipose 
tissue clearing-factor lipase activity. 
Tietz et al (196 7 ) 
Knobil et al (1957 ) 
Otway and Robinson (1968) 
Martin et al (1971) 
van Z-yl (1957) 
Zilversmi t et al (1972) 
TABLE 1.1 
Plasma Lipid Changes During Pregnancy and 
Animal 
Dog (Beagle) 
Rat 
Rat 
Rhesus Monkey 
Baboon 
-
Rabbit 
Le n g th of 
Ge station 
63 days 
22 days 
168 day s 
196 day s 
32 days 
~ 
During Pregnancy 
Plasma 
/ ) Cholesterol (mg 100 ml 
175 t 75% (control) 
t 150% 
145 ! 50% (control) 
138 t 70% (contro l 
I 
~1s t (control) 
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in the Puerperiurn: Animal Studies 
During Pregnancy In the Puerperiurn 
Plasma . 1 . d (rnEq/lOO ml) Trig yceri e Plasma Cholesterol 
t 4-fold 0.29 
118 t Slightly l Normal after 1 week 
No change 
j And remains elevated 
during lactation 
i After parturition then J slightly during lactation 
Plasma Trigylceride 
! At parturition 
l Norma 1 within 2 weeks 
B. THE EFFECT OF SEX STEROIDS UPON PLASMA LIPIDS 
1. Plasma Lipids 
Sex Differences. The effect of gestational hormones upon plasma lipids 
has been known for some time, the hyperlipidaemia of pregnancy having 
been recorded in the mid-eighteenth century (Boyd, 1934) , with more 
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recent observations on the effect of endogenous or administered hormones 
on lipid metabolism. The apparent sex diffe rence in the incidence of 
atherosclerotic disease promoted interest in plasma cholesterol levels 
particularly. One furthe r development has fostered recent inte r est in 
the possible mechanism of these hyperlipidaemias, namely the increased 
incidence of thrombotic disease among young women using oral contraceptive 
preparations (Vessey and Doll, 1969; Oliver, 1970; Hurtig, 1973). 
A difference in plasma cholesterol levels between males and 
females is demonstrable from birth, the concentration being significantly 
higher in the umbilical cord samples of female infants (Barnes et al , 
1972; Darmady et al, 1972), although smaller studies have failed to show 
a statistical difference. No difference was found between school age 
girls and boys in the Evans County study (Hames and Greenberg, 1961), 
whilst in an Australian population, school boys showed an adolescent 
increase in plasma cholesterol concentration earlier than the girls 
(Godfrey et al, 1972). Several studies have shown that the more rapid 
rise in plasma cholesterol concentration in the third decade of life is 
responsible for the higher level in adult males than adult females (e.g. 
Kannel et al, 1964; Prior and Evans, 1970). This difference is 
maintained for some 2 to 3 decades, but subsequently the level in the 
female increases, so that menopausal and post-menopausal values in women 
are equal to or greater than those in men of similar age. 
As with plasma cholesterol, there is an increase in plasma 
triglyceride concentration with increasing age. Schaefer (1964) showed 
that triglyceride values in females are generally lower than in males of 
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the same age until the mid-sixties. Carlson and Lindstedt (1968) showed 
similar differences between men and pre-menopausal women. 
The changes in plasma cholesterol and triglycerides seen with ag
e 
are reflections of changes in lipoprotein concentrations. The p
attern 
seen at birth is one of almost equal concentrations of HDL and L
DL with 
very low levels of VLDL (Table 1.8). The relatively greater increase 
in plasma lipids in men during the third and fourth decades is d
ue to 
increasing levels of LDL and VLDL (Fredrickson et al, 1967), a similar 
increase occurring in the f emale _IX)pulation after menopause. The 
concentration of HDL is higher in women throughout adult life. 
The Effect of Castration . Since the change in plasma lipids that occurs 
with the menopause has been attributed to declining ovarian func
tion, 
the effect of premature oophorectomy on plasma lipids has been s
tudied . 
The effe ct is generally more pronounced than that observed durin
g 
natural menopause. 
The investigation of women 20 years after bilateral oophorectomy
 
revealed a mean plasma cholesterol level of 251 mg/100 ml compare
d to 
217 mg/100 ml in a comparable group who had undergone only unila
teral 
oopherectomy (Oliver and Boyd, 1959). Similar results were found by 
Robinson et al (1957), although the age range of this population was 
rather wide (31-70 years). The age of the population is very important: 
among women who had undergone an hysterectomy only (the control group), 
there was a significant correlation between plasma cholesterol 
concentration and age (Aitken et al , 1971). No such relationship was 
present in the oophorectomized women of comparable ages. Howev
er, if 
the groups were subdivided into those younger than and older tha
n 45 
years of age, only the younger group of oophorectomized women ha
d 
significantly higher plasma cholesterol levels than the control
s (292 
and 244 mg/100 ml respectively). The levels in the olde r group were 305 
and 299 mg/100 ml respectively. Whilst t here was no difference i
n the 
levels of triglyceride , the slopes of the regressions of age on 
concentration in the 2 groups were significantly different, women with 
intact ovaries having a greater rise in plasma triglyceride with age 
than those who had been oophorectomized. Treatment of a subgroup of 
the oophorectomized women with oestrogen reduced the plasma cholesterol 
from 322 mg/100 ml to 268 after one year. This was accompanied by an 
increase in triglyceride levels from 97 mg/100 ml to 123 mg/100 ml. 
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These changes are similar to those reported by Robinson and Le Beau (1965) 
for 40 post-menopausal women given low dose equine oestrogen for one 
month. 
Castration in males also influences lipid metabolism. Early studies 
by Mccullagh and Renshaw (1934) and Hamilton et al (1956) suggested that 
post-pubertal orchidectomy resulted in an elevation of plasma cholestero
l 
levels. However, Furman et al (1957, 1958) could demonstrate no 
difference in total plasma cholesterol amongst middle-aged or elderly 
eunuchs, whilst the level was significantly lower in the group aged 
21-30 years. More interesting, however, was the observation that in all
 
age groups the levels of LDL were lower and HDL higher than in age-match
ed 
normal male controls. 
The Effect of Exogenous Oestrogens. Oestrogens alone decrease the plasma 
cholesterol concentration in both men and women, in the latter both pre-
and post-menopausally (Eilert, 1953; Russ et al, 1955; Robinson and 
Le Beau, 1965; Aitken et al, 1971). This applies also in 
hypercholesterolaemic men (Oliver and Boyd, 1956a,b). Plasma triglyceride 
levels, noted to be raised in post-menopausal women (Sznajderrnan and 
Oliver, 1963) were further increased by exogenous oestrogen (Robinson and 
Le Beau, 1965), and were increased in the group of oophorectomized women 
studied by Aitken et al (1971). If there is pre-existing elevation of 
plasma triglyceride, oestrogens will accentuate this (Zorilla et al, 1968). 
1 2 
Admini s tration of o es troge n a lone , both natural and synthetic , 
has resulte d in all popula tio n s in a de crease i n p lasma LDL a nd a 
concurrent incre a s e in HDL (Oliver and Boyd , 1 954 , 1956a , b ; Hood , 1959 ; 
Robinson and Le Be au, 1965). 
Corrbined Oestrogen-Androgen Preparati ons . These are mos t commonly taken 
by women as oral contraceptives. They have produce d inconstant changes 
in plasma choles terol leve ls, but have invariab ly increased the plasma 
triglyceride concentrat ion (Table 1.2). The latter usually remains 
within the broad limits of normality (i.e. <150 mg/100 ml). Since 
administration of oestroge n alone will produce a similar change in the 
triglyceride concentration, the increase has been attributed to the 
oestrogenic compone nt alone (Hazzard et al, 1969). The more "oestrogenic" 
the preparation, the greater the triglyceride change is likely to be 
(Stokes and Wy nn, 1971). 
The lipoprotein changes are also governed by the relative potencies 
of the individual components. The "oestrogenic" component increases 
VLDL (Wynn et al , 1966). Changes in HDL are variable; the more 
"androgenic" the activity, the lower the HDL concentration will become, 
and the higher the LDL and total plasma cholesterol level will be (Table 
1. 3) . 
The nature of the androgen is very important. Administration of 
naturally-occurring androgens (testosterone and 6-4-androstenedione) in 
combination with oestrogen will not reverse the oestrogen shift (Hood, 
1959). However, orally active androgens, such as methyltestosterone and 
19-nortestos terone, result in an increase in LDL with a concurrent de crease 
in HDL (Oliver and Boyd, 1956a; Hood, 1959; Cramer, 1961, 1962). 
Anabolic-And:Pogenic Steroi ds and Progestationa l Or a l Contraceptives . Wi th 
mounting evidence of alterations in lipid metabolism accompanying the 
administration of mixed oestrogen-progestin oral contraceptives, it has 
become desirable to find a pure progestational compound, hormonally a c t i v e 
TABLE 1. 2 
Plasma Lipid Changes in Women During Treatment With Oral Contraceptive Preparations 
Preparation 
Control Period Treatment Period 
n Cholesterol* Triglyceride* 
n Duration Cholesterol Triglyceride 
MIXED CONTRACEPTIVES 
Aurell et al (1966) Anovlar 179 
62 223 101 
Wynn et al ( 196 6) Various 38 181 ± 30 60 
58 198 ± 34
1 107 
Br~dy et al (1968) Anovlar 9 238 65 
8 205 ± 10
2 73 ± 7 6 months 
240 ± 9 80 ± 8 12 months 
Ovulen 9 211 74 
226 ± 13 121 ± 8 6 months 
Volidan 6 222 
225 ± 15 110 ± 11 6 months 
Hazzard et al (1969) Provest 10 45 
64 
Wynn et al (1969) Various 54 181 ± 41 
77 ± 31 194 ± 36
1 116 ± 45 
Barton et al (1971) Orthonovin 51 184 134 
197 171 6 months 
206 180 12 months 
Norinyl-L 118 203 117 
188 153 6 months 
200 156 12 months 
Kekki and Nikkila (1971a) Various 17 207 ± 26 64 ± 22 
13 193 ± 61~ 98 ± 32 
Rossner et al (1971) Anconcene 12 186 ± 6 81 ± 8 
209 ± 10 150 ± 10 
Stokes and Wynn (1971) Various: 179 ± 351 68 ± 231 191 ± 39
1 
50 µg oestrogen 116 256 
97 ± 35 
100 µg oestrogen 
163 ± 32 1 47 ± 12
1 
204 197 ± 37 113 ± 35 
Kuku and Akinyanju (1973) Orthonovin 40 100 
205 ± 29 1 109 ± 26 
Ovral 
PROGESTIN ONLY 
Barton et al (1971) Normenon 101 204 130 
211 114 
Glueck et al (1972b) Quinquestanol 21 68 ± 25 
56 ± 30 
*Plasma concentration: mg/100 ml 
1Mean ± S.D. 
2Mean ± S.E.M. 1--' 
w 
TABLE 1. 3 
Plasma Lipoprotein Changes in Women During Treatment with Oral Contraceptive Preparations 
Aurell et al (1966) 
Rossner et al ( 1971) 
Kuku and Akinyanju (1973) 
Preparation 
Anovlar 
Anconcene 
Orthonovin 
Ovral 
Control Period Treatment Period 
Lipoprotein 
Cholesterol* Triglyceride* Cholesterol Triglyceride 
LDL 124 48 151 73 
HDL 60 12 46 18 
VLDL 8 ± 2 38 ± 6** 14 ± 2 65 ± 9 
LDL 100 ± 7 25 ± 3 106 ± 9 43 ± 4 
HDL 67 ± 5 10 ± 2 74 ± 8 34 ± 3 
Percentage distribution 
VLDL 
LDL 
HDL 
10.8 ± 1.2 
64.3 ± 3.8 
24.1 ± 1.7 
*Plasma concentration: mg/100 ml 
**Mean ± S.E.M. 
17.8 ± 2.1 
69.0 ± 4.6 
14.4 ± 1.3 
1--' 
.t::. 
Brand Name 
Anconcene 
Anovlar 
Norinyl-L 
Normenon 
Orthonovin 
Ovral 
Ovulen 
Provest 
"Quinquestanol" 
Volidan 
TABLE 1.4 
Composition of Oral Contraceptive Preparations Used in Plasma Lipid Studies 
Manufacturer Oestrogen Progestigin 
Merck Mestranol 0.1 mg Chlormadinone 
Schering Ethinyl Oestradiol 0.05 mg Norethisterone Acetate 
Syntex Mestranol 0.05 mg Norethisterone Acetate 
Chlormadinone 
Ethnor Mestranol 0.1 mg Norethisterone Acetate 
Wyeth Ethinyl Oestradiol 0.05 mg Norgestrol 
Searle Mestranol 0.1 mg Ethynodiol Acetate 
Upjohn Ethinyl Oestradiol 0. 05 mg Medroxyprogesterone 
-
Quinquestanol 
Allen and Ethinyl Oestradiol 0.05 mg Megestrol Acetate 
Hanburys 
3 mg 
4 mg 
1 mg 
0.5 mg 
2 mg 
0.5 mg 
1 mg 
10 mg 
0.3 mg 
4 mg 
r-' 
V, 
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in terms of its contraceptive properties but not disturbing oth
er 
metabolic processes . Progesterone and testosterone alone gene
rally have 
little effect on plasma triglyceride or cholesterol levels in n
ormal 
subjects (men or women) or in those with moderately raised plasma 
cholesterol levels (Oliver and Boyd, 1956; Svanborg and Vikrot, 1966). 
However, this is not the case with synthetic, orally active an
drogens. 
Glueck et al (1969, 1971a) using the anabolic-androgenic compound, 
Norethindrone acetate, lowered the plasma triglyceride concent
rations of 
normal subjects as well as in patients with familial types III, IV and V 
hyperlipoproteinaemia. This followed the striking fall in plas
ma 
triglycerides in a young woman with familial type V hyperlipopr
oteinaemia, 
who was given the steroid for menstrual irregularity. By cont
rast, ~ 
exogenous oestrogen may severely exacerbate symptoms in a fami
lial type 
V hyperlipoproteinaemia patient (Glueck et al, 1970). 
Other gestational oral contraceptives which have been developed
 
include chlormadinone and quinquestanol acetate. They share th
e properties 
of norethisterone in that there may be a slight reduction in pl
asma 
triglyceride, but cholesterol remains unchanged (Table 1.2). 
2. Possible Mechanisms of Action and Associated Hormonal Cha
nges 
Triglyceride Mei;a,bolism. There are marked differences in triglyceride 
kinetics between men and pre-menopausal women. Nikkila and Ke
kki (1971), 
using norrnolipidaemic subjects, showed that whilst triglyceride turnover 
was the same in both sexes, women had a lower K than men on th
e basis of 
m 
Michaelis-Menton kinetics. That is, at any given level of tri
glyceride 
influx women showed a more efficient removal system (a higher enzyme-
substrate affinity), and therefore a lower plasma triglyceride. Reaven et al 
Q965) hadpreviously shown that triglyceride turnover, as measured by 
the disappearance of labelled plasma triglyceride-fatty acid ma
y obey 
the Michaelis-Menton equation . The sex difference in triglycer
ide kinetics 
also seems to apply in hypertriglyceridaemic subjects (Olefsky et al, 1974). 
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Whil s t the r emov al of triglyceride has yet to be defi
ned as a function of 
one enzyme system, the use of K in this context is 
as a descriptive, 
rn 
conceptua l t erm , and is more properly defined as trig
lyceride concentration 
at half-ma ximal production or r emoval rates . 
Use of combined oral contraceptives doubled plasma tr
iglyceride 
production (Kekki and Nikkila , 1971a; Kissebah et al , 1973), as
 did 
an oestrogen preparation alone (Kissebah et al , 1973). The incre
ase in 
plasma triglyceride concentration was less than pred
icted from a simple 
increase in production (Kekki and Nikkila, 1971a), and was sustai
ned for 
up to 6 weeks after discontinuing steroids. Calculat
ion of the removal 
rate of triglyceride from plasma in the subjects on mixed oral 
contraceptives showed the K to be greatly decreased 
(Kekki and Nikkila, 
rn 
1971a; Kissebah et al, 1973). Clearance of Intralipid, a comme
rcial 
fat emulsion preparation was also increased (Kissebah et al, 197
3). The 
turnover of plasma triglyceride was directly related 
to the length of 
oral contraceptive treatment in both studies. Whils
t oestrogen alone 
increased plasma triglyceride turnover, it did not a
lter the clearance 
rates of endogenous or exogenous triglyceride (Kissebah et al, 1
973). 
However, treatment with rnegestrol or progesterone pr
oduced the opposite 
effect viz: of increased clearance with no change in
 production rate. 
This would account for the observed changes in plasma
 triglyceride with 
the administration of oestrogen and androgen respecti
vely. Oxandrolone, 
an anabolic androgen , also increases VLDL-triglycerid
e turnove r in 
patients with familial type IV hyperlipoproteinaernia
 (Glueck et al , 1973a). 
Post-Heparin Lipolytic Activity (PHLA) . Several reports have been 
published describing marked reduction in PHLA in wom
en on mixed oral 
contraceptives (Hazzard et al, 1969; Harn and Rose, 1969; Adams e
t al , 
1970), or whilst taking oestrogen alone (Hazzard e t al, 1969). T
he 
decrease has been of the order of 30-50% below the no
rmal range and 
comparable with values recorded in familial type I hy
perlipoproteinaernia 
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(Fredrickson et al, 1963), the lipidaemia of uncontrolled diabetes 
{Bagdade et al, 1967) or that occurring in myxoedaema (Porte et al , 1966
). 
PHLA was found to be normal in plasma samples taken 5 minu
tes after 
the injection of heparin, but depressed after 40 minutes in patients 
taking oral contraceptives (Rossner et al, 1971), Kissebah et al (1973
) 
also found PHLA to be normal in women taking oral contrac
eptives, which 
is in keeping with the evidence now available that progest
erones and the 
progestogenic component of oral contraceptives may improv
e clearance of 
circulating triglyceride. The variability in PHLA finding
s may be due 
to the conditions under which the studies were carried out
 and the 
differences in the oral contraceptives. 
Other steroid hormones also affect PHLA. For instance, th
e lowering 
of plasma triglyceride in type V hyperlipoproteinaemic wom
en with 
Norethindrone acetate was accompanied by an increase in PH
LA into the 
normal range (Glueck et al, 1969, 1971a). However, a structurally rela
ted 
progestational oral contraceptive, quinquestanol acetate,
 given to normal 
subjects for one year, did not produce any change in PHLA (Glueck et al, 
1973a). An earlier report showed a slight decrease in plasma triglycer
ide 
(Glueck et al, 1972b) (Table 1.2). Oxandrolone, another anabolic 
androgen, also increased PHLA in patients with familial ty
pe IV 
hyperlipoproteinaemia (Glueck et al, 1971b), with concurrent changes in
 
triglyceride kinetics (Glueck et al, 1973b), but no correlation could b
e 
shown between triglyceride clearance rates and PHLA. 
Insulin~ Glucocorticoids and Growth Hormone. The interrelationship 
between the changes in carbohydrate and lipid metabolism d
uring treatment 
with oral contraceptives has proved extremely complex. An
 increase in 
the fasting level of imrnunoreactive insulin in subjects on oral 
contraceptives has been reported (Spellacy et al, 1967; Yen and Vela, 
1968; Hazzard et al, 1969). The increase of some 40% was attributed t
o 
the oestrogen component, as administration of oestrogen al
one resulted 
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in a similar increment (Hazzard et al , 1969). However, other r eports 
have found the leve l to be unchange d (Javier et al, 1968; Spellacy et 
al , 1968; Wynn and Doar, 1969). Similarly, changes in response to both 
oral and intravenous glucose tests have been at variance, with hi
gher 
insulin levels being found by Spellacy et al (1967, 1968) and Ye n and 
Vela (1968). Some of the differences may be due to the duration of 
treabnent with the steroid preparations, as Javier et al (1968) note d 
that whilst insulin was high during oral glucose tolerance testin
g early 
in treabnent, levels tended to become low after prolonged therapy
. 
Similarly , Wynn and Doar (1969) were able to show higher insulin levels 
in response to oral and intravenous glucose in women who had rece
ntly 
commenced taking oral contraceptives, but no such difference was 
p~esent 
in a second group who had been taking the preparations for a long
er 
period of time (2-72 months). 
Wynn and Doar (1966) have suggested that the impaired glucose 
tolerance associated with use of oraJ contraceptives is in fact a
 "steroid 
diabetes" . Oestrogen therapy , in the dosage used in oral contra
ceptives, 
increases plasma cortisol levels three-fold (Burke , 1969). The increase 
is mainly within the protein-bound fraction, but this does have 
biological activity (Matsui and Plager , 1966) . 
Growth hormone is also reported to be increased during oral 
contraceptive therapy. Levels are raised during treabnent both i
n fasting 
women (Spellacy et al, 1967a) and in response to hypoglycaemic stress 
such as produced by insulin (Spellacy et al, 1967b). This is consistent 
with sex differences in growth hormone levels both at rest and in
 response 
to provocation (e.g . Unger et al, 1965; Merimee et al, 1966). 
C. PLASMA LIPIDS IN THE FOETUS, NEONATE AND YOUNG CHILD 
1 . Plasma Lipid Le vels in the Young Mammalian young are b
orn with 
plasma cholesterol levels lower than those in the adult of the sa
me species. 
A representative sample of these is shown in Table 1 . 5, summarizin
g some 
.. 
TABLE 1.5 
Changes in Plasma Cholesterol and Triglyceride Concentration in the Young Animal 
Carroll (1964) 
Frie&nan and Byers (1961) 
Shope (1929) 
Carroll et al (1973) 
Plasma Lipid Concentration (mg/100 ml) 
Species 
Foetus Newborn Suckling 
Rat Cholesterol 109 ( 99-127) 
Rabbit Cholesterol 102 121 258 
(82-173) (62-178) (127-4 78) 
(n=l3) (n=3 3) (n=6) 
Triglyceride 50 259 167 
(34-118) (42-584) ( 54-494) 
Guinea-Pig Cholesterol 65
2 2312 
Calf Cholesterol <25 ::::100 
(n=6) (n=6 ) 
Lamb Cholesterol 50 :::: 70 (n=6 ) (n=6 ) 
Pig Cholesterol 50 135 (n=ll) (n=ll) 
1From "Blood and Other Body Fluids" (1961) ed. D.S. Dittmer 
2Guinea-pigs: mean value of 4-8 animals 
Weanling 
71 
(59-80 ) 
51 
(37-104) 
(n=l4) 
73 
(23-194) 
632 
::::so 
(n=6 ) 
::::40 
(n=6 ) 
70-100 
(n=ll) 
Adultl 
52 
( 28-76) 
45 
( 10-80 ) 
32 
( 21-43 ) 
110 
( 8-212) 
(152-154) 
l'v 
0 
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of the published values f o r various species . The changes which occur 
in the young with increasing age are also shown . The human is no 
exception to this rule, but the pattern of subsequent change with growth
 
is at slight variance with other species . Some values published during 
the l ast 15 years have been chosen to illustrate this point (Tables 1.6 
and 1.7). 
Experimental Animals . All animals illustrated in Table 1.5 develop 
hypercholesterolaemia when they are suckling. The plasma levels increa
se 
rapidly after birth, so that most species show significant changes withi
n 
the first week. The levels may continue to rise over successive weeks 
(e.g. Carroll et al , 1973) and/or remain at a plateau until weaning takes 
place. The association of weaning with the diminution in plasma 
choleste rol levels has led many to search for and implicate dietary 
components as responsible for the changes. For instance, Shope (1929), 
in reporting the hypercholesterolaernia in the suckling animal, considere
d 
that the cholesterol content of colostrum was responsible. Evidence for
 
the role of dietary cholesterol comes from supplementation experiments, 
such as the hypercholesterolaemia in calves that was aggravated when 
cholesterol was added to milk (Wiggers et al, 1971). Friedman and Byers 
(1961) demonstrated the importance of both milk fat and cholesterol in 
raising the suckling rabbit's plasma cholesterol. The suckling rat 
reacts slightly differently, in that milk fat alone will produce 
hypercholesterolaemia (Harris et al, 1966). This suckling animal is 
also interesting in that its cholesterol does not fall with the addition
 
of ethyl linoleate, though a fall occurs when residual bulk, in the form
 
of cellulose, is added to the diet. 
The effect of the combination of some or all of these factors may 
be seen in early or delayed weaning of pigs: those animals that have no
 
access to solid food prior to weaning show an abrupt fall in the plasma 
cholesterol level on weaning, whereas piglets that during suckling have 
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early access to the mother's f eed show a fall i n plasma cholesterol 
l e vels before weaning (Carroll et al , 1973). The same authors compared 
the response of calves fed whole milk or skim milk. The plasma 
cholesterol of the latter group decreased rapidly on commencing skim 
milk, but afte r weaning the levels in the two groups converged, so that 
no significant difference could be seen . 
The Human Infant: Perinatal Observations . The plasma cholesterol and 
triglyceride l evels of the human neonate are considerably lower than in 
the adult. Some published values are shown in Table 1.6. The mean 
cholesterol values at birth lie between 62 and 95 mg/100 ml in normal 
infants, whilst the triglyceride values range from 32 to 69 mg/100 ml. 
Few factors have been shown to affect the cholesterol level at 
birth. Sex may be an influence, female neonates having significantly 
higher cholesterol levels than males in 2 of the studies shown in the table 
(Barnes et al , 1972; Darrnady et al, 1972). It has been suggested that 
infants born to diabetic mothers have higher plasma cholesterols than 
healthy babies; both studies to date are of small numbers. Mortimer 
(1964) and Pantelakis et al (1964a ) showed that the cholesterol level 
tended to be higher in the infant born to a diabetic mother who had been 
treated with insulin throughout pregnancy, and even higher when the women 
were not treated with insulin (Table 1.6). Race appears to be of little 
importance, the New Guinean and Australian babies having similar 
cholesterol levels (Whyte and Yee, 1958), as did white and negro babies 
described by Glueck et al (1971). Maternal diet was also of no · importance. 
Other factors which have bee n found unimportant are the maternal plasma 
cholesterol at the time of delivery (Kaplan and Lee , 1965; Zee, 1968; 
Glueck et al , 1971; Barnes et al, 1972) and the infant's birth weight 
(Brody and Carlson, 1 962 ; Barnes et al , 1972). 
The possibility that strong genetic influences may b e detected at 
birth has received a great deal of attention, particularly in the field 
TABLE 1.6 
Plasma Cholesterol and Triglyceride Concentrations at Birth and During Infancy in the Human 
Plasma lipid concentration 
(mg/100 ml) (mean ± S . D . ) (n) 
Cord Blood First Week 3-6 weeks 12 months 
Barnes et al (1972) Cholesterol 76 ± 19 (747) 1 
Triglyceride 52 ± 18 (7 4 7) 
Darmady et al (1972) Cholesterol 78 ± 23 (302) 2 155 ± 31 (300) 155 ± 31 (257) 191 ± 36 ( 273) 
Glueck et al (1971) Cholesterol 64 ± 19(1800)3 
Tsang et al (1974b) Cholesterol 61 ± 11 ( 32) 131 ± 33 ( 32) 
Cholesterol 136 ± 47 ( 12)! 237 ± 59 ( 12) 
Cholesterol 116 ± 21 ( 30) 164 ± 17 ( 30) 
Cholesterol 95 ( 74) 6 161 ( 74) Zee (1968) Cholesterol 62 ± 19 ( 10) ng change 
Triglyceride 32 ± 15 ( 10) 60 
Kaplan and Lee (1965) Cholesterol 95 ± 18 ( 50) 140 7 
Triglyceride 34 ± 14 ( 50)8 92 7 
Mortimer (1964) Cholesterol 75 ± 25 ( 20) 
Cholesterol 105 ± 63 ( 13): 
Pantelakis et al (1964a) Cholesterol 71 ± 13 ( 5 ) 
Cholesterol 83 ± '2 3 ( 20) 9 
Cholesterol 110 ± 30 ( 11) 10 
( 20)11 McKerrow (1961, 1962) Cholesterol 77 (232) 191 ± 44 
Sweeney et al (1961) Cholesterol 75 ± 4 ( 21)* 136 ± 5 ( 10)* 
Triglyceride 69 ± 5 ( 21 )* 183 ± 25 ( 10) * 
Whyte and Yee (1958) Cholesterol 70 ± .19. ( 25) i; 145 ± 40 ( 6 ) 
Cholesterol ·68 ± 17 · ( ·13) · .. . . . . . .. . . . ' . . . . . . . .. 151 ± 37 ( 6) 
*Mean ± S .E .M. (n) 
1 Females, 79 ± 20; males, 74 ± 18 (p <.001) 
2 Females, 81 ± 25; males, 76 ± 22 (p <.05) 
Caucasion and Negro babies 
3Norrnolipidaemic infants at birth with norrnolipidaemic parents 
4Hypercholesterolaemic infant at birth with hypercholesterolaemic parent 
5Hypercholesterolaemic infant at birth with norrnolipidaemic parents 
All infants 
6 At 10 hours postpartum 
7 At 3 days of age 
8 Infants born to normal mothers 
9 rnfants born to diabetic mothers receiving insulin 
10rnfants born to diabetics not receiving insulin and to pre-diabetics 
8. vs 10. p = 0.001 
11Breast-fed infants only 
12 . ( 1 · ) . f Caucasion Austra ian in ants 
13 . . New Guinea natives 
N 
w 
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of the inheritence of Type II hypercholesterolaemia, a dise
ase which 
follows best a monogenic pattern of autosomal dominance (Fredrickson and
 
Levy, 1972). Early detection of babies inheriting Type II disease 
should allow prophylactic treatment to be instituted early
. The 
significance and reliability of cord blood lipid levels as
 a predictor 
of inheritence will be discussed later. The large America
n series 
(Glue ck et al, 1971) of 1800 births allowed an analysis of the 
distribution of cord cholesterol to be made. It did not c
onform to a 
single normal (Gaussian) distribution, and fitted best 2 overlapping 
normal distributions. Small subsets of the original data 
are included 
in Table 1.6 showing the difference in response with time o
f 3 groups of 
infants according to their initial umbilical cord blood re
cording and 
their family history of hypercholesterolaemia. 
The mean cord plasma triglyceride is lower than in the adu
lt 
(Table 1.6). The distribution is markedly skewed to the right (Barnes 
et al, 1972), and may be corrected to a normal distribution by expressi
ng 
the values logarithmically. A similar distribution and co
rrection was 
described by Brody and Carlson (1962). Recently there has been increas
ed 
awareness of the value of monitoring physiological and bio
chemical 
parameters during labour and immediately after delivery. 
This has 
emphasized the influence of perinatal environmental factor
s upon the 
infant, and a recent report (Tsang et al, 1974a) presents a strong 
association between perinatal events, particularly foeto-m
aternal 
problems, and cord triglyceride levels. Further evidence 
for this will 
be presented within this thesis. 
There are few systematic studies of plasma triglyceride ch
anges 
with age in infancy. Zee (1968) has reported little change in the 
triglyceride concentration from birth until about 9 hours p
ost parturn, 
when there was an apparent rapid doubling in normal babies
 that had 
received neither food nor water. Plasma choles terol did n
ot change . 
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Plasma free fatty acids, low at birth, rise rapidly in the neonatal 
period, reaching maximal levels at 6-12 hours post parturn (van Duyne and 
Havel, 1959). Concurrently with the increase in free fatty acid there 
is a reciprocal decrease in blood glucose (Chen et al, 1965). 
Administration of glucose in vivo will prevent the rise of free fatty 
acid (Novak et al, 1961). In vitro studies with neonatal adipose tissue 
show inhibition by glucose of free fatty acid release after 15 hours of 
age (Novak et al , 1965). The rise in plasma triglyceride 9 hours post 
partllltl may result from increased hepatic triglyceride synthesis secondary 
to fatty acid mobilization (Havel, 1961). 
The major increase in plasma cholesterol concentration occurs in the 
first week and subsequent increases are relatively smaller. For instance, 
in the group of children studied by Darrnady et al (1972), the cord blood 
cholesterol showed a doubling within the first week of life but subsequently 
rose only a further 13% during the first year. The plasma cholesterol 
concentration at one year is approximately 2 to 3 times that at birth. 
In the sample shown in Table 1.6 this relationship holds for the 
hypercholesterolaemic children as well (Tsang et al, 1974b). 
The plasma cholesterol concentration may increase slowly during 
childhood and adolescence in Western Society (Table 1.7: Whyte and Yee, 
1958; Hames and Greenberg, 1961; Godfrey et al, 1972; Friedman and 
Goldberg, 1973). A recent study of 613 school boys aged 11 to 18 years 
showed the plasma cholesterol decreased with age while plasma triglyceride 
increased (Hickie et al, 1974). Within Western Society there is no racial 
difference to be seen; the children in the white and non-white groups 
in Evans County have similar plasma cholesterol levels (Hames and 
Greenberg, 1961). There is a tendency for female adolescents to have 
slightly higher plasma cholesterol levels than males (Fredrickson et al, 
1967; Godfrey et al, 1972). Of interest, is the contrast between the 
two populations studied by Whyte and Yee (1958): the Australian group 
TABLE 1.7 
Plasma Cholesterol and Triglyceride Concentrations During Childhood and Adolescence* 
6-10 years 11-15 years 16-20 years 
- · 
Whyte and Yee (1958) Cholesterol 164 ± 35 ( 13) 186 ± 50 ( 15) 185 ± 33 ( 18) 1 
Cholesterol 141 ± 29 ( 24) 134 ± 38 ( 21) 122 ± 40 ( 20) 2 Hames and Greenberg (1961) Cholesterol 167 (166) 182 (198) 188 ( 80) 3 
Cholesterol 166 ( 143) 182 (184) 186 ( 66) 4 
Cholesterol 166 ( 85) 179 (104) 188 ( 37) 5 
Cholesterol 168 ( 92) 187 (110) 195 ( 47) 6 Wiese et al (1966) Cholesterol 157 ± 27 ( 45) 172 ± 22 ( 6) 
Fredrickson et al (1967) Cholesterol 172 ± 34 ( 43); 
Triglyceride 61 ± 34 ( 43) 
Cholesterol 179 ± 33 ( 38): 
Triglyceride 73 ± 34 { 38) 
Lopez-s et al {1967) Cholesterol 
~160 9 . 15510 29 
(1164) Godfrey et al (1972) Cholestero l (600 ) ~110 (728) ~1so11 ( 97) Cholesterol ~1659 
~16513 ~110 Friedman and Goldberg {1973a) Cholesterol ~15012 
~158 
Court et al (1974) Cholesterol 183 ± 40 ( 45) 14 
Triglyceride 73 ± 25 ( 45) 14 
Cholesterol 195 ± 47 (129)~~ 
Triglyceride 77 ± 41 (129) 
( 613) 16 Hickie et al (1974) Cholestero l 200 ± 33 
Triglyceride 
179 ± .27 ( 95) 17 
63 ± 42 ( 613) 16 Wilmore and McNamara (1974) Cholesterol 
Triglyceride 61 ± 38 { 95) 
*Plasma lipid concentration: mg/100 ml (mean± S.D.) 
1 1· . Austra 1an Caucasian 
2 G . t· New uinea na 1ves 
3Wh. 1 te: male 
4Wh. 1 te: female 
5 h' Non-w ite: male 
6Non-white: female 
7 Males: 0-19 years of age 
8 Females: 0-19 years of age 
9 d. Me ian 
10 Females 
11 Males 
12 7 months to 8 years of age 
13 9 years to 19 years of age 
14Normal children: 2-17 years of age 
15
obese children: 2-17 years of age 
16 Males: 11-18 years of age 
17 Males: 8-12 years of age 
t\.) 
(j\ 
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shows the increase in plasma cholesterol cormnon to the society from which 
it was drawn, whereas the New Guinea group shows a steady decrease in 
plasma cholesterol from the age of one year (Table 1.6) to young 
adulthood. The die t and way of life of the two populations after weaning 
are vas tly different: the diet of the Australian containing much 
cholesterol and being r elatively high in fat, whilst that of the New 
Guineans is rich in carbohydrate and low in fat. The triglyceride levels , 
not shown here , also reflect this difference in eating habits. This 
indicates that the increase in plasma cholestero l with age seen in 
. Western Society and the concurrent increase in arteriosclerotic disease 
is not an inevitable part of aging. 
Lipoprotein Distribution at Bir th and in Infancy. Table 1.8 shows some 
of the more recent published values for lipoprotein distribution at birth 
(part A) and in early infancy (part B). Most of these have been obtained 
by ultracentrifugation combined with lipoprotein-complex precipitation 
using polysaccharides and divalent ions (Hatch and Lees, 1968). They 
compare well with percentage distributions obtained by lipoprotein 
electrophoresis. 
There is very little cholesterol present in VLDL at birth, with the 
bulk being distributed between LDL and HDL . The ratio between HDL and 
LDL in cord blood is of the order 4 to 3 in most reports apart from 
Glueck et al (1971): the LDL value quoted in that study contains VLDL 
plus LDL. With increased production of triglyceride 12 hours postpartum, 
there is an increase in VLDL levels (Zee, 1968) and within the first 24 
hours, LDL increases also (Abrams and Freeman, 1969). HDL has been found 
to increase 25 % in the first week of life, and only slowly thereafter 
(Abrams and Freeman , 1969; Studd et al , 1970). Dietary cholesterol a nd 
fatty acid composition of milk formulas have been shown to influence the 
levels of cholesterol and lipoproteins in the infant (Table 1.9). 
TABLE 1.8 
Distribution of Plasma Lipoproteins and Lipids at Birth and During Infancy 
n 
VLDL 
Plasma lipid or protein concentration 
(mg/100 ml) 
LDL HDL 
A. AT BIRTH IN UMBILICAL CORD PLASMA 
Glueck et al (1973) 1 
1 
Greten/Schettler (1973) 1 
Kwiterovich et al (1973) 
(1971) 2 3 Glueck et al 
Wille and Phillips (1971) 
Sweeney et al (1962)4 
Cholesterol 39 4 ± 9* 26 ± 13 
Triglyceride 
Cholesterol 1323 35 ± 12 
Cholesterol 36 6 ± 4 31 ± 6 
Triglyceride 
Cholesterol 596 37 ± 21 
Protein 12 24 ± 12 
Protein 19 
Cholesterol 
*Mean± S.D. apart from 
**Mean± S.E.M. 
58 ± 15 
59.6 ± 3.1% 
Method of Separation: 
1ultracentrifugation and precipitation 
2 . . . Precipitation 
3Agarose gel electrophoresis 
4Paper electrophoresis 
36 ± 11 
37 ± 8 
32 ± 11 
81 ± 43 
40.4 ± 3.1% 
Total 
71 ± 15 
33 ± 47 
60 ± 20 
74 ± 8 
37 ± 15 
75 ± 3** 
Continued 
N 
(X) 
B. DURING INFANCY 
Greten/Schettler (1973) l Cholesterol2 
Fredrickson et al (196 7) Cholesterol 
Triglyceride 
Cholesterol3 
(1962) 4 
Triglyceride 
Sweeney et al Protein 
Cholesterol 
TABLE 1.8 
(Continued) 
n 
Plasma lipid or protein concentration 
(mg/100 ml) 
VLDL 
126 
43 9 ± 7 
38 11 ± 8 
9 
*Mean± S.D. apart from 
**Mean± S.E.M. 
Age: 
1 1 year of age 
LDL 
113 ± 33 
108 ± 33 
108 ± 10 
69.4 ± 4.9% 
2 Males: 0-19 years of age 
3 Females: 0-19 years of age 
4 6-8 weeks of age 
HDL Total 
49 ± 11 172 ± 34 
61 ± 34 
53 ± 12 179 ± 33 
73 ± 34 
30.6 ± 4.9% 
135 ± 5** 
1') 
I!) 
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2. Diet and Plasma Cholesterol Concentration During the
 Firs t 
Year of Life Numerous short term studies have been underta
ken in the 
young infant demonstrating the effect on plasma cholesterol leve
ls of 
different milks. Some of these studies are summarized in Table 
1 . 9 . 
They show mainly the effect of fatty acid composition of differe
nt 
formulae. The studies are not strictly comparable in terms of e
ither the 
age of the children or the composition of formulae. 
Diet is a very important determinant of the plasma cholesterol l
evel 
during infancy. Comparing groups at any age during the first ye
ar, there 
is a marked difference in the levels found in infants consuming 
evaporated 
cow's milk products and milk products to which vegetable oils ha
ve been 
added. The plasma cholesterol level is generally reciprocally r
elated to 
the level of linoleic acid in the milk, i.e., the higher the lev
el of 
linoleic acid, and the higher the ratio of polyunsaturated to sa
turated 
fatty acids, the lower the plasma cholesterol of the group. From
 most of 
the studies in Table 1.9, it is not possible to draw any conclusi
ons 
about the relative importance of cholesterol in the products. A
s pointed 
out by Tsang et al (1974b) it is often very difficult to separate the 
effect of cholesterol and fatty acid in analyzing dietary effect
s, since 
diets low in cholesterol generally also contain vegetable oils. 
Although human milk has a higher linoleic acid content than cow's
 
milk, the majority of studies comparing the two demonstrate either very 
similar plasma cholesterol levels in the infants, or even a hig
her l e v el 
in the breast-fed children. One exception to this (Gyorgy et al , 1963) 
is a study in premature infants in whom human milk led to lower 
plasma 
cholesterol values than feeding with evaporated cow's milk. How
ever, the 
former infants had very poor weight gain and were suffering from
 
hypoproteinaemia. Children being fed pooled breast milk to whic
h casein 
had been added had plasma levels very similar to those taking co
w's milk 
and evaporated milk and gaining weight normally. 
Sweeney et al (1961, 1962) 
Lowe et al (1964) 
Fomon and Bartels (1960) 
Gyorgy et al (1963) 6 
Woodruff et al (1964) 
Darmady et al (1972) 
TABLE 1.9 
The Effect of Diet on Plasma Cholesterol Levels During Infancy 
Milk Formula 
Evaporated 
Soya/Coconut 
Milk/Vegetable Oil 
. f 3 Milk+ Butter a 4 
Milk+ corn Oil 
Human Milk 
Cow's Milk 
Milk/Vegetable Oil 
Soya/Vegetable Oil 
7 Lactum7 
S .M .A 7 Sobee 
Human Milk 
Cow's Milk 
Human Milk 
Evaporated Milk 
7 S.M.A. 
Human Milk 
Cow's Milk 
Linoleic 
Acid* 
1.2% 
39.2% 
30% 
8% 
4% 
30% 
46% 
10.5% 
2.6% 
~20% 
1 6-8 weeks 
136 ± 5 ( 10) 2 
89 ± 5 ( 10) 
88 ± 4 ( 9) 
8 weeks 
142 ± 235 
117 ± 31 
3-5 weeks 2 
144 ± 4 ( 95) 
104 ± 3 ( 77) 
99 ± 5 ( 25) 
106 ± 7 ( 8) 
111 ± 3 
6 weeks 2 
159 ± 9 ( 22) 
156 ± 5 ( 21) 
6 weeks 
129 ± 27 ( 19) 5 
175 ± 29 ( 24) 
158 ± 26 (148) 
Plasma Concentration 
(mg/100 ml) 
16 weeks 
143 ± 29 
114 ± 35 
1 week-6 month3 
172 ± 42 ( 21) 
156 ± 56 ( 8) 
144 ± 43 ( 30) 
108 ± 27 ( 5) 
9-13 weeks 
145 ± 3 ( 6 7) 
112 ± 4 ( 72) 
122 ± 6 ( 26)8 
117 ± 6 ( 12) 
119 ± 4 
3 months 
145 ( 5) 
155 ± 7 ( 19) 
4 months 
149 ± 30 ( 31) 
196 ± 30 ( 15) 
190 ± 33 (199) 
21-25 weeks 
163 ± 7 ( 41) 
129 ± 4 ( 42) 
139 ± 8 (14) 
148 ± 6 
6 months 
163 ( 2) 
146 ± 20 (13) 
12 months 
147 (7) 
134 ± 11 (9) 
Continued 
w 
I-' 
Tsang et al (1974b) 
Milk Formula 
Low Cholesterol 
9 
Moderate/High10 
Cholesterol 
TABLE 1.9 
(Continued) 
Linoleic 
Acid* 
Birth 
66 ± 44 
138 ± 37 
61 ± 11 
136 ± 47 
( 
( 
( 
( 
10) 5 
5) 
32) 
12) 
*When concentration included in the report. 
1Age of infants 
2Mean ± S .B .M. (n) 
3Butterfat = 51% of calories 
4 
· 1 5 ' Corn Oi = 2% of calories 
5 Me an ± S . D • ( n) 
6 . f Premature in ants 
7 
. 1 'lk . Cornrnercia mi preparations 
8Poor weight gain and hypoproteinaemic 
9 100-300 mg cholesterol/day and P/S ~ 1.5:1 
10 500-1000 mg cholesterol/day and P/S ~ 0.4:1 
Plasma Concentration 
(mg/100 ml) 
12 months 
135 ± 19 
161 ± 27 
131 ± 33 
233 ± 59 
w 
(\.) 
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The importance of diet in determining plasma cholesterol levels 
during infancy is illustrated by the results of Tsang and his colleagues 
(1974b) (Table 1.9). This compares infants who were normo-
cholesterolaemi c and hypercholesterolaemic at birth. At 12 months of ag
e 
both groups had similar cholesterol l e v els when on a low cholesterol , 
high P/S ratio die t. Only when challenged with a high cholesterol, low 
P/S ratio diet did the genetic trait show. 
Reservations on the Early Use of Diet . The hurnan infant responds rapidly 
to changes in the saturation of dietary fatty acids. Pomeranze et al 
(1958) studied 3 infants for 15 to 31 weeks, alternating feeding periods 
of evaporated milk and corn oil-supplemented milk. The plasma cholester
ol 
levels rose and fell. They noted also that infants placed on a soy milk 
preparation from birth did not show the expected increase in plasma 
cholesterol concentration after birth. Concern has been expressed 
regarding long term exposure to low cholesterol or high P/S ratio diets.
 
It has been feared by some that inadequate exposure to cholesterol in 
early infancy or childhood may prevent the child from responding 
appropriately to dietary cholesterol later in life (Fomon, 1971). The 
argument is, that low cholesterol diets early in life would be 
detrimental and achieve the opposite of that desired, namely 
hypercholesterolaemia later in life. This has received support from som
e 
animal experimentation conducted in rats and pigs. Kubat (1966) weaned 
rats at 18 and 30 days with a high fat, low cholesterol diet. Serum 
cholesterol levels at 10 months revealed no difference, but following 
exposure to a cholesterol-rich diet for 2
1
;2 months, the serum cholesterol 
was higher in the group weaned early. Further experiments in rats by 
Reiser and Sidelrnan (1972) manipulated the maternal diet to raise the 
cholesterol concentration of the rat's milk (from a "normal" 24 mg/100 ml 
to 40 mg/100 ml). Suckling, with access to the maternal feed, was 
allowed for 30 days post parturn, following which a low cholesterol, 10% 
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stripped lard diet was instituted . At 60 days, the animals we r e challeng
ed 
with 0.5 % cholestero l in lard. Among the male rats, the r esultant sermn 
cholesterol was inversely related to their dam's milk cholesterol 
concentration. The authors attributed the r esults to the presence of 
dietary cholesterol from early in life , which primed the negative feedba
ck 
mechanism. Howe v e r there is no data about the fatty acid compositions 
of the milks, and the young had free access to the maternal diet. They 
conside red the presence of another inhibitor of cholesterol synthesis 
in rat milk most unlikely. However, such an agent does appear to exist,
 
in both rat milk, cow's milk and human milk (McNamara et al, 1972; 
Boguslawski and Wrobel , 1974). Evidence for a possible need for early 
exposure to cholesterol comes from another study by Reiser (1971) in 
which small groups of pigs were given low (1.4 mg/100 ml) or high 
(115 mg/100 ml) cholesterol diets whilst suckling. Subsequent challenge 
with high cholesterol diets resulted in higher plasma cholesterol levels
 
in those previously fed small amounts of cholesterol. 
Considering the human infant, the response as seen in plasma 
cholesterol levels at 12 months of age does not seem to be affected by 
the dietary intake of cholesterol during the first 6 months of life 
(Glueck et al , 1972). The response was similar among normocholesterolaemic 
and hypercholeste rolaemic infants. However, long term follow-up will be
 
necessary to determine with certainty the long term effect of low 
cholesterol, high P/S ratio diets in ensuring an adequate feedback 
mechanism to dietary cholesterol in adulthood. In view of the widesprea
d 
use of commercial milk formulae containing lower amounts of cholesterol
 
and higher P/S ratios than are present in human or cow's milk, this 
subject should be kept under review. A preliminary report states that 
no long term differences in sermn cholesterol could be detected in 
adolescents aged 15-19 years who had been breast-fed or artificially-fed 
on low cholesterol milk formulae (Friedman and Goldberg, 1973b). This 
35 
study did however find that the breast-fed children had higher chole ster
ol 
levels at 2 years of age, 20 months after having been weaned on a skim 
milk , "generally low" cholesterol and saturated fat diet. 
Another area of concern associated with the feeding of artificial 
linoleate enriched diets has been the effect on growth, development 
and maturation of the central nervous system. In the human infant, the 
brain is relatively inunature at birth; further growth and myelination 
occurs at a high rate in the first few months of life. Cholesterol is 
an essential component of membrane structure. Animal experimentation 
however has demonstrated that whilst preformed, and therefore dietary, 
cholesterol can be incorporated into brain sterols, this occurs only at 
• 
relatively slow rates. Most of the CNS cholesterol is derived from in 
situ biosynthesis, an efficient precursor for which is glucose. Specific 
examples of this work include that by Morris and Chaikoff (1961) in 
neonatal rats, to whose mothers labelled-cholesterol had been administer
ed 
pre- and post-partum, and by Chevallier (1965) , who demonstrated minimal 
contributions from exogenous cholesterol to the brain in the neonate. 
Numerous other studies are discussed in relation to brain cholesterol 
synthesis and turnover in Kabara's review (1965) . 
Changes in the total fat content or fat composition of milk have 
also been raised as areas for caution in infant nutrition. The total 
fat requirement in the infant diet has not been defined (Schubert, 1973). 
In human milk some 50% of the calories are derived from fat. The anxiety
 
regarding reduction of total fat in infancy is again based on animal 
experimentation. Rats, weaned early and therefore receiving fewer 
calories from fat, suffer from defects in conditioned reflexes and 
learning behaviour as adults (Novakova, 1966). No comparable human data 
is available. The composition of fat in terms of individual fatty acids
 
is important. Linoleic acid deficiency is well documented in human 
infants and a minimal requirement equivalent to 1 percent of the total 
calories, and optimally 4.5 percent, has been determined (Combes et al, 
1962). These values are comparable to the levels of linoleic acid in 
human milk. The desirability of increasing the polyunsaturated 
fatty 
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acid content of foods in infancy has also been questioned. Huma
n infants, 
particularly premature infants, have low levels of vitamin E, du
e to 
limited placental transfer (Wright et al, 1951), and it has been shown 
that polyunsaturated fatty acid rich formulae increase the requir
ements 
for vitamin E in the premature baby (Hassan et al, 1966). Symptoms do 
not appear in healthy full-term infants. Supplementation of the
 
cormnercially available formulae with a-tocopherol has been instit
uted. 
A short-term study of children aged 5-21 years, with familial typ
e II 
hypercholesterolaemia, during which treatment with diet and chol
estyramine 
was instituted, showed that neither was an inunediate threat to 
maintenance of adequate vitamen E levels in the blood (Glueck et al, 1974). 
In defence of the low cholesterol, higher P/S ratio diet of infa
ncy, 
it must be said that to date there is no evidence of any harmful
 effects. 
In terms of positive benefit to a population at risk the potenti
al has 
yet to be proven. However, in all studies to date, infants usin
g 
conunercial formulae grow well and develop normally during infanc
y and 
childhood (Fomon and Bartels, 1960; Sweeney et al , 1961; Fomon et al, 
1970). Similarly, children participating in a long term trial of 
treatment at the University of Arizona have shown no distinguish
ing 
features from the remainder of the population in parameters of g
rowth and 
development or illness (Goldberg and Friedman, 1973). 
D. THE SECRETION OF MILK 
The following section on milk secretion will describe the functi
ons 
of the manunary gland. This includes derivation of the substrate
s from 
plasma , such as fatty acids, the processes by which the gland 
concentrates the substrates and converts them into products such
 as 
triglycerides, and finally the mechanisms for excreting the prod
ucts 
from the cell into the alveolus. Emphasis will be placed on the
 process 
of fat secretion, fat being the constituent of major interest in the 
dietary studies to be discussed later in the thesis. 
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Lactation may be divided into two physiological entities: the 
first, lactogenesis or the initiation of milk secretion, and the second , 
gelactopoiesis , which is the maintenance of milk secretion . The type o
f 
milk produced during the periods differs quite markedly, colostrrnn being
 
secreted within the fir s t 5-6 days post partrnn in the human, with a 
transitional p roduct preceding mature milk. The interplay of contributin
g 
factors, particularly hormonal, that occur pre-partum and post-partum 
and which result in milk secretion have been sununarized by Baldwin (1969) 
in terms of 3 interrelated events which occur almost simultaneously. As
 
he sees it, there is 
(1) the formation of functionally differentiated secretory cells, 
(2) the development of characteristic enzyme complements, which 
have the ability to synthesize milk components, and 
(3) the regulation of the capacity for milk synthesis by substrate 
availability, hormonal interaction and demand. 
1. Cellular Morphology of the Alveolar Cells and the Secretion of Mil
k 
The alveolar cells are variable in size and shape, depending upon the 
stage of secretion (Richardson, 1947; Folley, 1952). The changing 
morphology is related to the two major stages of milk secretion. Emptying 
of the gland is dependent up::>n either suckling or milking, and this 
defines both the beginning and the end of a milk secretion cycle. At 
the beginning, the secretory phase, the cells are tall and colrnnnar, wit
h 
the alveolar epithelium folded into the lumen. As milk collects in the 
alveoli, the cells become stretched. 
During the secretory phase, the cell nucleus moves away from the 
base of the cell and striations appear (Grynfellt, 1936). These have 
been likene d to the ergastoplasmic filaments of secretory cells as 
described by Limon (1902) and give positive cytochemical reactions of RNA 
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(Verne, 1951; Vendrely, 1951). The nucleus itself changes also, with 
an increase in the number of vesicles and movement of its chromatin to 
the periphery (Bourne, 1952). 
The formation of lipid inclusions in the basal part of the alveolar 
cells and their subsequent coalescence was described as early as the 
mid-nineteenth century, by Koelliker (1852) and Virchow (1858). The 
association of the lipid inclusions with a cellular organelle, the 
mitochondrion, was first noted by Hoven (1911). Lipid droplets have been 
detected in alveolar cells early in pregnancy in rabbits (Uggeri, 1939). 
In the rat, sudanophil droplets in the alveolar cells and lumen 
immediately preceded the secretion of colostrum (Dempsey et al, 1947). 
In the secretion phase of mature milk, migration of lipid droplets 
occurs from base to apex in the alveolar cells of the rat (Dempsey et al, 
1947). The synthesis of fat is believed to take place in the rough 
endoplasmic reticulum of the cell. For instance, Stein and Stein (1967) 
using autoradiography combined with electromicroscopy, demonstrated that
 
fatty acid esterification into glycerides takes place here, and in situ 
aggregation of lipid then occurs with the appearance of fat droplets. 
The secretion phase is succeeded by one of cellular excretion, 
which results in distension of the alveoli. Grynfellt (1936) described 
colostral excretion as follows: 
a thickening of the apical membrane of the alveolar 
cell preceeds a change in shape of the membrane, firstly 
hemispherical convex to the lumen and then clubshaped; 
contained within the super-apical club, the collection 
of material, lipid and/or protein . The base of the club 
finally breaks, and the club and its contents become part 
of the lurninal contents. 
Electron microscopy has been used to study milk secretion and 
excretion. Bargmann and Knoop (1959) and Hollmann (1959), using rat and 
mouse mammary tissue, described the excretion of lipid inclusions. The 
globules leave the cell in the form of fat corpuscles surrounded by a . 
cytoplasmic membrane, double in outline and 170-200 i thick. Expulsion 
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occurs by a process of constriction and the cell cytoplasm is never 
expos e d. This process has also been observed in bovine marmnary cells 
in culture (Kinsella and McCarthy, 1968). As the constriction narrows , 
varying amounts of cytoplasm may be entrapped (Stein and Stein , 1967; 
Helmine n and Ericsson, 1968). It has been estimated that 1-5% of fat 
globules in milk may be secreted with cytoplasm attached (Wooding et al 
(1970) . 
The milk-fat globule membrane is derived from the plasmalenuna of 
the alveolar c ell (Patton and Fowkes, 1967), with subsequent rearrangement 
of the membrane constituents to increase its stability (Keenen et aZ , 
1970). A thick layer of adsorbed or bound neutral lipid apparently 
derived from the fat globule accurnulates on the apical plasma membr-an
e 
as the fat globule is enveloped (Keenen et al, 1971). 
Milk protein appears as finely granular material within the Golgi 
apparatus of the cell, having bee n synthesized in the rough endoplasm
ic 
reticulurn. From here the proteins move towards the apex of the cell, 
enclosed in vacuoles along with other cellular products such as lacto
se 
(Keenen et al, 1970). The vacuoles come to rest just below and in 
contact with the plasmalenuna, and finally open outwards (Helminen and 
Ericsson, 1968). These vacuolar membranes may help replace plasmalenuna 
lost during lipid excretion. 
2. Composition of Milk The composition of milk and its variati
on 
in differen t species of mammal, particularly in terms of its nutritive
 
value, has frequently been used as a means of assessing lactation itse
lf. 
The following section will present, mainly in tabular form, some of th
e 
basic compon ents of hurnan milk, compared with the concentration in co
w's 
milk. Many variations exist, not only inter-species, but intra-spe ci
es, 
with individuals producing milk of widely differing composition. Fac
tors 
which may alter both the quality and quantity of milk secrete d have b
een 
enumerated by Macy and Kelly (1961); 
(1) the stage of lactation, 
(2) inherent biochemical and physiological differences, as 
well as psychological contributions, 
(3) the amount and kind of food consmne d, 
(4) environmental conditions, 
(5) disease, 
(6) the size and structure of the mammary gland, 
(7) heredity, and 
(8) the method of sampling. 
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Physically milk is a complex system, at its time of secretion 
consisting of two liquid phases, fat and water, between which are
 divided 
over 40 different compounds. Table 1.10 shows these constituents
 
divided into three main groups, with average values of their major 
components. Dissolved in the fat, within the emulsified part of 
the 
milk, or held at the fat globule surface, are the compounds of G
roup A, 
for instance phospholipids, sterols and fat-soluble vitamins. T
he 
aqueous phase may be subdivided into two categories, once again d
efined 
in physical terms, for it carries in solution compounds such as l
actose 
and in colloidal suspension proteins, whilst the mineral element
s are 
divided between the two. 
Milk Fat . The bulk of lipid in milk is present in fat globules 2-3µ in 
diameter, each globule being surrounded by a membrane whose hydr
ophilic 
surface is responsible for maintaining it in an emulsified state,
 and 
which is considered to offer the contained glycerides some protec
tion 
against lipase activity (Ling, Kon and Porter, 1961). Rearrangement may 
occur in the post-secreted membrane with aging as seen in ultrast
ructural 
studies (Bargmann and Knoop, 1959), particularly apparent loss of 
globule membrane into the milk plasma (Wooding, 1971). At the time of 
secretion, the membrane has the classical trilaminar structure of
 the 
0 
plasma membrane, approximately 90 A thick, of lipid/protein (Patton, 
1973). Little is known to date of the molecular architecture of the 
TABLE 1.10 
Constituents of Human Colostrum and Mature Milk Compared With Cow's Milk 
(values per 100 ml of whole milk) 
A. FAT 
Total, inc. Triglyceride, g 
Fat Soluble Compounds 
Cholesterol, mg 
Phospholipids, mg (phosphorus) 
Caretenofds, µg 
Vitamins 
B. NON-FAT SOLIDS 
Nitrogenous 
Protein - Total, g 
Casein, g 
Albumin 
S Lactoglobulin, 
a Lactalbumin, g 
Serum Albumin, g 
Globulin 
Ser~ Globulin, 
Enzymes 3 
Non-Protein - Total, 
Non-Nitrogenous 
Lactose, 4g 
Vitamins 
g 
g 
mg 
-
x* 
2.9 
27 
2 
112 
2.3 
1.2 
0.3 
0.1 
5.3 
Colostrum 
range** 
Human Milk 
2. 5- 3. 2 
1.5-6.8 
-X 
3.8 
20 
4 
27 
1.1 
0.4 
0.2 
0.3 
0.03 
0.01 
42 
7.0 
Mature 
range 
1.3 -8.3 
0.7 -2.0 
0.14-0.60 
17-60 
5.0 -9.2 
Cow's Milk 
Mature 
X 
3.7 
14 
4 
38 
2.8 
0.2 
0.4 
0.04 
0.1 
21 
4.8 
Continued ~ I-' 
B. NON-FAT SOLIDS (Continued) 
Non-Nitrogenous 
Minerals 
C. WATER 
Calcium, mg 
Potassium, mg 
Sodium, mg 
Chlorine, mg 5 Trace Elements 
Dissolved co2 , o2 , N2 
TABLE 1.10 
-
x* 
31 
74 
48 
91 
(Continued) 
Colostrum 
range** 
Human Milk 
24-66 
66-87 
26-136 
44-101 
*Mean values taken from Table III, p. 275-277, Macy and Kelly (1961). 
**Ranges taken from Table I, p. 268-269, Macy and Kelly (1961). 
1Fat-Soluble Vitamins - A, D, E, K. 
X 
33 
55 
15 
43 
Mature 
range 
17-61 
37-64 
6-44 
9-73 
2Enzymes - many have been identified, e.g. 5'-nucleotidase (Kobylka and Carraway, 1972). 
3Non-Protein Nitrogen - creatine, creatinine, urea, uric acid. 
Cow's Milk 
Mature 
X 
125 
138 
58 
103 
4water-Soluble Vitamins - e.g. Ascorbic acid, Biotin, B6 , B12
, Folic acid, Nicotinic acid, Riboflavin, Th iamine . 
5Trace Elements - e.g. Iron, Copper, Zinc, Iodine, Fluor i ne. 
~ 
N 
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membrane, but it is apparent that many of the marker enzym
es associated 
with the plasma membrane are to be found on the milk fat g
lobule membrane, 
for instance 5'-nucleotidase (Kobylka and Carraway, 1972). 
Milk cholesterol and phospholipid are important structural 
components of membrane. Partition of these chemicals in m
ilk has 
indicated in the cow and goat, that some 60% of the phosph
olipid (Patton 
and Keenan, 1971) and 80-85% of the cholesterol (Patton, 1973) is 
associated with the globule, the remainder occurring in sk
im milk. 
The maJor milk fat is triglyceride. The major fatty acids found 
in human milk are shown in Table 1.11. As many factors ar
e known to 
modify milk fat composition, the figures are only approxim
ations. The 
relative proportions of saturated and unsaturated fatty ac
ids impart 
many of the characteristic physical properties of milk fa
t, such as 
hardness and melting point, which may be important in the 
dairy industry. 
Human milk fat has only traces of fatty acids shorter than
 decanoic, 
whilst the presence of significant amounts of butyric acid
 is 
characteristic of ruminant fat. The unsaturated fatty aci
ds are 
divided according to the number of double bands present, i
nto monoethenoid, 
the main representative being oleic acid, and diethenoid. 
In human milk, 
a considerable portion of the major diethenoid acid, linoleic, remains 
in the cis-cis form, characteristic of the form derived from vegeta
ble 
material, and one of the essential fatty acids for human n
utrition. 
Ruminant milk contains a lower content of linoleic acid, a
nd some of 
this is in the trans-trans and cis-trans forms, probably as a resul
t of 
ruminal isomerization (Scott et al, 1959) . 
3. Synthesis of Milk Fat 
Fatty Acids and Triglyceride. The arterio-venous difference of total 
fatty acids across the perfused cow udder is sufficient to
 account for 
all milk lipid as described by Graham et al (1936). This observation 
has been confirmed for both cow and goat by other workers 
using similar 
TABLE 1.11 
The Fatty Acid Composition of Milk 
Fatty Acid Composition 
(g/100 g fat) 
SATURATED 
Butyric 
Caproic 
Caprylic 
Capric 
Laurie 
Myristic 
Palmitic 
Stearic 
Arachidic 
UNSATURATED 
Decanoic 
Dodecanoic 
Tetradecanoic 
Hexadecanoic 
Oleic 
Octadecadienoic 
Arachidonic 
Human Milk 
Colostrum 
0.2 
0.1 
0.4 
2.2 
1.8 
3.8 
26.2 
8.8 
3.8 
0.2 
0.1 
0.2 
2.4 
36.6 
6.8 
1.7 
10.2 
Mature 
0.4 
0.1 
0.3 
1.7 
5.8 
8.6 
22.6 
7.7 
1.0 
0.1 
0.1 
0.6 
2.9 
36.4 
8.3 
0.8 
4.2 
Cow's Milk 
Mature 
3.1 
1.0 
1.2 
2.6 
2.2 
10.5 
26.3 
13.2 
1.2 
0.2 
0.2 
1.1 
3.1 
32.2 
1.6 
1.0 
1.0 
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t echniques (e . g . Maynard et al , 1938; Shaw et al , 1940). This was the 
culmination of many years during which attempts were made to demonstrate 
a r e lationship between blood and milk lipids. However, whilst the 
quantity was now accounted for, the quality in terms of fatty acid 
composition was not. That fatty acids derived from plasma will appear 
unchanged in milk . was demonstrated using elaidic acid (McConnell and 
Sinclair, 1937) and since then many have shown the ready passage of 
labe lled fre e fatty acid into milk (e.g. Glascock et al, 1956; Annison 
et al, 1957; Bickerstaffe, 1972). 
The high respiratory quotient (RQ) of lactating udder pointed to 
the synthesis of fat from carbohydrate (Graham et al, 1938) and 
Rittenberg and Bloch (1944, 1945) were subsequently able to demonstrate 
13 
synthesis of fatty acids from 1- C acetate in the mammary glands of 
mice. The incorporation of acetate-carbon into the mammary gland of 
pregnant rabbits (Popjak and Beeckmans, 1950) was soon followed by the 
demonstration of labelled short chain fatty acids appearing in goat's 
14 
milk after administration of 1- C acetate (Popjak, French and Folley, 
1951). In vitro studies have demonstrated that both ruminant and rodent 
mammary tissues synthesize fatty acids via the malonyl-CoA pathway, 
using NADPH, most of which is supplied from the pentose cycle (Glock 
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and McLean , 1958; Jones, 1969). The difference in substrate utilization 
in different animals is well documented. The rat is able to incorporate 
glucose-·carbon into fatty acids (Folley and McNaught, 1961; Katz and 
Wals, 1972), whilst the ruminant does not, relying on plasma acetate and 
S-hydroxybutyrate as its prime sources (Folley and McNaught, 1961; Wood 
et al, 1965; Smith, 1971). These differences result in characteristic 
fatty acid patterns, ruminant milk fat having a high proportion of short 
chain acids, i.e. c4-c14 (Garton, 1963). 
The mammary gland, then , has the capacity to extract fatty acid 
from the blood and to synthesize fatty acid from small carbon precursors. 
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What is the relative importance of the two mechanisms? 
Linzell (1968) 
studied the contributions of the two systems in the goat
 and found that 
the animal removed significant quantities of acetate, S-h
ydroxybutyrate, 
free fatty acid and triglyceride from the chylomicron an
d LDL fractions 
of plasma, as well as some free glycerol. All the milk
 fatty acid up 
to and including c14 (myristate), pl
us some 50% of c16 (palmitate) 
was 
exclusively synthesized from acetate and B-hydroxybutyra
te. This 
accounted for 40% by weight of the total milk fatty acids. 
The remainder, 
that is mainly c18 (stearate and o
leate), was taken up directly from 
plasma free fatty acids and triglyceride . This is in ag
reement with the 
findings of Popjak et al (1951b) who found that the goat was unable to 
synthesize fatty acids beyond c 16 . 
The mammary gland extracts from plasma both dietary lipi
d and lipid 
synthesized elsewhere in the body . That non-physiologic
al fatty acids 
may find their way into milk lipids was demonstrated by 
the elaidic acid 
study mentioned earlier (McConnell ahd Sinclair, 1937) . In the same 
year , Aylward et al (1937) found iodized-fat in milk after administering
 
it in food . Using tracer doses of labelled stearic acid
 in the diet, 
Glascock et al (1956) achieved recoveries of up to 60% in cow ' s milk 
and 45% in goat ' s milk, radioactivity being detected as e
arly as 4 hours 
and reaching maximal activity within 23 hours . Thereaft
er the specific 
activity decreased, with a half-life of some 15 days. It w
as calculated 
that a maximum of 27% of the milk fat was derived directly
 from dietary 
fat in these studies provided that labelled stearic acid
 was 
representative of other dietary fatty acids. 
The influence of diet upon the fatty acid composition of
 milk has 
received considerable attention. The first attempt to a
lter human milk 
fat by dietary means was by Thiemich in 1898, during studi
es 
demonstrating changes in the iodine number of milk fat a
fter feeding 
mothers unsaturated fat. Soderhelm (1953), using corn and fish oils, 
was able to increase the diene and higher polyene fatty 
acid contents 
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of milk. In a study designed primarily to investigate fat metab
olism, 
Insull et al (1959) markedly influenced the fatty acid profile in human 
milk by dietary change. With a 40% fat (corn oil) diet, there was a 
5-fold increase in linoleate and linolenate compared to a diet in
 which 
the fat was more saturated. With carbohydrate-rich diets, wheth
er given 
in hypocaloric or hypercaloric amounts, the proportion of long 
chain 
acids (c18) decreased and shorter chain fatty acids (c12 
and c14 ) increased. 
Both Insull et al (1959) and Read et al (1965) who demonstrated similar 
effects with high carbohydrate, low fat diets, considered that t
he c12 
plus c14 
fatty acids reflected intrarnammary synthesis of fat. Changes 
in the fatty acid pattern of milk may also be achieved in animal
s by 
dietary manipulation, particularly in regard to increasing the p
oly-
unsaturated fatty acid content of milk (Parry et al, 1963; Cook et al, 
19 70) . 
In discussing the relative contributions to milk lipid from diet
ary 
and endogenous sources, it was stated that in the goat, signific
ant 
amounts of lipid precursor are derived from the chylomicron and 
LDL 
fractions of plasma (Linzell, 1968). This transfer is brought about by 
lipoprotein-lipase, which increases in mammary tissue during lac
tation 
(McBride and Korn, 1963; Robinson, 1963; Hamosh et al, 1970). The 
release of lipoprotein lipase into venous plasma has been demon
strated 
in the goat (Barry et al , 1963), with resultant hydrolysis of chylomicrons 
(West et al, 1967). With the electron microscope, Schoefl and French 
(1968) demonstrated an initial adhesion of chylomicrons to the 
endothelium of capillaries in mouse mammary tissue, followed by 
their 
engulfment. It has been estimated that up to 50% of chyle leavin
g the 
intestine of the goat may be extracted by the mammary gland (Lascelles 
et al , 1964). 
The site of esterification of fatty acids is the rough endoplasm
ic 
reticulum of mammary alveolar cells (Stein and Stein, 1967). More 
recently it has been demonstrated that a component within the cytosol 
of homogenized pig or goat marmnary tissue will stimulate synthesis 
(Bickerstaffe and Annison, 1971). 
In vi-tro tissue slice and perfusion experiments have indicated 
that the mammary gland itself is not the site of glycerol production 
(Balmain et al , 1953; Dunant et al , 1953; Lauryssens et al, 1957) . 
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In several species , the glycerol moiety as well as the fatty acids 
released by triglyceride hydrolysis is incorporated into milk triglyceride 
(McBride and Korn , 1964c; West et al , 1972). Although glycerokinase 
is present in guinea pig mammary tissue (McBride and Korn, 1964a), the 
2-monoglyceride derived by hydrolysis of plasma triglyceride is probably 
the primary form in which the glyceryl moiety is taken up by the 
alveolar cells, with glycerol itself being released into the bloodstream 
(Scow et al, 1973). In the goat, the incorporation of glycerol into 
milk triglyceride is negligible (Pynadath and Kumar, 1964; West et al, 
1972). Two potential pathways for triglyceride synthesis have been 
demonstrated in the mammary gland in vitro. The first is the 
2-monoglyceride pathway, which was shown to exist in guinea pig mammary 
tissue by McBride and Korn (1964b). This requires prior activation of 
the fatty acid with adenosine triphosphate and coenzyme A, and is siinilar 
to that in intestinal mucosa (Senior, 1964). However, unequivocal 
evidence for this pathway has not been forthcoming (Dimick et al , 1966; 
Patton, 1973; Scow et al , 1973). The second pathway is that utilizing 
a-glycerophosphate (Kennedy, 1957), which is generated by glycolysis or 
the action of glycerol-kinase, which is present in mammary tissue 
(McBride and Korn, 1964a). It is acetylated with 2 moles of fatty acid 
to give 1,2-diacylphosphatidic acid. This, in turn, is converted to a 
diglyceride and finally acylation with a further mole of fatty acid 
results in triglyceride. This system has been demonstrated in vi-tro 
(Pynadath and Kumar, 1964; Kuhn, 1967), but until recently there has 
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been considerable difficulty in identifying the intennedia te 
phosphatidic acid in the gland of the intact animal. Preliminary r esults 
from Patton (1973) report recent success. 
Cholesterol. As with other components of milk, there are two possible 
sources of cholesterol, the plasma and the gland. Cholesterogenesis in 
the mammary gland -has been established with tissue slices, perfusion 
experiments and whole body studies. 
In slices of lactating rat ma:rmnary gland, acetate and mevalonate 
are incorporated into digitonin-precipitable sterols (Clarenberg and 
Chaikoff , 1966). Popjak and his colleagues demonstrated this in the 
whole animal (Popjak and Beeckmans, 1950; Popjak et al, 1951), and the 
perfused udder (Cowie et al, 1951). Incorporation of precursors into 
sterols occurred rapidly following injection of label into the lactating 
goat (Popjak et al, 1951), but since the cholesterol specific activity 
in milk and in plasma were not the same , the results were interpreted 
as showing cholesterol synthesis within the gland. Injecting labelled 
mevalonate into the lactating rat gives rise to labelled cholesterol 
and also triglyceride in milk , maximal activity being detected within 
10 hours of injection (Patton , 1973). 
The contribution of plasma cholesterol to milk has been partly 
resolved by measuring the influx of dietary 
14
c-cholesterol into milk. 
In the rat, Chevallier (1964) found that some 80% of milk cholesterol 
was derived from plasma, and similar figures were published by 
Clarenberg and Chaikoff (1966), (73%), and by Easter (1971), (70%). The 
rats in Chevallier's experiments were maintained on diets containing 
0 . 035% cholesterol, those of Clarenberg et al and Easter on 0.05% and 
0 . 06% cholesterol respectively. Connor and Lin (1967) have examined the 
situation in lactating rabbits and guinea pigs. Labelled cholesterol 
appeared rapidly in milk following administration, becoming maximal 
within 2-5 days of a single dose. In the guinea pigs, a mean value of 35% 
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of the milk cholester o l was derived from plasma , whilst in the r abbit ~ 
it was mostly derived from plasma. Cholesterol may accumulate within 
the rabbit .mammary gland prior to parturition because in animals to 
whom labelled choles terol was fed during gestation, the specific 
activity of the milk on days 1 and 2 after parturition was higher than 
that in plasma at the time of parturition. 
The question arises whether dietary cholesterol can influence the 
milk cholesterol concentration. Clarenberg and Chaikoff (1966) whilst 
studying the origin of rat milk cholesterol, showed that on a 0.05% 
cholesterol diet, 11% of milk cholesterol was derived from the diet at 
isotopic equilibrium, with mammary gland and milk attaining similar 
specific activities. In the guinea pig, the cholesterol content of milk 
responds to changes in dietary cholesterol, an increase of 0.1-0.5% 
cholesterol in the diet resulting in a 2-3 fold increase in milk 
cholesterol, the relative contribution from plasma being increased 2 
fold, i.e. from 35% on a cholesterol~·free diet to 70% on the cholesterol-
containing diet (Connor and Lin, 1967). Reiser and Sidelman (1972) 
increased rat milk cholesterol by altering the dietary fat content, the 
P/S ratio or the cholesterol content. 
To elucidate the way in which cholesterol is secreted into milk, 
it is necessary to examine its distribution within various milk fractions. 
Cholesterol is a major component of cell membranes, including that of the 
milk fat globule. Cholesterol comprises 5.2% of the membrane lipid of the 
bovine globule (Brunner, 1969). Milk from the cow and the goat has 
80-85% of the cholesterol associated with the fat globules (Patton and 
Keenan, 1971; Patton, 1973). The further subdivision of this cholesterol 
into membrane and globule core poses technical and artefactual problems, 
with possible redistribution of the cholesterol during attempts at 
fractionation. The remaining 15-20% of milk cholesterol is found in the 
"skim milk" phase after removal of the fat globules. Some, if not all, 
of the choles t e rol in thi s fract i o n i s undoubtedly ass ocia t ed wi
th the 
membranes found in the fra ction, s ome of wh i c h a r e de rived from 
microvilli s h e d from the alveolar c e ll s urface {Ste wart e t al , 19 72 ), 
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and some i s s h e d from the fat globule membrane by v e siculatio n {Wooding , 
1971) . Choleste rol is pre sent in both its fr e e and este rified forms , 
but the ratios vary wide ly in the literature {e .g. Hua ng a nd Kuks i s , 
1967). The r e is a v e ry rapid turnover of fatty acid in the cholester o l 
ester of whole milk {Ke enan and Patton, 1970), and at l e a s t a portio n 
arises from the plasma membrane of the secreting cell {Keenan and Pa tton, 
1970). 
Easter (1971, 1973) has attempted a model system of cholesterol 
excretion into milk. Following alimentary administration of lab
elled 
cholesterol , 25-50 hours {Easter, 1971) or 2-5 days {Connor and Lin, 1967) 
is required before maximal specific activity is attained in milk
. Easter 
(1971) demonstrated a good precursor-product relationship between serum 
and milk cholesterol with an estimated turnover time of 17-20 ho
urs for 
the movement from serum to milk . On this basis cholesterol is i
ncorporated 
indirectly into milk, being incorporated into the alveolar cell 
membranes 
in a regenerative capacity , the cell membranes of the endoplasmi
c 
reticulum and Golgi apparatus being directly involved in the fer
rying of 
protein and lactose to the luminal surface, and then themselves 
being 
utilized in the milk fat globule membrane (Section 1) . Subsequent 
confirmation of this was obtained by preferential labelling of t
he skim 
milk membrane ma t e rial from radioactive plasma cholesterol, the 
specific 
activity of the forme r exceeding that of the total plasma (Easte r, 1973). 
On the other hand, use of the precursor mevalonate results in la
bel being 
detected in the cholesterol of the milk fat globule fraction, wi
th 
maximal spe cific activity occurring within 10 hours. This imp li
ed direct 
incorporation of endogenously synthesized cholesterol into the m
ilk fat 
globule its e lf during its secretion from the alveolar cell. In 
summary 
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then, Easter has hypothesized that plasma cholesterol is initially 
incorporated into alveolar membranes via cell membrane r egeneration and 
later excreted into milk indirectly , whilst cholesterol which is 
synthesized within the gland is an immediate component of the milk fat 
globule itself. 
Phospholipid. The third lipid component of milk to be considered is 
phospholipid . It comprises 20.4% of bovine milk fat globule membranes 
(Brunner, 1969). Differences in fatty acid composition of milk 
phospholipids are attributed to nutritional, environmental and genetic 
factors (Jense n, 1973). Fractionation of milk indicates that 42 % of 
lipid phosphorus is in the skim milk, whilst 58% is in the milk fat 
globule (Patton and Keenan, 1971). In most cases the phospholipids from 
both sources are similar, as are the fatty acid profiles, with some 
differences in the partitioning of cerebrosides. This implies differenc
es 
in origin of the two fractions. 
The source of milk phospholipids is predominantly de nova synthesis 
within the gland. Labelled phospholipid and inorganic phosphorus is 
detected in rat milk maximally 6 hours after intravenous radioactive 
inorganic phosphate is administered (Easter et al, 1971). In the goat 
the label appears for the first 12 hours as inorganic phosphate with 
progressively more radioactivity appearing in lipid thereafter. This 
was compatible with a single pool of phosphate within the tissue with a 
slow rate of turnover. When c
14
-phosphatidyl-choline is administered 
in the diet, the dietary contribution to milk phospholipid was calculate
d 
t b . 1 0 05 . k . th f 
32 
· · b 
o e approximate y . %. Li ewise, e uptake o P -l1poprote1n y 
mammary tissue does not result in labelled milk phospholipids. The 
synthesis of phospholipid by isolated cultured mammary cells occurs 
from glycerol (Kinsella, 1968). 
4. Lactogenesi s and the Secretion of Colostral Fat The foregoing 
discussion dealt mainly with the synthesis of mature milk, and little 
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consideration has been given to lactogenesis . In general , the en
zymatic 
activity of mammary tissue incre ases at or near parturition and c
oincides 
with the appearance of milk. In cow mammary tissue, the rate of
 
lipogenesis as measured by cytos ol enzyme activities increases by
 10- to 
40-fold from 30 days pre-partum to 40 days post-pa rtum (Mellenberger et 
al, 1973). Accompanying this is a change in the fatty acid pattern 
towards an increase in short and medium chain fatty acids, simila
r to the 
distribution typically found in milk fat (Glass et al, 1967). Rabbi t 
mammary tissue displays similar behaviour, with the fatty acid p
attern 
of mid-pregnancy milk being characteristic of cellular lipids r at
her than 
milk fat (Strong and Dils, 1972). Changes in the lipogenic enzyme 
activity of mammary tissue have also been demonstrated in rat (Baldwin 
and Milligan, 1966; Howanitz and Levy, 1965), mouse (Jones, 1972) and 
rabbit (Harbnann and Jones, 1970). Read and Sarriff (1965) considered 
that the change in fatty acid composition antepartum to mid-way t
hrough 
the first week post parturn, with increasing levels of lauric and 
myristic 
acids, is evidence of increasing intramamrnary synthesis in human m
ilk, 
most of the fatty acids of early colostrum being derived from pla
sma. 
Lipoprotein-lipase activity increases in mammary tissue 2-3 days 
pre-partum and is maintained at a high level throughout lactation
 
(McBride and Korn, 1963; Robinson, 1963; Otway and Robinson, 1968; 
Hamosh et al , 1970). Lipoprotein lipase activity in the gland depends 
to some extent on prolactin (Zinde r et al , 1974). 
E. CHOLESTEROL AND BILE ACID METABOLISM 
1. Synthetic Pathways The synthesis of cholesterol in an anim
al 
system utilizing acetate as the substrate was first demonstrated 
by Bloch 
and Rittenberg in 1942 using deuterated-acetate. The multiple st
eps 
in the biosynthetic pathway have, in the main, been demonstrated 
subsequently , and have been reviewed by Holloway (1970). The pathway 
consists of the formation of Acetyl CoA from acetate, with Aceto
acetyl CoA 
proceeding to B-hydroxy- B-methyl glutaryl CoA (HMG-CoA) and the 
irreversible formation of mevalonic acid . The subsequent steps are not 
as open to physiological influences as those prior to mevalonate 
formation (Gould and Popjak, 1957; Bucher et al, 1957; Siperstein and 
Guest, 1960), the early chemical r eactions being common to other 
metabolic pathways (Bortz, 1973). Following mevalonate formation, 
phosphorylation and condensation results sequentially in squalene, 
lanosterol and cholesterol. 
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One of the functions of cholesterol is that of precursor for the 
production of steroid hormones. the recovery of deuterated-pregnandiol 
from the urine of a woman 8 months pregnant following administration of 
deuterated-cholesterol, prompted Bloch (1945) to suggest the in vi~o 
synthesis of ste roid hormone via cholesterol degradation. Demonstration
s 
of the derivation of pregnenolone from cholesterol, the former being a 
precursor of the corticosteroids (Lynn et al, 1954), and the pathways of 
androgen and oestrogen synthesis have since occurred (Samuels and Eik-nes, 
1968; Holloway, 1970). Under normal conditions, however, transformation 
of cholesterol into adrenal or gonadal hormones would probably account 
for less than 10% of the total daily cholesterol production (Miettinen, 
1970) . 
Cholesterol is the precursor of a second group of sterols, namely 
the bile acids, the latter also serving as a maJor route for the excretio
n 
of chole sterol. The transformation of cholesterol into bile acid was 
first observed in the dog when injection of deuterium-labelled cholesterol 
gave rise to de utero-cholic acid (Bloch et al, 1943). The role of the 
liver in this degradation was confirmed by Harold et al (1955) using 
the isolated perfused rat liver. The liver is responsible for the 
production of the primary bile acids, (cholic acid and chenodeoxycholic 
acid in man), which arise via a stepwise pathway following ?a-hydroxylation 
of cholesterol (Danielsson and Tchen, 1968) and this is followed by their 
conjugation with taurine and glycine (Harold et al , 1955). Secondary 
bile acids arise from the primary acids as the result of degrada
tion 
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by microorganisms in the caecum and large intestine . The conjugated 
primary bile salt is first hydrolyzed to release the free acid a
nd then 
the 7a -hydroxyl group is removed from cholic or chenodeoxycholic
 acids 
to give rise to deoxycholic and lithocholic acids respectively . 
Some 
of the secondary bile acid is reabsorbe d and reconjugate d in the liver 
(Hayakawa, 1973). While cholesterol gives rise to the bile acids, bile 
acid regulates the absorption of cholesterol and the two sterols
 
participate mutually in the control of their production. 
2. Cholesterol Synthesis 
The Site of Synthesis . All tissues have been found capable of cholesterol 
synthesis with the exception of the adult central nervous system
 (Srere 
et al, 1950; Dietschy and Siperstein, 1967). The most active sites are 
the liver and the small intestine, and together these are respon
sible for 
80% and 97% of the total synthesis in rat and monkey respectively (Dietschy 
and Wilson, 1968), when the animals are maintained on low cholesterol 
diets. In the monkey, 82% was attributable to the liver. 
Considering cholesterol synthesis at a cellular level, 
compartme ntalization of the synthetic pathway exists. The init
ial 
condensation of acetyl CoA occurs within the cytosol, whilst the
 enzyme 
responsible for converting HMG··CoA to mevalonate, namely HMG-CoA
 reductase, 
is found almost exclusively in the microsomes (Bucher and McGarrahan, 
1956; Siperstein and Fagan, 1966). This is ultimately where newly 
synthesized cholesterol is recovered (Bucher and McGarrahan , 1956) and 
where most cellular cholesterol is to be found (Rice et al, 1953). 
Regulation of Synthesis . The regulation of cholesterol synthesis was 
deduced by Gould and Popjak (1957) to occur early in the pathway, prior 
to mevalonate formation, and was subsequently demonstrated to oc
cur at 
the level of the reduction of HMG-CoA to mevalonate (Siperstein and 
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Guest, 1960). Bucher et al (1960) showed HMG-CoA reductase activity to 
be decreased in the fasting animal, whilst more r ecently, Regen 
et al 
(1966) have shown that this was due to decreased enzyme synthesis. Steps 
further along the pathway of cholesterol synthesis may also be c
oncerned 
with regulation (Gould and Swyryd , 1966). 
Bile acids may inhibit cholesterogenesis (Beher and Baker, 1958; 
Grundy et al, 1966) at the level of HMG-CoA reductase (Back et al, 1969; 
Harnprecht et al, 1971), with an additional effect on bile acid synthesis 
itself, probably at the level of 7a-hydroxylase (Shefer et al, 1969). 
These studies are sometimes difficult to interpret, however, the
re being 
the additional change in cholesterol absorption. This objection is 
overcome in studies utilizing lymphatic diversion (Hamprecht et al, 1971) 
or ileal exclusion (Grundy et al, 1971), when it is clear that disruption 
of bile acid metabolism affects cholesterol synthesis directly, 
without 
altering cholesterol absorption. 
Excretion of Cholesterol. Cholesterol is excreted via 2 main routes, the 
intestine and the skin. The skin loss is via degradation of sup
erficial 
cells, and under most conditions probably occurs at a constant r
ate. 
That excreted through the intestine is in 2 forms, neutral stero
ls 
(comprising cholesterol and degradation products) and acidic sterols 
(the bile acids). 
The cholesterol in faeces may be both endogenous and exogenous, 
the latter dietary cholesterol that had not been absorbed. Endo
genous 
faecal cholesterol arises from biliary secretion and intestinal 
synthesis, 
the latter being mainly from shed mucosal cells. Just as bile a
cids are 
subject to bacterial degradation, so cholesterol may give rise to several 
products. In normal adult animals, the most common excretory pr
oduct 
in the neutral sterol fraction is coprostanol, with cholesterol
 being 
present in fairly small quantities. In germ-free animals, or i
n those 
treated with antibiotics, coprostanol is entirely absent or decr
eased 
substantially (Coleman and Baumann, 1957; Danielsson and Gustasson , 
1959) . 
A third, and minor route , is that of the e xcretion of hormones , 
often via the kidney , following detoxification in the liver. 
3. Bile Acid Synthesis 
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The Site of Synthesis . In isolated perfused rat liver preparation, 
taurochenodeoxycholic acid is the main end product, exceeding tau
rocholic 
acid (Ha rold et al, 1955). This is the converse of the situation in the 
intact animal. Bile acids formed with the liver are, by definiti
on, 
primary acids, whils t secondary bile acids are those formed duri
ng 
enterohepatic circulation. Their formation within the intestin
al lumen 
is due to bacterial action and several anaerobic microorganisms 
found 
as normal flora within rat and human intestine have been found t
o degrade 
primary acids, e . g . Ba~tero{J~s: Clostridium, Enterococcus, Lactobacillus 
(e.g. Midtvedt and Norman, 1967). The extent to which microbiological 
degradation occurs varies considerably between species, as well 
as 
between animals of the same species. Additional factors include
 changes 
in flora caused by diet, changes in bile acids caused by diet, a
nd the 
rate of faecal flow (Bergstrom and Danielsson, 1968). 
It should be mentioned at this stage that, in some species (rat and 
mouse) (Bergstrom et al , 1960), chenodeoxycholic acid may be further 
metabolized by the liver, and by definition, these products are 
also 
primary bile acids. In rat liver, a mitochondrial system produc
ing 
lithocholic acid from cholesterol has been described by Mitropou
los and 
Myant (1966), this being usually considered a secondary bile acid. 
Bile acid formation probably begins in the microsomes where the 
changes in the steroid nucleus, such as 7a-hydroxylation occur; 
oxidation 
of the side chain takes place in mitochondria (Bergstrom and Danielsson, 
1968). The conjugation of bile acids by taurine and glycine involves 
activation of the carboxyl group, catalyzed probably by the micr
osomal 
fraction, with subsequent conjugation being associated with lysosomal 
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activity (Schersten, 1967) . 
Regulation of Synthesis . The site of control of bile acid biosynthe sis 
has been suggested as lying at the first steps in the pathway, that of 
?a- hydroxylation. Early, Bergstrom and Danielsson (1958) showed that 
homeostatic control was dependent on the return of bile acids to the 
liver via the portal blood . Drainage of bile acids via bile fistulae is 
followed by a several-fold increase in bile acid production due to 
interruption of bile acid resorption. This has been shown in liver 
homogenates (Danielsson et al, 1967) and in the whole rat (Shefer et al, 
1969) . In the latter experiments, intraduodenal infusion of taurocholate 
resulted in depression of the accelerated bile acid production brought 
about by a biliary fistula . The same authors later presented (1970) 
f urther evidence that 7a- hydroxylase was capable of regulating bile acid 
biosynthesis via feedback control , but only if hepatic cholesterol 
synthesis was "adequate" . They concluded that this involved enzyme 
synthesis and degradation as with HMG ··CoA reductase (Regen et al, 1966). 
The Enterohepatic ,irculation and Excretion of Bile Acid. At least 95% 
of bile acids excreted in bile a r e r esorbed in the gut . In animals, bile
 
acid absorption has been demonstrated along the whole length of the smal
l 
intestine, utilizing various transport mechanisms according to the site 
and the bile acid concerned (Dietschy , 1968) . The situation seems to be 
substantially the same in the adult hmnan . There is little net absorptio
n 
of bile acid from the proximal small intestine , as demonstrated by 
perfusion studies (Borgstrom et al, 1963; Simmonds et al , 1967), a fact 
well supported by the marked increase in bile acid turnover seen in 
patients who have undergone ileectomy (Hofmann and Grundy , 1965; Hardison 
and Rosenberg , 1967) . Both perfusion studies used taurine conjugates, 
whereas if the glycine compounds are used, passive absorption occurs in 
the jejunmn (Hislop et al, 1967) . Of that small percentage of bile acid 
which escapes into the caecmn, most will undergo transformation into 
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secondary acids , with a r elatively small amount of p rimary bile acid 
detectable in faeces (e .g. Danielsson et al , 1963). Colonic resorption 
of bile acid is well documented (Mekhjian et al , 1968), but is less 
efficient than that in the small intestine, due to the unfavorable 
physical state of some of the acids, such as lithocholic , which tends to
 
precipitate in the colonic environment. After continuous biliary 
drainage for a few days , secondary bile acids tend to disappear from bil
e 
(Samuel et al , 1968) . Resorbed bile acids and salts are carried back 
to the liver via the portal blood. Under normal circumstances only low 
concentrations can be detected in the peripheral circulation (Sandberg 
et al , 1965; Simmonds et al, 1973). Both conjugated and free acids are 
taken up by the liver, the latter being conjugated (if secondary) or 
reconjugate d (if primary) prior to re-excretion into bile. 
Using isotopic dilution techniques, it has been estimated that in 
the adult human the bile acid pool is 2-5 g (e.g. Lindstedt, 1957), and 
that circulation is of the order of 5 to 10 times per day (Hofmann, 1967), 
with the component bile acids having different half-lives (that of cholic 
acid being shorter than that of chenodeoxycholic acid). 
1. 
F. THE ORIGIN OF FOETAL CHOLESTEROL BILE ACIDS AND BIOSYNTHESI S 
IN THE YOUNG 
Cholesterol Theoretically the origin of foetal cholesterol is 
two-fold, from d,e novo synthesis within the foeto-placental unit and 
from the maternal circulation. This problem has been considered by many
 
workers but generally in non-primates, though in the last 10 years both 
human and sub-human p rimate studies have been carried out. 
A limited degree of transfer in the rat, amounting to about 11% of 
total foetal cholesterol, was demonstrated using deuterium-labelled 
cholesterol injected into the mother (Goldwater and Stetten, 1947). 
14 
Chevallier (1964 ) using cholesterol-4- C, showed a diminishing contribution 
from the maternal circulation as the foetus matured: whereas at term 
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approximately 15-20% was derived from the mother, as much as 60-70% was 
of maternal origin in the 12 day foetus (about mid-gestation). These 
results contrast with those of Popjak and Beeck.mans (1950) , who were 
unable to demonstrate transfer of cholesterol from the rabbit's maternal
 
circulation to the foetus. Having shown that the foetal liver was 
capable of synthesizing cholesterol from acetate, they concluded that al
l 
foetal cholesterol was derived from within the foetus. However, since 
the foetal rabbit's plasma cholesterol exceeded that of the mother, the 
higher specific activity within the foetus did not exclude synthesis in 
the mother and some transfer to the foetus. This view is supported by 
Connor and Lin (1967), who showed substantial transfer of maternal 
cholesterol across the placenta in both rabbit and guinea-pig. In -vitro 
synthesis of cholesterol in foetal liver and placenta of sheep and pig 
has also been demonstrated (Nitchuk and Ainsworth, 1972). Foetal 
cholesterol is probaply derived from endogenous synthesis and from the 
mother's circulation. 
Studies in the human have been carried out by a group of workers 
in Scandinavia. They have utilized a technique of perfusing either the 
foetus, the placenta or the combined foeto-placental unit, the specimens
 
being obtained at hysterotomy during therapeutic abortion. In 1967, 
Solomon et al, using mid-trimester foetuses at 18-22 weeks of gestation, 
showed that both the foetal adrenal and liver were capable of cholestero
l 
synthesis from acetate. This has been confirmed several times using 
similar preparations (Mathur et al, 1970; Telegdy et al, 1970a). The 
foetal liver and adrenal account for 98% of the synthesis under these 
conditions (Telegdy et al, 1970a) and acquire the ability to synthesize 
cholesterol very early in their uterine existence. Liver and adrenal 
tissue from foetuses of 11 to 14 weeks' gestational age incorporated 
large amounts of acetate into cholesterol . The rate of synthesis withi
n 
the liver was some 5-9 times that in the adrenals per gram of tissue 
(Givner and Jaffe, 1971). These organs are also the most active sites 
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for de nova synthesis of cholesteryl esters in the mid-gestation foetus 
~ (Cekan et al, 1973), the main area in the adrenal being the foetal zone 
(Isherwood and Oaken, 1972). 
The role of the placenta as an endocrine organ has become 
increasingly r ecognized , for instance its synthesis of pregnenolone from 
cholesterol (Telegdy et al, 1970b). It is of interest, therefore, to 
define its capacity for de nova synthesis of cho lesterol as a source for 
this role as well as for the growing foetus. Cholesterol synthesis may 
be governed by the age of the placenta; for instance at term, the 
placenta is able to synthesize small amounts of cholesterol from acetate 
(van Leus d e n and Villee, 1965; Zelewski and Villee, 1966; Boguslawski 
and Zelewski, 1971) and from mevalonate (Zelewski and Villee, 1966), 
whilst perfusion experiments of either the mid-trimester placenta or 
foeto-placental unit have been unable to demonstrate significant de nova 
cholesterol production (Telegdy et al, 1970a; van Leusden et al, 1971). 
The relative importance of foetal synthesis of cholesterol and 
transfer from the maternal circulation has been studied in non-human 
primates, which may only give an indication of the human situation (taking 
into account wide species differences) and in a small group of human 
subjects. In the latter, either a therapeutic abortion was to be carried 
out or the subject was known to be carrying a foetus that would not live 
after birth, for instance, an anencephalic. 
Pitkin et al (1972) using the rhesus monkey showed that maternal 
transfer of cholesterol accounted for some 42.6% of serum cholesterol in 
the foetus at term . There was a strong net flux of cholesterol across 
the placenta from the maternal to the foetal circulation, labelled 
cholesterol being detected on the foetal side less than 24 hours after 
administration to the mother. Equilibration of the two specific activities 
occurred after 10-12 days, whilst maternal serum cholesterol attained a 
specific activity only 5% of the foetus if the latter were labelle d in 
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utero. The difference in total plasma poo l between mother and foetus 
could not account for all thi s difference. Plasma cholesterol 
concentration in the mother was 80 .3 ± 18.5 rng/100 ml and in the foetus 
59.6 ± 15.6 mg/100 ml . The baboon has also been used in placental 
transfe r studies . Kharnsi et al (1972), using 2 animals, showed the 
foetal esterified plasma cholesterol to h ave a lower specific activity 
than non-este rified cholesterol. The liver was the major site of foetal 
choleste rol synthesis . 
The anencephalic foetus at term has been used to study the human 
situation in utero . Hellig et al (1970) published a report of 2 such 
cases, administering labelled cholesterol to the mother during the forty-
first week of gestation, 8 and 3 days prior to delivery. At the time of 
delivery, the plasma specific activity of the first foetus was 18% that 
of the maternal level; the second was very much lower. The esterified 
cholesterol isolated from foetal plasma and liver and placenta showed 
only half the specific activity of free cholesterol. These figures are 
in good agreement with those of Davis et al (1956) and Plotz et al (1968). 
This group demonstrated that some 20% of foetal cholesterol arises from 
the maternal circulation in the mid-trimester. 
Negative feedback control of synthesis seems to operate in the foetus 
in view of the findings of Connor and Lin (19 67) , that an increased 
proportion of foetal cholesterol is derived from the maternal circulation 
if the mothe rs had been fed cholesterol-containing diets during pregnancy. 
But do change s in cholesterol synthesis contribute to the rise in plasma 
cholesterol concentration after birth? Carroll (1964) compared the 
incorporation of c
14
-acetate into cholesterol in vitro and in vivo in the 
liver of suckling and weanling rats. Incorporation was significantly 
lower in the suckling animals. However, if mevalonate was used as the 
precursor, in vitro the 2 groups of animals gave substantially the same 
incorporation into cholesterol. The control point seemed to lie therefore 
prior to the production o f mevalonate. If the older sucklinq animals 
had access to the adult diet, there was little difference in the 
utilization of acetate . Ballard and Hanson (1 96 7), considering that 
glucose was a more physiological substrate , compared it and acetate 
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(both labelled) in the foetal (18 days ' gestation), neonatal, suckling 
and adult rat. Their results generally showed that the incorporation of
 
both precursors was greatest in the foetus, decreas ing sharply in the 
neonate and with suckling , but the n increasing slightly upon weaning to 
reach adult values. 
Further evidence for the control point lying prior to mevalonate 
synthes is was furnished by Harris et al (1967). McNamara and his 
colleagues (1972) have studied the developmental patterns of hepatic 
HMG-CoA reductase in the rat. Because of the known diurnal variation of
 
HMG-CoA reductase activity in the adult, a standard time of 12 noon was 
adopted for assay. A sharp rise in activity was seen in the foetus just 
prior to term, but this was short-lived, and followed by a rapid decline
 
in the post-natal period. For the first 8 days of the rat's extra-uteri
ne 
existence, activity was maintained at adult levels, and then declined 
further, to a very low level until weaning. An overshoot in activity 
occurred on weaning , of about 2 weeks duration and it could be advanced 
or retarded by changing the time of weaning. In the same paper, the 
authors explore changes in the diurnal variation of HMG-CoA reductase 
activity. In the 6 day old suckling rat, there is an inversion of the 
rhythm, with peak activity occurring in the 12 noon-4 p .m. period, which
 
probably reflects the suckling's feeding pattern, most milk being drunk 
during daylight hours, in contrast to the adult nocturnal habit 
(Greengard, 1970). 
It has been suggested that in the pathway of cholesterol synthesis 
in the adult live r, control points exist beyond HMG-CoA reductase, and 
with this in mind, work has been carried out in the young animal. Shah 
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(1973), u sing mevalonate as precursor, has demonstrated low incorporation 
in vitro into both non-saponifiable and digitonin-precipitable lipids in 
the suckling rat compared with the weaned rat . The author considered 
that the cholesterol content of milk acted to inhibit endogenous 
cholesterol synthes is. Wrobel (1972), examining 7-dehydrocholesterol 
reductase as a possible rate-limiting enzyme in the perinatal animal 
reported that activities of this enzyme were low in the foetal and newborn 
rat, and increased sharply to adult levels between days 19 and 22. 
However, since 7-dehydrocholesterol does not accumulate in the newborn 
rat liver the increase in activity of 7-dehydrocholesterol reductase 
coinciding with weaning and maturation of other hepatic enzymes of 
lipogenesis (Ballard and Hanson, 1967) probably reflects an overall 
increase in cholesterogenesis. 
The question that remains is the nature of the inhibitor that reduces 
HMG-CoA reductase activity during suckling. Incubation with either a 
supernatant fraction of the suckling liver homogenate or pre-incubation 
with rat milk decreased the activity of adult liver HMG-CoA reductase 
(McNamara et al , 1972). The inhibitory activity of the milk was 
non-dialyzable , relatively heat stable and was associated with the protein 
fraction. A recent paper by Boguslawski and Wrobel (1974) presents 
evidence for the existence of a similar inhibitor in cow's milk and human 
milk. In their experiments, they used 5-6 week old male rats and studied 
the inhibition in vivo and in vitro. In vitro, the production of 
digitonin-precipitable sterols from acetate and mevalonate was decreased 
by the addition of small amounts of cow's or human milk, fresh or boiled. 
Further examination of cow's milk showed that the inhibitor was probably 
not associated with protein, remaining in the supernatant after 5% 
trichloracetic acid or lactic acid precipitation. In vivo, when mature 
animals were fed on cow's milk or a diet supplemented with cow's milk, 
the livers showed a 50% decrease in acetate, but not mevalonate, 
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incorporation into sterols. 
Some other inhibitors of sterol synthesis, in vivo and/or i n vitro 
which have been tentatively identified, and which may operate in the 
neonatal period, are the bile acids (e.g. Harris et al, 1967) and 
cholesterol itself (Shah, 1973). These are included in Table 1.12. 
In surmnary then, the biosynthetic pathway for choleste rol synthesis 
is essentially the same as in the adult liver. Marked changes in 
enzyme activity occur during the transition from foetus to neonate and 
from suckling to juvenile animal. Control occurs at the level of HMG-CoA 
reductase as well as beyond, though the later rate-controlling enzymes 
are not clearly defined. Slow bile acid turnover in the suckling rat 
may be involved in negative feedback control (Harris et al, 1967), as 
may cholesterol itself, and other milk constituents yet to be fully 
characterized and evaluated . 
The Role of Diet and Intestinal Micro -Organisms . Another maJor dietary 
change at the time of weaning is the increase in bulk, including fibre. 
The importance of the fibre content of diet in modifying experimental 
atherosclerosis has been demonstrated in rabbits (Kritchevsky, 1964; 
Kritchevsky and Tepper, 1965, 1968; Moore, 1967). It may be due to the 
binding of bile salts to non-nutritive fibre (Kritchevsky and Story, 1974). 
The excretion of sterols and bile acids is higher in animals fed on chow
-
type diets (Portman and Murphy, 1958; Bloomfield, 1963; Horlick et al, 
1967), and the low excretion of bile acid in the suckling rat (Harris 
et al , 1967) may be related to the absence of fibre. The increased 
fibre-bound loss of sterols at weaning may stimulate synthesis of 
cholesterol and bile acids, while at the same time lower the plasma 
cholesterol. 
It is difficult to separate the effects of changes in dietary 
composition and changes in bacterial flora of the gut, since a change 
in diet often alters the latter (e.g. Crowther et al, 1973). The infant's 
TABLE 1.12 
Possible Influences Upon Sterol Synthesis in the Young Animal 
Source of Material 
NEONATE - in vitro 
Suckling rat liver-supernatant 
from homogenate 
Rat milk 
Cow's milk 
Human milk 
NEONATE - in vivo 
Rat milk in suckling animal 
Cow's milk in 5-6 week old rat 
Bile - including cholic acid 
Dialyzable 
+ 
Characteristics 
Precipitable 
+ [ (NH 4 ) 2 SO 4 ] 
+[ethylene/ 
ether] 
-[TCA] 
Heat 
Resistant 
+ 
+ 
+ 
+ 
Known or Possible Action 
1 Acetate conversion to mevalonate1 
1 HMG CoA reductase activity2 
l HMG CoA reductase activity1 
J Acetate and mevalonate conversion3 
to digitonin-precipi table sterols 
l Acetate and mevalonate conversion3 
to digitonin-precipitable sterols 
I d . . 2 + HMG CoA re uctase activity 
l Acetate conversion to digitonin-
precipitable sterols3 
l Acetate conversion to mevalonate1 
Continued 
°' 
°' 
Source of Material 
ADULT - in vitro 
Bile acids 
Bile protein 
ADULT - in vivo 
Dietary cholesterol 
(short-term) 
Bile acids 
TABLE 1.12 
(Continued) 
Characteristics 
Dialyzable Precipitable 
1Harris et al (1967) 
2 McNamara et al (1972) 
Heat 
Resistant 
3Boguslawski and Wrobel {1974) 
4
ogilvie and Kaplan (1966) 
5
shapiro et al (1971) 
Known or Possible Action 
l Acetate 
t Acetate 
conversion to mevalonate1 
conversion to cholesterol
4 
l HMG CoA reductase production5 
1 Acetate conversion to mevalonate1 
O'I 
-.....J 
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gut at birth is sterile, but within hours bacterial colonization has 
occurred (Davies, 1971). The total faecal bacterial count in a human 
baby is maximal by day 2 postpartum, and does not change significantly 
over the next year (Smith and Crabb, 1961). The individual composition 
does vary however, with, for instance, a decrease in E. coli. In the 
adult, cholesterol undergoes microbiological degradation in the gut, 
most commonly to coprostanol. Analysis of faecal sterols in the young 
human infant shows an absence of coprostanol. It appears in some babies 
at about S months, and is usually present in reasonable quantities by 
the time the infant is one year of age, the percent conversion of 
cholesterol to coprostanol varying from Oto 83% in infants 52-90 weeks 
of age (Gustafsson and Werner, 1968; Gustafsson and Sjovall, 1969; 
Gustafsson et al , 1970). This makes an interesting contrast to the 
findings in the weanling rat which does excrete coprostanol (Coleman and 
Baumann, 1957). 
2. Bile Acids Bile acid metabolism in the neonate and young child 
has received most attention in terms of its role in fat absorption, 
particularly since lipid absorption is relatively inefficient in the very 
young. 
Information regarding the component bile acids of the newborn has 
been obtained from post-mortem studies, duodenal intubation and faecal 
and plasma analysis . Poley et al (1964) found that the principal bile 
acids of the mid-trimester foetus, 22 to 26 weeks' gestation, were 
dihydroxy acids, conjugated with taurine, whilst a slightly older foetus 
(28 weeks) showed a predominance of taurocholic acid with very small 
amounts of glycochenodeoxycholic acid. This predominance of taurine as 
the conjugating amino acid of bile acids is the reverse of that found in 
the adult, in whom the ratio of glycine to taurine conjugates is of the 
order of 3:1. 
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In the neonate both primary and seconda ry bile acids are p r esent
 
during the first wee k of life, as demonstrated by studie s of the 
me coniurn 
(Sharp et al , 1971; Back and Ros s , 1973), duodenal contents (Poley et al, 
1964; Bongiovanni, 1965) and serum (Sandberg, 1970). The major p rimary 
acid of the first week of life is cholic acid, the ratio of chol
ic to 
chenodeoxycholic acid being 2.5:1 (Encrantz and Sjovall, 1957; Watkins 
et al , 1973a). Over the next month, with increasing maturity, the ratio 
decreases, becoming 1.2:1 (adult proportion) . Only very small amounts of 
deoxycholic acid, or none at all, have been detected in neonates
 
(Encrantz and Sjovall, 1957, 1959). 
Synthesis of bile acids in the foetal liver may occur via at lea
st 
2 pathways. The first is the accepted adult sequence, resulting
 in cholic 
and chenodeoxycholic acids. The second pathway utilizes a system
 
demonstrated in the rat by Mitropoulos and Myant (1967), in which 
lithocholic acid and 3S-hydroxy-5-cholenoic acid occur as interme
diates, 
and which may be a minor pathway in the adult liver (Anderson et al, 1972). 
Whilst 3S-hydroxy-5-cholenoic acid has been detected in the plasm
a of 
women with recurrent cholestasis of pregnancy (Back et al, 1972), it 
could not be found in normal subjects. It is present in higher amounts 
in the meconium of the premature infant as compared with the mat
ure 
neonate (Back and Ross, 1973). Further evidence for the pathway in the 
immature human liver is provided by the finding of large amounts
 of 
3S-hydroxy-5-cholenoic acid in the urine of infants suffering from
 liver 
disease, including extrahepatic biliary atresia (Makino et al, 1971). 
This seems to make placental transfer from the maternal circula
tion of 
this intermediate unlikely. However, the latter mechanism must 
be 
considered to account, at least partly, for the presence of othe
r minor 
constituents, such as deoxycholic acid (Lester et al, 1972). 
The Enterohepatic Circulation and the Bile Acid Pool. Maintenance of 
the bile acid pool requires a delicate balance between rates of 
synthesis 
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and excretion, and the coordination of several organs and enzyme s y s t ems. 
In the adult this is achieved by the enterohepatic circulation of bile 
acids. Many functions of the foetal and neonatal liver are extreme ly 
inunature, and maturation of the enzyme systems may not occur until 
post~natally. 
There is little direct information on the enterohepatic circulation 
in the human infant . Some earlier published studies of duodenal bile 
indicated that bile acid concentrations in samples obtained without 
stimulation of the gallbladder were similar to those in adults or older 
children (Poley et al, 1964; Encrantz and Sjovall, 1959). However, 
bile acid concentrations within the gallbladder are lower than in the 
adult (Encrantz and Sjovall, 1957), and recent work suggests that the 
intraduodenal concentration is relatively low (Lavy et al, 1971), in 
premature infants being less than the critical micellar concentration 
after a meal (Signer et al, 1974). 
The foetal dog has been used as a model for the investigation of 
bile acid metabolism in a series of experiments by Lester, Smallwood 
and colleagues. The liver of the foetal dog, when examined near term, is 
able to take up, conjugate and secrete tracer doses of cholic acid 
(Jackson et al , 1971). The existence of a foetal enterohepatic circulation 
was demonstrated by the administration of a taurocholate load, which 
was excreted by the liver and concentrated within the gallbladder, then 
resorbed (Smallwood et al, 1972). Absorption of bile acids is not fully 
developed within the ileum of the foetus, and the jejunum absorbs nearly 
as much as the ileum (Smallwood et al , 1970). Conversion of labelled 
cholesterol into bile acids enabled estimates of the rates of sy~thesis 
and pool sizes of bile acids to be made (Lester et al, 1972). In studies 
lasting 36-53 hours, cholic acid was observed to be the maJor bile acid, 
with smaller amounts of chenodeoxycholic acid. Whilst the foetal pool 
size was reduced compared to the adult (on a weight basis), there was a 
marked increase in synthesis of bile acid from cholesterol when the 
pool was depleted by biliary drainage. Placental transfer from the 
mate rnal circulation of cholic and deoxycholic acids was also shown . 
Deoxycholi c acid was not synthesized in the foetal liver. 
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Understandable reluc tance by investigators to use r adioactive 
isotopes in infants and children has limited data on bile acid kinetics . 
Watkins et al (197 3a ) have r e c ently used deuterated-bile salts to 
overcome this problem . Five full-term infants were studied between 2 and 
8 days of age , with samples either by total faecal collection (3 infants) 
or duodenal sampling over 5 consecutive days (2 infants). A mean value 
of 41.4 mg was found for the size of the cholate pool, with a rate of 
synthesis of 22.7 mg/day. No measurement of chenodeoxycholate kinetics 
was made, apart from the relative amounts of the 2 primary bile acids 
in faeces. The data was expressed in terms of body surface area, which 
is proportional to the metabolic rate of an organism (Kleiber, 1947) 
and provides better comparison between adults and children. The cholate 
pool was 290 mg/m
2 
and the synthetic rate 110 mg/m
2/day, both values 
being about half of those in adults. In further studies, Watkins et al 
(1973b) have extended their technique to 4 premature infants of 34-36 weeks' 
gestation. Synthesis of cholate was found to be 6.3 mg/day and that of 
chenodeoxycholate 1.6 mg/day; the pool sizes were 15 and 3.8 mg 
respectively, that is half the value for the full-term infants. 
In the adult, in the steady state, the rate of bile acid excretion 
is equal to the rate of synthesis . In a young infant, whose rate of 
growth precludes him being truly in a steady state, the measurement may 
only give an indication of the true value. Few values of faecal bile acids 
are available. Weber et al (1972, 1973) in 18 normal infants and children, 
varying in age from 4 months to 5 years (mean age 2.4 years) obtained 
2 
values of 18.3 mg/kg body weight/72 hours (or 110 mg/m /day). This is 
identical to the rate of synthesis for cholate obtained by Watkins et al 
(1973a). Leyland (1970) found mean daily excretion of faecal bile acid 
to be between 10 and 85 mg/day . The 16 children whom he studied w
ere 
aged between 2 months and 14 years, and mean daily excretion "app
eared 
to correlate with body weight". 
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It would appear then, that in the infant, bile acid synthesis is 
increased relative to the total pool size, in comparison with the
 adult, 
but that the rate is not sufficient to achieve optimal intraduode
na l 
concentrations for fat absorption. Synthesis is probably under t
he same 
controls as in the adult, as demonstrated by the increased synth
esis in 
foetal dogs during biliary drainage. Signer et al (1974) have demonstrated 
an increased loss of bile acid in premature infants fed a cow's m
ilk 
substitute as compared with those on hmnan milk. Sequestration o
f bile 
acid may occur in the unabsorbed lipid, particularly in the long 
chain 
fatty acids, which are poorly tolerated by the neonate (Fomon et al, 1970; 
Hann et al, 1970) and excreted as calcimn soaps and glycerides (Watkins 
et al, 1974). A similar sequestration of bile acid is seen in children 
suffering from cystic fibrosis, when bile acid loss is increased 
several 
fold (Weber et al , 1973). 
The bile acid pool in the neonate appears to have the same 
physiological confines as in the adult, as shown by measurements 
of bile 
acids in the peripheral circulation which are comparable to those
 of 
adults (Sandberg, 1970), and excretion of only trace amounts by the kidney 
(Norman and Strandvik, 1973). 
The presence of secondary bile acids in the neonate has been 
attributed to placental transfer from the maternal circulation in
 the 
case of deoxycholic acid, and to possible foetal production of li
thocholic 
acid. The level of deoxycholic acid decreases and then disappear
s from 
the plasma in the first few days of life (Sandberg, 1970) and then 
reappears in bile and faeces during the course of the first year 
(Encrantz 
and Sjovall, 1959; Poley et al, 1964; Sandberg, 1970). Recently Watkins 
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et al (197 3b ) detected small amounts of secondary bile salt in faeces 
at 7 days of age. Colonization of the gut by micro-organisms capable 
of ?a-hydroxylation of cholesterol is thought to coincide with the 
appearance of secondary bile acids (Eyssen , 1973). Overgrowth of 
bacterial flora, resulting in increased deconjugation of bile acids and 
formation of free bile acid may l ead to bile acid loss in infancy (Watkins 
et at , 1973c). 
G. THE EFFECT OF SEX STEROIDS ON CHOLESTEROL AND BILE ACID 
METABOLISM 
Interes t in this field is based on the finding that women of 
child-bearing age develop gallbladder disease more often than men of the 
same age (Kaye and Kern, 1971). Recently the results of clinical surveys 
have been released, the first concerning the incidence of gallbladder 
disease amongst users of oral contraceptives, and the second amongst 
those undergoing post-menopausal treabnent with oestrogens (Boston 
Collaborative Drug Surveillance Program, 1973, 1974). In both there was 
a significant increase in the incidence of gallbladder disease 
(cholelithiasis and cholecystitis) amongst users as compared with age-
matched controls [in the case of the oral contraceptive, 2-fold (1973) 
and oestrogens, 2.5-fold (1974)]. Among the users of oral contraceptives, 
those women aged 20-35 years and taking the "pill" for 6-12 months had a 
higher incide nce than those who had taken it for a longer period of time. 
This has been attributed to the possibility that those destined to 
develop gallbladder disease will do so early in the course of therapy. 
The apparent association of gallbladder disease with pregnancy led 
Riegel et al (1935) and Potter (1936) to analyze gallbladder bile obtained 
at the time of Caesarian section. Riegel et al (1935) reported an 
increase in cholesterol concentration coupled with a decrease in bile 
acid in 34 subjects , whilst Potter (1936) considered the bile composition 
to be abnormal , with the gallbladde r generally large and distended. 
Large et al (1960), however, in repeating this experiment could detect 
no statistical diffe rence in cholesterol, cholate or phospholipid 
concentrations of gallbladder bile obtained at Caesarian section when 
compared with normal non-pregnan t controls. 
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Comparing parameters of cholesterol and bile acid metabolism in 
men and women has shown some differences. There are altered proportions
 
of cholesterol and bile acid present in the bile of some women (Grundy 
et al , 1972). A difference in the bile acids may also e xist. Using 
needle aspiration of the gallbladder during abdominal surgery, bile 
samples were obtained from 12 females and 17 males, aged 20-72 years 
(Fishe r and Yousef, 1973). The bile acid concentration was almost twice 
as great in the f emale patients (being 159 µ mole/ml compared to 86 
µ mole/ml in the men). The contributions of cholic and chenodeoxycholic 
acid were 37% and 45% respectively in the women, being the reverse of 
that in the men, and having different proportions of taurine and glycine
 
conjugates. Differences in the composition of rat bile attributable to 
sex have also been demonstrated (Fisher et al, 1972). In studies of sterol 
balance, when the difference in weight between men and women is taken 
into account, the apparent sex difference in the excretion of neutral 
sterols and bile acids is reduced (Grundy et al, 1972; Miettinen, 1973). 
These studies and associations suggest a causal role for the sex 
steroids. Davis and Preston (1972) sampled duodenal bile in women aged 
20-37 years , comparing a group taking oral contraceptives with one 
sampled on days 15-30 of a normal menstrual cycle. The groups were 
matched for age and gravity. They found that the cholesterol and bile 
acid concentrations were significantly elevated in the treatment group 
(p <0.005), the cholesterol difference being more pronounced among young 
subjects. In a smaller group of women (3), hepatic bile was samp led from 
a tube left indwelling in the cystic duct following cholecystectomy 
(Pertsemlidis et al , 1973a). Using labelled cholic acid, the authors 
demonstrated an increase in pool size, synthesis rate and concentration 
of cholic acid during treatment with mixed contraceptive steroid 
preparations. 
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The effect of ethinyl oestradiol on bile acid excretion in the rat 
has been explored by Davis and colleagues (1973, 1974). Bile acid 
synthesis was increased 4-fold in male Sprague-Dawley rats treated with 
ethinyl oestradiol, 0.5 mg/kg/day, whilst bile flow decreased to one-
quarter. In a second series of experiments, treatment with 5 mg/kg/day 
produced a decrease in the degradation of cholesterol (19.8 ± 11.1 µ mole/ 
day versus 41. 7 ± 14.0). Concurrently the biliary cholesterol 
concentration increased 2-fold, whilst bile acid decreased by approximately 
50%. Men given ethinyl oestradiol showed a marked increase in cholesterol 
turnover (Nestel et al, 1965). 
There is little information available regarding the status of 
cholesterol and bile acid metabolism during pregnancy. Sjovall and 
Sjovall (1966) found that the concentration of bile acids in plasma was 
the same in pregnant and non-pregnant women, having a mean of 0.87 µg/ml 
(range 0.24-1.65) compared with normals of 0.82 vg/ml (Sandberg et al, 
1965). There was no correlation between plasma levels and the time of 
gestation, and the concentrations of deoxycholic, chenodeoxycholic and 
cholic acids were approximately equal. In a single study during pregnancy, 
bile was sampled from an indwelling T-tube left in situ after 
cholecystectomy (Large et al, 1960). Biliary bile acid and cholesterol 
concentrations decreased in the second half of pregnancy, and increased 
in the first week postpartum. 
The most recent study which may be applicable to the human situation 
is one conducted in female baboons before and during pregnancy (Dietrick 
et al , 1973). Percutaneous gallbladder aspiration was utilized to 
investigate bile acid kinetics. During pregnancy, bile salt pool size 
and synthesis were reduced and half-life increased. A note of caution may 
be necessary, however, for the baboon undergoes a lowering of plasma 
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cho l esterol during pregnancy in contradistinction to the htnnan (van Zyl , 
1957). 
CHAPTER 2 
THE HYPERLIPIDAEMIA OF PREGNANCY 
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I NTRODUCTION 
Historically there was early recognition of the hyperlipaemia of 
pregnancy, with John Hunter in the eighteenth century ascribing it to the 
absorption of chyle. Virchow in the nineteenth century demonstrated that 
it was due to lipid in the blood by clearing the plasma by the simple 
means of using the lipid solvent , ether. The theories as to its causation 
have b een multiple (Boyd, 1934). 
There i s general agreement that in Western populations normal 
pregnancy leads to an increase in the major plasma lipids, which is 
followed by a decrease in the puerperium. There is some dispute as to 
the timing of the rises of individual plasma lipids. Plasma cholesterol 
may decrease during the first trimester of pregnancy, though still remain 
within the normal range for the population (de Alvarez et al, 1959). 
Subsequently the level increases, usually progressively throughout 
pregnancy , then either decreasing slightly prior to delivery (Oliver and 
Boyd, 1955) or remaining elevated during the whole of the last trimester 
(de Alvarez et al, 1959). The increase is of the order of 25%. Post 
partum there is usually a slow steady decrease (Watson, 1957) with blood 
lipids being still above normal several months after delivery (Peters et 
al, 1951; Oliver and Boyd, 1955; de Alvarez et al , 1959). 
Most authors report a 2-3 fold increase in plasma triglyceride 
concentration during pregnancy (e.g . Cramer et al, 1964/5; Svanborg and 
Vikrot, 1965a; Knopp et al, 1973). The level decreases rapidly following 
delivery, being some 50% of the maximal value by day 7 postpartum 
(Konttine n et al , 1964; Svanborg and Vikrot, 1965b) . 
The increasing density of the B band on lipoprotein electrophoresis 
with pregnancy (Watson, 1957) was confirmed by ultracentrifugation 
(Pantelakis et al , 1964a,b). The ratio of B/a bands was reported as being 
uniformly increased (e . g . Russ et al, 1954; Oliver and Boyd, 1955). A 
recent study by Knopp et al (1973) showed the triglyceride content of all 
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3 ultracentrifugal fractions to be increased (i.e. VL DL , LDL and HDL), 
whilst they could detect increases in cholesterol only in VLDL and LDL in 
the third trimester. 
The effect of intervening factors on the normal pattern of changes 
has received some attention. In toxaemia of pregnancy plasma cholesterol 
and phospho lipid leve l s have risen higher than in normal pregnancy in 
some studies, though the increase was not always significant (Boyd, 1934b; 
de Alvarez and Bratvold, 1961; Konttinen et al, 1964). Plasma 
triglycerides also tend to be higher (Nelson et al, 1966), whilst the 
placental triglyceride content is significantly higher (136 mg/100 g 
tissue in toxaemic pregnancy vers us 89 mg/100 gin normal placenta). 
Hormonal Effects . It is believed that the considerable hormonal changes 
that occur during pregnancy must influence lipid metabolism. The 
widespread use of steroid sex hormones, both post-menopausally and in the 
form of oral contraceptives, has given further opportunity for the study 
of hormonal effects. Whilst the levels of circulating hormone are 
different in pregnancy and on taking the oral contraceptive, the trend 
may be analogous. 
There is a difference in the level of plasma lipids between males 
and females during the reproductive years (20-45 years) (Jones et al , 1951; 
Adlersberg et al , 1956; Lawry et al, 1957; Lewis et al, 1957), which 
disappears after natural (Schaefer, 1964; Carlson and Lindstedt, 1968) 
or surgical menopause (Oliver and Boyd, 1959; Aitken et al, 1971). 
Castration in the male also produces changes that can be predicted from 
the imbalance between oestrogen and androgen, S-lipoprotein being lower 
and a-lipoprotein higher than in age-matched normal males (Furman et al, 
1957, 1958). 
Administration of oestrogen to all groups, male and female, pre-
and post-menopausal, norrno- and hyper-cholesterolaemic, results in a 
decrease in plasma cholesterol (e.g. Eilert, 1953; Oliver and Boyd, 1956 
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a,b; Robinson and Le Beau, 1965; Aitken et al , 1971) and an increase in 
plasma triglyceride levels (Sznajde rman and Oliver, 1963; Robinson and 
Le Beau, 1965; Aitke n et al , 1971), which is large in the case of a 
pre-existant elevation (Zorilla et al , 1968). The lipoprotein pattern 
shows a decrease in LDL and an increase in HDL (Oliver and Boyd , 1954, 
1956a ,b; Hood, 1959; Robinson and Le Beau, 1965). 
The administration of combine d oestrogen-androgen preparations, as 
with the oral contraceptives, leads to an invariable increase in 
triglyceride levels, but inconstant changes in cholesterol. The more 
"oestrogenic " the preparation , the greater the triglyce ride raising 
effect (Stokes and Wynn, 1971). The lipoprotein changes are governe d by 
the relative proportions of the two hormones. The "oestrogenic" 
component raises VLDL (Wynn et al, 1966). Changes in HDL are variable; 
the more "androgenic" the activity, the lower the HDL concentration and 
the highe r the LDL and total plasma cholesterol level (e.g. Aurell et al, 
1966; Rossner et al, 1971). These compounds are orally active 
preparations such as methyl testosterone and 19-nortestosterone which 
increase LDL and decrease HDL (Oliver and Boyd, 1956a; Hood, 1959; Cramer, 
1961, 1962); the naturally occurring androgens, testosterone and 
~-4-androstenedione, cannot reverse an oestrogen change (Hood, 1959). 
Triglyceride transport has been studied by isotope kinetics. 
Turnover is profoundly influenced by gonadal hormones, the clearance from 
plasma being greater in women than in men in both normo- and hyper-
triglyceridaemic subjects (Nikkila and Kekki, 1971; Olefsky et al, 1974). 
Use of combined oral contraceptives doubles triglyceride production 
(Kekki and Nikkila , 1971a) due to the action of the oestrogenic component 
(Kissebah et al , 1973) . Clearance of endogenous and exogenous triglyceride 
is enhanced by the progestational drugs (Kikki and Nikkila, 1971a; 
Kissebah et al , 1973) and by oxandrolone, an anabolic androgen (Glueck 
et al , 1973b). 
This chapter describes the changes in concentration and 
distribution of cholesterol and triglyceride between the lipoprotein 
fractions of plasma during pregnancy and in the puerperiurn. The effect 
of the occurre nce of pre-eclampsia as a complication in late pregnancy 
upon this pattern has been studied. Pre-existe nt hype r cholesterolaemia 
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in women will also profoundly influence the observed changes. The contr
ol 
group is of the effect of the hormonal change of the combined oral 
contraceptive upon the plasma lipids in young women. 
METHODS 
1 . 
A . EXPERIMENTAL DESIGN 
Plasma Lipid and Lipoprotein Concentrations During Pregnancy 
and in the Puerperium 
Serial Changes During Pregnancy . The subjects for this study were derived 
mainly from one private obstetric practice . The group consisted of both
 
nulliparous and multiparous women , the only criterion for inclusion in 
the longitudional study being their cooperation with regard to repetitiv
e 
testing during pregnancy and in the puerperium . A total of 43 women 
were studied , their ages ranging from 20 to 41 years (mean 27 . 2 years). 
They were studied in a free-living situation , with routine ante-natal 
care . Apart from control of excess weight gain , no dietary instruction 
was given. 
Blood samples were collected after an overnight fast, at 4-6 week 
intervals . Samples were obtained for the first time from several women 
on admission to hospital for induction of labour, or in labour. This 
group included women with pre-eclampsia, several of whom were referred 
from other practitioners. These latter samples were not necessarily in
 
the fasting state . However, as may be seen in the results section, ther
e 
are no statistical differences between the fasting lipid levels close to
 
term and those at induction of labour, early in labour, or at delivery. 
Associated with delivery, blood samples were taken 
(1) at the time of delivery, 
(2) the following morning following an overnight fast, 
within 12-24 hours of delivery (designated day 1), and 
(3) on the fifth day postpartum. 
Following discharge from hospital further samples were taken 6-7 weeks 
postpa rtum , and at 12 months. 
The blood samples were immediately place d on ice, and kept at 4°C 
until lipid extraction was completed. The plasma lipoproteins were 
separated by a combination of preparative ultracentrifugation and 
precipitation as will be described below. 
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Factors That May Influence Lipid Metabolism During Pregnancy. The plasma 
concentrations of cholesterol and triglyceride at delivery and in the 
puerperium we re measured in a second larger group of women (n=86). 
Record was made of the parity, labour, any coexisting conditions such as 
pre-eclampsia and age. Retrospectively an attempt was made to define 
maternal factors which may influence the concentration of plasma lipids 
at delivery. 
2. Changes in Plasma Lipids Associated with the Use of a "Low Dose" 
Oestrogen Oral Contraceptive To complement the studies during 
pregnancy, the plasma lipoproteins from a small group of women were 
analyzed before and after commencing use of a mixed oral contraceptive 
(Nordiol 28 , Wyeth Pharmaceuticals Ltd.). The girls were attending the 
University Stude nt Health Service and had not used oral contraceptives 
recently. Their ages ranged from 17-22 years. The week prior to their 
next expected period and immediately prior to commencing taking the oral 
contraceptive, a blood sample was taken following an overnight fast. A 
second sample was taken during the third week of the first cycle on the 
"pill". 
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B. LABORATORY TECHNIQUES 
1 . Plasma Cholesterol and Tri glyceride Concentra tion s These we r e 
measured in a Technicon Auto Ana l yser II (Ma nua l, 1971). This utili ze s 
the Liebe rma n-Burchard reaction for colorime tric estima tion of cho l es t e rol. 
Triglyce ride s are determined by fluorimetry, using a rrodifica tion of the 
method of Kessler and Le d e r e r (1965). 
Known standa rds of both cholesterol (SMA Reference Serum, Extract 
cholesterol) and triglyceride (Triolein, Calbiochem) were treated in the 
same way as test samples . An 0.5 ml aliquot of plasma was extracte d in 
9.5 ml of isopropanol (redistilled --- all isopropanol required 
redistillation to decrease high background fluorescence). Following 
addition of 2 gm of zeolite mixture (zeolite mixture -- zeolite:Lloyd 
reagent:Cupric sulphate:Calcium hydroxide; 400:20:10:20 (w:w)), the 
samples were rotated for 30 minutes, then spun at 4°C at 2,000 rpm for 20 
minutes (MSE, Mistral 6L centrifuge). The supernatant was decanted off. 
2. Separation of Plasma Lipoproteins Plasma lipoproteins were 
separated according to their flotation into very low density lipoprotein 
(VLDL), having a density greater than 1.006, low density lipoprotein 
(LDL) of density 1.006-1.063, and high density lipoprotein (HDL), density 
>1.063. On occasions an "intermediate" fraction (LDL1 ), of density 
1.006-1.019, was also isolated. If the LDL1 frac
tion was required, all 
4 fractions were obtaine d by preparative untracentrifugation. If only 
the 3 major fractions we re required, centrifugation and precipitation 
techniques were combined, as described below. 
Preparati on of Lipoprote i ns Using Ultracentrifugation. Five ml of 
heparinized plasma, at 4°C and density 1.006, containing 0.1-1 mM EDTA 
(dipotassium ethylene diamine tetra acetate) was centrifuged in cellulose 
acetate tube s in a Spinco L2-50 Preparative Ultracentrifuge at 39,000 rpm 
for 16 hours using a 40.3 fixed angle rotor (105,000 g). The supernatant 
containing VLDL was removed from the top by a tube slicing technique. 
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'Any resulting pellet was redissolved in the infranatant, the volume of 
which was made up to 5 ml, and the density adjusted to 1.019, as 
described by Havel et al (1955). It was then centrifuged at 4°C for 18-
20 hours at 39,000 rpm. The supernatant containing fraction 1.006-1.019 
(LDL1 ) was removed using the same slicing tec
hnique, and the 5 mls 
infranatant adjusted to density 1.063 by addition of potassium bromide 
solution. Recentrifugation at the same velocity for 20 hours resulted 
in a clear separation of d 1.019-1.063 (LDL2 ) in the supernatant and HDL 
in the infranatant. 
Isolation of Lipoproteins Using Precipitation. Following removal of VLDL 
by ultracentrifugation at density 1.006, LDL were precipitated from the 
infranatant by adding 1000 units of heparin sulphate and 0.25 ml of 1 mM 
manganous chloride to every 5 ml of infranatant (Fredrickson et al, 1967). 
The precipitate was centrifuged at 4°C for 20 minutes at 2,000 rpm in a 
refrigerated centrifuge, and the supernatant containing HDL was decanted 
from the pellet (LDL). The latter was suspended in normal saline. 
Lipid Extraction from the Lipoproteins . Lipoprotein lipids were extracted 
in Dole's solution (Isopropanol:Heptane:l N Sulphuric acid; 400:100:10) 
(Dole, 1956), using a ratio of 10 ml of Dole's solution for 2 ml of 
lipoprotein solution. Lipids were then separated from the precipitated 
proteins using heptane (Dole's:heptane:water; 10:6:8). Aliquots of each 
fraction were analyzed for cholesterol and triglyceride content using the 
Technicon Auto Analyser Mark II Colorimeter. 
Recoveries of cholesterol and triglyceride using these techniques 
averaged 93 and 91% respectively. For each plasma sample the lipid 
content of each fraction was proportionately adjusted to 100% according 
to the percentage recovery for that individual sample. 
3. Separation of Free and Esterified Cholesterol Samples of the 
lipid extracts of the lipoprotein fractions were applied to silica gel 
plates (0.3-0.4 mm thick) and separated using a solvent mixture of 
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hexane :diethyl ether: rnethanol : acetic acid; 180:40:6:4. The separated 
bands of free cholesterol and esterified cholesterol were v isualized 
using Rhodamine Gunder ultraviolet light and eluted with diethyl ether . 
The cholesterol content was then estimated in the Auto Analyser . 
RESULTS 
A. PLASMA LIPID AND LIPOPROTEIN CHANGES DURING PREGNANCY 
Plasma Cholesterol a:nd Triglyceride . The plasma cholesterol level showed 
an ove rall 53% increase during pregnancy (Table 2.1, Figure 2.1), some 
two-thirds of which occurre d within the second trimester. The plasma 
triglyceride concentration increased 3-fold during pregnancy. Most of 
this increase took place in the last trimester of pregnancy. 
Plasma Lipoproteins. All 3 major lipoprotein groups increased during 
pregnancy. 
VLDL There was no change in VLDL-cholesterol until midway through 
gestation, when the concentration doubled; this rose during the last 
trimester to a value four-times greater than normal. The ratio of free 
to este rified cholesterol was maintained at 1:1 throughout pregnancy 
(Table 2.2). VLDL-triglyceride concentration underwent approximately 
parallel changes, so that the triglyceride:cholesterol ratio remained 
constant throughout pregnancy (control 4.5:1, at delivery 4.2:1), even 
though the triglyceride level exceeded normal by statistical definition 
later than the cholesterol level (Table 2.la). 
LDL LDL-cholesterol was also unchanged at the end of the first trimester, 
with a cholesterol:triglyceride ratio very similar to normal (Table 2.1). 
However, the cholesterol concentration then increased rapidly, being 56 % 
greater than normal at its maximal point close to term. The free to 
esterified cholesterol ratio decreased slightly during pregnancy from 
0.42:l in the control group to 0.35:1 during labour. The triglyceride 
increase in LDL was proportionately greater than that of cholesterol, so 
that the choleste rol:triglyceride ratio changed from greater than 3:1 in 
Normalt 
<8 wks gestation 
9- 12 wks gestation 
13-18 wks gestation 
19-24 wks gestation 
25-30 wks gestation 
31-36 wks gestation 
37-40 wks gestation 
During labour 
Delivery 
Day 1 postpartum 
Day 5 postpartum 
6-7 wks postpartum 
12 mths post parturn 
TABLE 2 .1 
Plasma Lipid and Lipoprotein Changes During Pregnancy and in the Puerperium 
n 
15 
6 
5 
9 
10 
13 
23 
25 
20 
35 
23 
43 
30 
14 
Plasma Lipid VLDL LDL 
Chol. 
202 ± 4.7* 
200 ± 13.2 
198 ± 5.9 
223 ± 12.9 
279 ± 10.4 
274 ± 15.2 
297 ± 14.6 
317 ± 17.1 
303 ± 17.0 
312 ± 13.9 
268 ± 15.4 
283 ± 10.9 
257 ± 13.2 
204 ± 11.7 
T .G. Chol. T.G. Chol . 
95 ± 9.5 9 ± 1.2 45 ± 8.6 129 ± 3 . 9 
96 ± 12.1 
123 ± 12.9 
113 ± 8 . 6 10 ± 1.9 32 ± 7.8 137 ± 13 .1 
168 ± 20.9 18 ± 4 . 4 59 ± 16.0 179 ± 9 . 0 
208 ± 18.2 20 ± 3.3 8 2 ± 12.8 176 ± 13.0 
294 ± 23.9 39 ± 5.2 130 ± 14.7 189 ± 12.7 
312 ± 22.5 37 ± 3.2 148 ± 12.6 214 ± 16.2 
306 ± 23.9 40 ± 4.4 155 ± 13.9 190 ± 14.0 
296 ± 15.9 35 ± 2.7 140 ± 9.8 192 ± 10.8 
224 ± 19.2 26 ± 2.7 106 ± 9.0 168 ± 14.4 
174 ± 8.6 21 ± 1.8 79 ± 6 .3 189 ± 10.8 
123 ± 7.5 13 ± 1.5 49 ± 4.8 184 ± 13.1 
117 ± 12.6 12 ± 1.8 5 0 ± 9 . 2 141 ± 10 . 7 
*Concentration: mg/100 ml (mean± S.E.M .) 
t"Normal: 3rd week of menstrual cycle 
HDL 
T.G . Chol . 
31 ± 2 . 2 63 ± 3.7 
49 ± 4 . 6 76 ± 3 . 5 
66 ± 7.0 81 ± 5 . 1 
81 ± 5 . 9 79 ± 10. 9 
118 ± 11. 2 67 ± 3 . 9 
122 ± 11. 7 66 ± 3.1 
108 ± 9 . 8 75 ± 3.9 
109 ± 8 . 4 82 ± 4.5 
85 ± 9 . 9 75 ± 4.4 
71 ± 4 . 2 73 ± 2 . 9 
54 ± 3.9 61 ± 3.9 
47 ± 4 .2 52 ± 3 . 6 
T.G . 
20 ± 1 . 9 
32 ± 4 . 4 
42 ± 2 . 9 
44 ± 5 . 9 
48 ± 3 . 1 
42 ± 2 . 2 
42 ± 2 . 0 
46 ± 2 . 4 
33 ± 2.5 
25 ± 1.0 
21 ± 1 . 1 
20 ± 1 . 5 
00 
U1 
FIGURE 2.1 Plasma Lipid Changes During Pregnancy and in the 
Puerperium 
Fasting plasma cholesterol and triglyceride concentrations were 
measured serially t hroughout pregnancy, and in the puerperium and 
at 12 months. The results are the mean ± S. E.M. of the g r oup, 
including normal and complicated pregnancies. 
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TABLE 2. la 
Plasma Lipid and Lipoprotein Changes During Pregnancy and in the 
Puerperiurn: Significant Differences of Some Comparisons Before , 
During and After Pregnancy 
87 
Cholesterol Triglyceride 
Unpaired t-testing 
PLASMA LIPIDS 
Normal vs 19-24 wks gestation 
Delivery vs Day 1 postpartum 
Normal vs 6-7 wks postpartum 
LIPOPROTEIN FRACTIONS 
VLDL 
Normal vs 19-24 wks gestation 
Normal vs 25-30 wks gestation 
Delivery vs Day 1 postpartum 
Normal vs 6 wks postpartum 
LDL 
Normal v s 13-18 wks gestation 
Normal vs 19-24 wks gestation 
Delivery vs Day 1 post parttnn 
Normal vs 6 wks postpartum 
HDL 
Normal vs 13-18 wks gestation 
Normal vs 19-24 wks gestation 
Normal vs 25-30 wks gestation 
Delivery vs Day 1 postpartum 
Normal vs 6 wks postpartum 
Paired t-testing* 
DELIVERY vs DAY 1 POSTPARTUM 
Total plasma 
VLDL 
LDL 
HDL 
DAY 1 vs DAY 5 POST PARTUM 
Total plasma 
VLDL 
LDL 
HDL 
p <0.001 
<0.05 
<0.01 
<0.05 
<0.05 
n.s. 
n.s. 
<0.001 
n.s.* 
<0.01 
<0.05 
<0.05 
n.s. 
n.s. 
n.s. 
<0.001 
<0.05 
<0.001 
n.s. 
<0.05 
<0.01 
<0.001 
n.s. 
p <0.01 
<0.01 
<o.o5 
n.s. 
<0.01 
<o.o5 
n.s. 
<0.001 
0.06 
<0.001 
<o.o5 
<0.001 
<0.001 
<0.001 
n.s. 
<0.01 
0.06 
<0.01 
<0.001 
<0.001 
<0.001 
<0.01 
<0.001 
Normalt 
25-30 wks gestation 
31-36 wks gestation 
37-40 wks gestation 
During labour 
At delivery 
Day 1 postpartum 
Day 5 postpartum 
6-7 wks postpartum 
TABLE 2 . 2 
Plasma Lipoprotein Changes During Pregnancy and in the Puerperium: 
n 
12 
5 
5 
8 
5 
8 
8 
12 
8 
Free 
5 ± 3.6* 
8 ± 4.0 
19 ± 12.2 
19 ± 7.4 
18 ± 12.4 
14 ± 8.4 
12 ± 7.7 
9 ± 5.3 
7 ± 6.7 
Free and Esterified Cholesterol 
VLDL 
Esterified 
5 ± 2.5 
10 ± 5.8 
30 ± 25.0 
24 ± 12.1 
22 ± 17.0 
17 ± 10.4 
14 ± 9.4 
12 ± 8.3 
8 ± 7.1 
LDL 
Free 
38 ± 5.1 
39 ± 11.1 
73 ± 39.8 
61 ± 30.0 
50 ± 25.2 
55 ± 27.6 
48 ± 28.4 
48 ± 14.6 
44 ± 11.5 
Esterified 
89 ± 8.8 
104 ± 32.6 
171 ± 69.5 
162 ± 79.0 
144 ± 76.4 
143 ± 58.6 
123 ± 84.7 
130 ± 55.3 
116 ± 28.9 
*Concentration: mg/100 ml (mean± S.D.) 
tNormal: 3rd week of menstrual cycle 
Free 
15 ± 6 . 9 
17 ± 5 . 1 
18 ± 11.5 
16 ± 5.3 
15 ± 3.3 
19 ± 7.7 
17 ± 4.9 
17 ± 5 . 5 
13 ± 5 .3 
HDL 
Esterified 
48 ± 21 . 9 
53 ± 15 . 2 
54 ± 16.8 
49 ± 12 . 0 
54 ± 13.0 
63 ± 17.4 
59 ± 14.5 
59 ± 15.6 
51 ± 10 . 6 
OJ 
OJ 
the control group to 2.2:1 late in the second trimes ter and 1.76:l at 
delivery. When the LDL was subfractionated into 2 classes, tho se having 
densities of 1 . 006-1.019 (LDL1 ) and of 1.019-1.063 (LDL 2), it was found 
that a large portion of the excess triglyceride was containe d within 
89 
LDL
1 
(Table 2.3) . The ratio of cholesterol to triglyceride in LDL1 was 
maintained close to that of the normal population (0.55:1) during 
pregnancy, but increased to 0.68:l at delivery. This was closer to the 
ratio found in VLDL rather than the LDL 2 fraction
 (0.20:l and 5.2:l 
respectively), and was a reflection of the heterogeneity of the total 
class of LDL. The ratio of cholesterol to triglyceride in LDL2 decreased 
in p~egnancy, but less markedly than the total LDL fraction, close to 
term being 2.09:l and 1.75:l respectively. 
HDL The least dramatic increase in cholesterol concentrations occurred 
in the HDL fraction. The increase took place in the first trimester, but 
was only 21% above the level found in the third week of the normal 
menstrual cycle (the probable level at the time of conception). In 
contrast, the triglyceride component of HDL increased by 60% in the first 
trimester and a further 50% in the second trimester, remaining at that 
level until delivery. This resulted in a decrease in the cholesterol: 
triglyceride ratio from 3.1:1 (day 21 of the menstrual cycle, Table 2.1) 
to 2.4:1 early in the second trimester and 1.8:1 at delivery. 
If the distribution of cholesterol and triglyceride in each fraction 
is expressed in terms of percentages of the total present in the plasma, 
the proportion of cholesterol carried in VLDL increased from 4.5% in the 
non-pregnant controls to 11.0% at delivery. In LDL and HDL cholesterol 
decreased (from 64 . 0% and 31.5% to 61.5% and 26.5% respectively). The 
percentage of total plasma triglyceride carried in VLDL was unchanged 
(47.5 %), but increased in LDL (from 32.5% to 37.0%) and decreased in HDL 
(from 21 . 0% to 15.5%). 
TABLE 2.3 
Plasma Lipoprotein Changes During Pregnancy and in the Puerperiurn: LDL and LDL 1 2 
n 
Norrnalt 13 
13-18 wks gestation 9 
19-24 wks gestation 10 
25-30 wks gestation 13 
31-36 wks g e station 23 
37-40 wks gestation 25 
At delivery 35 
Day 1 post parturn 23 
Day 5 post parturn 43 
6-7 wks post parturn 30 
LDL (1.006-1.063) 
n 
LDL1 (1.006-1.019) 
Chol. T.G. Chol. 
129 ± 3.9* 31 ± 2.2 5 ± 0.5 
137 ± 13.1 49 ± 4.6 3 4 
( 2- 5)** 
179 ± 9.0 66 ± 7.0 8 7 ± 1.8 
176 ± 13.0 81 ± 5.9 7 10 ± 2.7 
189 ± 12.7 118 ± 11.2 9 24 ± 7.1 
214 ± 16.2 122 ± 11.7 8 32 ± 6.3 
192 ± 10.8 109 ± 8.4 10 34 ± 6.6 
168 ± 14.4 85 ± 9.9 2 24 
(14-33) 
189 ± 10.8 71 ± 4.2 13 21 ± 4.5 
184 ± 13.1 54 ± 3.9 7 13 ± 6.9 
*Concentration: mg/100 ml (mean± S.E.M.) 
**Range 
tNorrnal: 3rd week of menstrual cycle 
T.G. 
9 ± 0.9 
8 
( 1-11) 
19 ± 3.3 
16 ± 3.4 
36 ± 6.2 
36 ± 4.7 
50 ± 11.5 
28 
(25-30) 
21 ± 3.7 
14 ± 3.8 
LDL2 (1.019-1.063) 
Chol. T.G. 
125 ± 3.6 24 ± 1.3 
140 34 
(113-156) ( 28-39 ) 
175 ± 7.6 51 ± 5. 8 
161 ± 21.8 58 ± 7.8 
158 ± 17.2 73 ± 6.7 
205 ± 28.0 98 ± 16.8 
168 ± 27.8 90 ± 14. 6 
121 43 
( 96-146) (38-48) 
174 ± 26.9 51 ± 7.0 
182 ± 40.8 43 ± 7. 8 
\.0 
0 
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B. PLASMA LIPID AND LIPOPROTEI CHANGES IN THE PUERPERIUM 
Plasma Cholesterol a:nd Triglyceride . Within 12-24 hours of d elivery , the 
mean plasma cholesterol had d ec reased from 312 mg/100 ml to 268 mg/100 ml, 
i.e. by 14% (Table 2.1, Figure 2.1). Measurement on day 5 post partwn 
showed that some rebound had occurred, and at 6-7 weeks post partwn, the 
women still had raised cholesterol levels (Table 2.la). 
Plasma triglyceride also decreased rapidly following delive ry, 
having fallen from 296 mg/100 ml at delivery to 224 mg/100 ml within 24 
hours (24%), and to 174 mg/100 ml by the fifth day. The plasma triglyceride 
concentration was only minimally raised 6-7 weeks after delivery (Table 
2.1, 2.la). 
Plasma Lipoproteins. 
VLDL Both cholesterol and triglyceride decreased markedly within the 
first 24 hours after delivery (26% and 24% respectively). This decrease 
continued over the next few weeks, so that by 6-7 weeks post partwn, the 
lipid concentration within this fraction had returned to the non-pregnant 
state. 
LDL As in all other fractions, the lipid content decreased following 
delivery; by 12% for cholesterol and 22% for triglyceride. However, the 
early rebound seen in the total plasma cholesterol level was totally 
accounted for in the LDL moiety, the cholesterol content of which, 5 days 
postpartum, was the same as that at the time of delivery, and decreased 
only slightly over the next few weeks. Most of this was within the LDL 2 
fraction (Table 2.3). In contrast, the triglyceride concentration 
decreased much more rapidly over the next few weeks on both LDL 
subfractions. 
HDL Both lipids changed rapidly, returning to normal levels within the 
puerperiwn, following a 9% decrease in cholesterol and 28% in triglyceride 
within the first 24 hours. 
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C. I NTER- AND I TRA- LIPOPROTEIN RELATIONSHIPS 
It has been noted that the increase in plasma triglyceride during 
pregnancy was reflected by an increase in the trigly c eride content of all 
l ipoprotein fractions (Table 2 .1). Part of the increase of triglyceride 
in the LDL fraction could be attrib ted to a five-fold increase in the 
subfraction d 1.006-1.019. A positive significant correlation was found 
for the concentration of triglyceride in these two fractions in both the 
non-pregnant controls and in women during the third trimester of pregnancy 
(Table 2.4) . 
TABLE 2.4 
Plasma Lipoproteins: The Relationship Between the 
, 
Triglyceride Concentrations of VLDL (d <1.006) 
and LDL1 (d 1.006-1.019) 
Non-pregnant 
Second trimester 
Third trimester 
n 
13 
11 
16 
Correlation 
Coefficient 
(r) 
0.626 
0.496 
0.844 
Significance 
(p) 
<0.05 
n.s. 
<0.001 
It has been shown that VLDL and HDL metabolism are interrelated 
in several ways (Margolis and Capuzzi, 1972). Some relationships were 
therefore sought between VLDL and HDL lipids. Figure 2.2 s hows 3 sets of 
data; from normal , non-pregnant controls, from uncomplicated pregnancies , 
and from hypertensive pregnancies. There is a positive, but weak 
relationship betwee n the VLDL-triglyceride concentration and the ratio of 
the triglyceride and cholesterol c oncentrations in HDL (Table 2 . 5 ). 
FIGURE 2. 2 Plasma Lipoproteins: The Relationship Between the 
Ratio of HDL Triglyceride:Cholesterol 
Concentrations and VLDL-Triglyceride 
The ratio of the triglyceride and cholesterol concentrations in the 
HDL fraction in plasma samples from normal, non-pregnant women and 
from women at delivery was compared against the triglyceride content 
of VLDL from the sample sample. The correlation coefficient for the 
whole group was 0.536 (p <0.001) e 
Normal, non-pregnant· women 
At delivery, normal pregnancy 
~ At delivery, with pre-eclampsia 
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TABLE 2.5 
Plasma Lipoproteins: The Relationship Between the Ratio 
of HDL Triglyceride:Cholesterol Concentrations 
and VLDL-lipids 
HDL I Triglyceride l 
Lcho1estero1 J 
VLDL-Triglyceride VLDL-Cholesterol 
Non-pregnant 
Pregnant: 
Normal delivery 
Hypertensive delivery 
All subjects 
n 
13 
19 
13 
47 
r 
0.381 
0.614 
-0.067 
0.536 
p 
n.s. 
<0.01 
n.s. 
<0.001 
r 
0.340 
0.584 
-0.065 
0.506 
p 
n.s. 
<0.01 
n.s. 
<0.001 
The correlation was not significant in the normal, non-pregnant subjects 
alone, but did become highly significant at delivery and for the whole 
group. The above relationship also held true between VLDL-cholesterol 
and the HDL triglyceride:cholesterol ratio (Table 2.5). 
D. FACTORS THAT MAY INFLUENCE LIPID METABOLISM DURING PREGNANCY 
1. Maternal Age and Parity The plasma lipid levels at the time of 
delivery were analyzed in a group of 86 women, to examine the possible 
effects of age and parity . In neither the whole group (Table 2.6a) nor 
among those women who had a total uneventful pregnancy and labour (Table 
2.6b) was there a significant effect on the plasma cholesterol and 
triglyceride levels attributable to age or to parity. 
2. Pre-Existing Hypercholesterolaemia Three of the women included 
in the study were known to have pre-existing hypercholesterolaemia. A 
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summary of the changes in their plasma lipids during the 3 trimesters is 
shown in Figure 2.3. Table 2.7 summarizes the cholesterol and triglyceride 
TABLE 2.6 
Plasma Lipid Changes During Pregnancy: 
The Effect of Maternal Age and Parity at Delivery 
(a) Among all women 
Age 
1 
PLASMA CHOLESTEROL* 
(20 years 367 ± 14.8 
(3) 
21-25 years 309 ± 14.8 
( 2 2) 
26-30 years 334 ± 19.5 
( 7) 
31-35 years 265 
(225-305) 
~36 years 
PLASMA TRIGLYCERIDE* 
<20 years 386 ± 93.0 
(3) 
21-25 years 291 ± 20.2 
( 22) 
26-30 years 270 ± 25.0 
( 7) 
31-35 years 166 
(155-178) 
~36 years 
Parity 
2 
303 ± 22.1 
(12) 
286 ± 10.6 
(9) 
249 
281 ± 22.1 
(12) 
270 ± 16.4 
(9) 
338 
3 
290 
326 ± 38.3 
(5) 
369 ± 28.4 
(6) 
285 
275 
270 ± 29.5 
(5) 
319 ± 35.1 
(6) 
255 
298 
(295-308) 
294 
( 288-300) 
289 
(280-298) 
359 
(32 8-390) 
254 
(220-273) 
258 
(245-280) 
279 
(220-378) 
358 
(316-400) 
*Concentration: mg/100 ml (mean+ S.E.M.) (n) or (range) 
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TABLE 2 . 6 
(b) Among women with a normal pregnancy and labour 
Age 
THE EFFECT OF AGE 
_f20 years 
21-25 years 
26-30 years 
31-35 years 
Pari ty 
THE EFFECT OF PARITY 
1 
2 
3 
~4 
n 
2 
21 
16 
4 
n 
34 
22 
13 
8 
Plasma 
Cholesterol* 
318 + 27.5 
291 + 15.9 
317 + 10.8 
292 + 5.8 
Plasma 
Cholesterol.* 
317 + 11.1 
293 + 12.8 
340 + 20.4 
310 + 14.6 
Plasma 
Triglyceride* 
273 + 2.5 
270 + 18.4 
284 + 15.6 
248 + 34. 0 
Plasma 
Triglyceride* 
288 + 17.1 
279 + 13.8 
292 ± 20.1 
288 ± 21.3 
*Concentration: mg/100 ml (mean+ S.E.M.) (n) or (range) 
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FIGURE 2.3 Plasma Lipid Ch anges During Pregnancy and in the 
Puerperium: The Effect of Pre-Existing 
Hypercholeste rolaemia 
The fasting plasma cholesterol and triglyceride concentrations of 
3 women with pre-exis ting hypercholeste rolaemia (2 with type IIa, 
and one with IIb) are shown compared to value s obtained from women 
during normal, uncomplicated pregnancies. The concentrations in 
the first trimester are value s up to 12 weeks' gestation, in the 
second trimester the mean o f me asur~~ents for any individual subject 
between weeks 13 to 24 , and up to 36 we eks for the third trimester. 
The puerperal value is a t 6-7 week s post parturn. 
Women having normal, uncompl icate d pregnancies 
Women with pre- existing hyperch o lesterolaemia 
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TABLE 2. 7 
Plasma Lipid and Lipoprotein Changes During Pregnancy: 
The Effect of Pre-existing Hypercholesterolaemia on Levels During the Third Trimester 
Normocholesterolaemic women 
(n=23) 
Hypercholesterolaemic women 
(n=3) 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Whole 
Plasma 
297 ± 14.6* 
294 ± 23.9 
501 ± 42.0 
412 ± 98.8 
*Mean± S.E.M. 
VLDL 
39 ± 5.2 
130 ± 14.7 
45 ± 18.5 
157 ± 65.3 
LDL 
189 ± 12.7 
118 ± 11.2 
403 ± 100.5 
219 ± 37.2 
HDL 
67 ± 3.9 
48 ± 3.1 
53 ± 2.5 
42 ± 7.5 
\.0 
a> 
concentrations of the lipoprotein fractions during the third trimester. 
The only treatment during pregnancy was a low cholesterol diet in one 
individua l. The percentage incre ase in whole plasma cholesterol and 
triglyceride at delivery was of the same order as seen in the total 
population, plasma cholesterol being 39%, 69 % and 51% greater and plasma 
triglyceride 2.70-, 4.10- and 2.29-fold greater respectively. 
The absolute amount of cholesterol and triglyceride within VLDL in 
the third trimester was only slightly above that found for the total 
population (Table 2.7), whilst the cholesterol content of HDL was 
significantly less (p <0.05). The large increase in cholesterol and 
triglyceride occurred in the LDL fraction, the ratio of cholesterol to 
triglyceride being similar to that in the total pregnant population 
(1.84:l and 1.60:l r espectively). 
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Clinically, the tendinous xanthomata of one subject showed a marked 
increase in size from early in the second trimester. These appear to be 
slowly regressing 6 months after delivery. Prominent arcus senilis also 
developed early in pregnancy . By 6-8 weeks postpartum this had regressed 
and disappeared . 
3. Hypertension and Pre-Eclampsia Hypertension is not uncormnonly 
recorded during labour . In the event of this occurring there is a 
difference in both whole plasma lipids and in the lipoprotein distribution 
(Table 2 . 8) . For the purposes of this analysis, the control group 
consisted of all samples obtained from normal deliveries in women who 
had an uncomplicated pregnancy . Cases of pre-existing hypercholesterolaemia 
have been excluded from both groups. The hypertensive group included all 
women in whom a recording of hypertension (~140/90) was made during labour, 
within 6 hours of delivery, and women with essential hypertension 
throughout pregnancy . The hypertensive group consisted of 3 women in 
whom the diagnosis of pre-eclampsia had been made (1 severe), 3 women 
with essential hypertension and 7 women who developed hypertension in 
AT DELIVERY 
Norrnotensive women 
(n=l9) 
Hypertensive women 
(n=l3) 
Significant differences 
(p) 
DURING PREGNANCY (31-40 wks) 
Norrnotensive women 
(n=l2) 
Hypertensive women 
(n=7) 
Significant differences 
(p) 
TABLE 2 .8 
Plasma Lipid and Lipoprotein Changes During Pregnancy: 
The Effect of Hypertension and Pre-Eclarnpsia 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Whole 
Plasma 
299 ± 12.1* 
237 ± 14.2 
308 ± 16.7 
327 ± 15.7 
<0.001 
274 ± 15.0 
231 ± 21.1 
307 ± 21.8 
332 ± 20.6 
<0.01 
VLDL 
27 ± 2.4 
109 ± 10.5 
43 ± 3.5 
167 ± 14.2 
<0.001 
<0.01 
24 ± 3.5 
112 ± 15.0 
43 ± 5.1 
171 ± 20.9 
<0.01 
<0.05 
*Concentration: mg/100 ml (mean ± S.E.M.) 
LDL 
184 ± 8.5 
90 ± 4.6 
186 ± 15.7 
108 ± 7.7 
<0.05 
170 ± 13.4 
84 ± 7.3 
198 ± 20.9 
115 ± 9.7 
<0.05 
HDL 
87 ± 6.3 
39 ± 1.7 
71 ± 6.5 
50 ± 2.9 
<0.01 
75 ± 4.0 
35 ± 2.4 
64 ± 7.1 
47 ± 3.4 
<0.01 
I--' 
0 
0 
labour. In one of the latter , the diagnosis of eclampsia was made 
r etrospectively following an abrupt increase in b lood pressure and a 
post-partl.IlTI haemorrhage . The strict definition of pre-eclampsia should 
include all subjects who develop hypertens ion during labour, as well as 
those diagnosed during g e station on grounds of weight , hypertension and 
oedema (Baird, 1969). 
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As mentioned in the methods section, samples taken during labour 
and at delivery are technically non-fasting, but there was no statistical 
difference in plasma lipid concentrations between these two groups (i.e. 
during labour and at delivery) and that taken in the fasting state at 
37-40 weeks of gestation (Table 2.1). 
As can be seen from the data in Table 2.8, the plasma triglyceride 
concentrations at delivery of the normal and hypertensive women were 
significantly different. There was no difference in total cholesterol 
levels. This was confirmed among the larger group of women (n=86), from 
whom data for age and parity were extracted. The excess plasma triglyceride 
occurred mainly in the VLDL, with a corresponding increase in cholesterol, 
so that the triglyceride:cholesterol ratio was maintained at approximately 
4:1. The absolute amount of LDL-cholesterol was similar in the two 
groups, but there was a significant excess of triglyceride in the 
hypertensive groups. The LDL1 subfrac
tion also reflected this, the 
cholesterol and triglyceride concentrations being 20 mg/100 ml and 25 
mg/100 ml respectively in the normals compared with 26 and 35 mg/100 ml 
in the hypertensive groups. In the hypertensive women the HDL-triglyceride 
content was increased, but cholesterol decreased. 
In the normal and hypertensive women , lipid measurements were also 
made during the third trimester of pregnancy in about half. These are 
shown in Figure 2.4 and Table 2 . 8 . The highe r triglyceride values were 
already present in the hypertensive group, as was the differenc e in 
lipoprotein distribution. In the puerperium there was no statistical 
FIGURE 2.4 Plasma Lipid Changes During Pregnancy: The Effect 
of Hypertension and Pre-Eclampsia 
The fasting plasma cholesterol and triglyceride concentrations found 
in women who already had hypertension, or developed hypertension and 
pre-eclampsia are compared with values found in women who had 
uncomplicated pregnancies. The third trimester values are 
measurements made between weeks 31-36 of gestation. 
Women with normal, uncomplicated pregnancies 
Women who had hypertension and/or pre-eclampsia 
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difference between the triglyce rid e l e v e l s in the hyp erte n s ive and normal 
groups. 
The age distribution of the incidence of pre-eclampsia wa s as 
expected, with the younger age groups having a higher incidence. Among 
those 20 years or younger, 50% had pre-eclampsia (2/4), 39% of those 
between 21 and 25 years (22/47), 23% between 26 and 30 years of age 
(8/33). The definition of pre-eclampsia used here was the same as 
previously, i.e. including all subjects who developed hypertension during 
labour. 
4 . Pre-Existing Renal Disease This study is of a single patient 
previously diagnosed as having Alport's Syndrome, an hereditary condition 
of chronic renal disease and deafness. She was normotensive. Plasma 
lipids were normal during the first trimester, but subsequently the plasma 
cholesterol increased sharply, with a concurrent increase in LDL-cholesterol 
(Table 2.9). The major change, however, was in the plasma triglyceride, 
which occurred in mid-pregnancy, being 305 mg/100 ml at 22 weeks, compared 
with the group mean of 168 mg/100 ml at 19-24 weeks (Table 2.1). This 
increase was accompanied by a marked increase in proteinuria, which 
persisted until after delivery. The plasma lipids fell rapidly in the 
puerperium. 
E. PLASMA LIPID AND LIPOPROTEIN CHANGES DURING USE OF A 
"LOW DOSE" OESTROGEN ORAL CONTRACEPTIVE 
The plasma lipid and lipoprotein distribution of 5 women were 
measured b e fore and after commencement of a "low dose" oestrogen mixed 
oral contraceptive (Nordiol 28 , Wyeth Pharmaceuticals Ltd.). The 
pre-treatment sample was taken in the third week of the menstrual cycle 
prior to commencing treatment, and the treatment sample during the third 
week of the first cycle on the contraceptive preparation. 
Table 2.10 shows the plasma lipid and lipoprotein distributions. 
Whilst the change in plasma cholesterol was not statistically significant, 
TABLE 2.9 
Plasma Lipid and Lipoprotein Changes During Pregnancy: 
The Effect of Pre-existing Renal Diseaset 
7 weeks gestation 
14 weeks gestation 
22 weeks gestation 
36 weeks gestation 
At delivery 
6 wks post parturn 
Cholesterol* 
Triglyceride* 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
Cholesterol 
Triglyceride 
*Concentration: mg/100 ml 
Whole 
Plasma 
224 
140 
280 
158 
318 
305 
415 
387 
537 
543 
236 
135 
** Cholesterol 
LDL1 77 
Triglyceride 
140 
216 189 
tone subject only 
VLDL 
12 
5 
9 
59 
36 
154 
49 
167 
43 
112 
10 
57 
LDL 
149 
63 
196 
69 
205 
96 
258 
160 
293** 
329** 
163 
55 
HDL 
62 
23 
75 
29 
77 
54 
104 
60 
100 
101 
72 
23 
104 
105 
the increase in triglyceride concentration was. Few of the lipoprotein 
changes achieved the level of statistical significance. In LDL1 
(d 1.006-1.019), both cholesterol and triglyceride concentrations 
increased (p <0 . 001 and p <0 . 01 respectively). The cholesterol 
concentration of HDL decreased (p <0.001) . 
DISCUSSION 
A. PLASMA LIPID AND LIPOPROTEIN CHANGES DURING PREGNANCY 
Normal Pregnancy . Both plasma cholesterol and triglyceride concentrations 
increased markedly during pregnancy. The major increase in cholesterol 
occurred during the second trimester, becoming maximal during the 3lst-
36th weeks of gestation, remaining high until delivery. This pattern is 
similar to that reported by De Alvarez et al (1959) and Pantelakis et al 
(1964b), in contrast to descriptions of either acontinuedincrease up to 
term (Moses et al , 1952; Vernet and Smith, 1961; Svanborg and Vikrot, 
196 5a) or a slight decrease prior to term (Oliver and Boyd, 1955; Watson, 
1957; Hashmi and Afroze, 1972). The studies were not commenced early 
enough during gestation to determine the earliest changes in plasma lipids, 
having in mind the decreases in plasma cholesterol which have been 
reported during the first trimester (De Alvarez et al , 1959; Green, 
1966). The small sample in Table 2.1 showed no decrease. 
Plasma triglyceride levels became maximal in the third trimester 
and remained elevated until delivery . Other workers have also demonstrated 
a 2 to 3-fold increase (Cramer et al , 1964/5; Konttinen et al, 1964; 
Svanborg and Vikrot , 1965a; Renkonen , 1966; Damiani et al , 1972; Knopp 
et al, 1973). Svanborg and Vikrot (1965a) found a positive correlation 
between plasma triglyceride and time of gestation. 
The lipoprotein changes during pregnancy varied in the different 
fractions. A significant increase in the triglyceride content of LDL had 
occurred by the 13th-18th weeks of gestation and in the cholesterol content 
TABLE 2 .10 
Plasma Lipid and Lipoprotein Changes During the First Cycle on a "Low Dose" Oestrogen Mixed Oral Contraceptive 
Subject 1 Before 
After 
D. 
Subject 2 Before 
After 
D. 
Subject 3 Before 
After 
D. 
Subject 4 Before 
After 
D. 
Subject 5 Before 
After 
D. 
Group Before mean 
S.D. 
After mean 
S.D. 
Significant difference 
(paired t-test) 
Cholesterol Concentration* 
Whole 
Plasma 
191 
205 
+14 
205 
216 
+11 
227 
262 
+35 
228 
199 
-29 
199 
194 
- 5 
210 
16.7 
215 
27.4 
n.s. 
VLDL 
3 
6 
+3 
2 
6 
+4 
16 
13 
-3 
9 
14 
+5 
10 
15 
+5 
8 
5.7 
11 
4.4 
0.06 
LDLl LDL 2 
3 106 
6 131 
+3 +25 
4 131 
6 159 
+2 +28 
6 138 
12 177 
+6 +39 
4 133 
7 119 
+3 -14 
4 129 
7 136 
+3 + 7 
4 127 
1.1 12.9 
8 144 
2.5 23.3 
<0.001 0.06 
HDL 
80 
62 
-18 
67 
45 
-22 
63 
59 
- 4 
82 
59 
-23 
56 
36 
-20 
70 
11.1 
52 
11.2 
<0.001 
*Concentration: mg/100 ml 
Triglyceride Concentration* 
Whole 
Plasma 
80 
92 
+12 
35 
56 
+21 
136 
136 
0 
119 
142 
+23 
106 
109 
+ 3 
95 
39.4 
107 
35.0 
0.01 
VLDL 
19 
36 
+17 
8 
16 
+ 8 
82 
58 
-24 
61 
81 
+20 
57 
62 
+ 5 
45 
30.9 
51 
25.1 
n.s. 
LDL
1 LDL 2 
7 24 
13 26 
+6 + 2 
3 14 
9 19 
+6 + 5 
11 23 
18 40 
+9 +17 
12 25 
15 25 
+3 0 
11 22 
10 23 
-1 + 1 
9 22 
3.8 4.4 
13 27 
3.7 8.0 
<0.01 n.s. 
HDL 
28 
15 
-13 
10 
12 
+ 2 
21 
20 
- 1 
20 
21 
+ 1 
16 
13 
- 3 
19 
6.6 
16 
4.1 
n.s. 
1--' 
0 
(J) 
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by the 19th-24th weeks. The choles t e rol and triglyce rid e o f HDL we re 
significantly higher during the first half of pre gnancy than in non-
pregnant women, but while the triglyce ride compone nt remaine d ele vated 
throughout pregnancy , the cholesterol content of HDL decreased to that 
found in non-pre gnant women. Because of the wide range of values in 
VLDL composition, no significant increase in VLDL cholesterol or 
triglyceride was found until mid-pregnancy. There are no figures 
available for comparison of the cholesterol and triglyceride content of 
lipoprotein fractions prior to the third trimester of pregnancy . The 
change in the ratio of 6 and a lipoproteins on electrophoresis during 
pregnancy (Oliver and Boyd, 1955; Russ et al , 1954; von Studnitz, 1955) 
and the presence of an increasing quantity of lipid in the pre-6 
lipoprotein band, which corresponded with VLDL on ultracentrifugation 
(Pantelakis et al , 1964b), are in accord with this study and that of 
Knopp et al (1973). During the third trimester of pregnancy, the latter 
authors found the triglyceride content of the 3 major lipoproteins to 
be increased, while the cholesterol content of VLDL and LDL was also 
increased. 
Complications of Pregnancy . In this current study, the occurrence of 
hypertension and pre-eclampsia resulted in an increase in whole plasma 
triglyceride concentration, which was reflected mainly as an increase in 
VLDL. Similarly, in the case of pre-existing renal disease, the 
triglyceride increase was greater than in the normal population. 
Hypercholesterolaemia magnified the hypercholesterolaemic response. In 
studies of the effect of complications on plasma lipid changes, diabetic 
pregnancy and pre-eclampsia are two factors to have been considered. In 
pre-eclampsia, plasma cholesterol levels have risen higher than in normal 
pregnancy in some studies , though the increase was not always significant 
(Boyd, 1934a,b; De Alvarez and Bratvold , 1961; Konttinen e t al, 1964). 
Plasma triglycerides also tend to be higher (Nelson et al, 1966). The 
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lipid changes during diabetic pregnancies have been shown to be greater 
than in normal pregnancies , with an increased S-band on electrophoresis 
evident from early in pregnancy (Vernet and Smith, 1961; Pantelakis et 
al, 1964a), and a pre-S band which may r emai n e l evated for up to 2 weeks 
postpartum (Vernet and Smith, 1961). Knopp et al (1973) have r eported 
the plasma triglyceride leve l to be significantly higher during the third 
trimester in a group of diabetics. 
Hyperlipoproteina,emic Phenotype . Considering the distribution of lipid 
among the lipoproteins during the third trimester, the elevation of plasma 
choles terol was distributed between VLDL and LDL, whilst triglyceride was 
increased in all 3 fractions. The situation earlier in pregnancy differed 
only in that HDL cholesterol was also raised. This pattern (reported 
also by Knopp et al, 1973) conforms ~ost closely to that of genetic 
combined hyperlipoproteinaemia (Rose et al, 1974), which may or may not 
correspond to Type IIb hyperlipoproteinaemia (W.H.O., 1972) and mixed 
hyperlipoproteinaemia (Brown et al, 1973). In this phenotype there is 
elevation of both plasma cholesterol and triglyceride with elevations of 
both VLDL and LDL. Such a combined pattern has been described in 
other metabolic disorders, notably in the nephrotic syndrome (Baxter et 
al, 1960), amongst monotropic growth hormone-deficient dwarfs (Merimee 
et al, 1972) and in insulin-deficient diabetics (Chance et al, 1969; 
Wilson et al, 1970). In nephrosis, the higher the VLDL increase, the 
less dramatic the LDL rise (Baxter et al , 1960) and vice versa; VLDL and 
HDL are also reciprocally related. Reciprocal relationships between VLDL 
and LDL have also been noted during weight reduction, carbohydrate 
induction of hypertriglyceridaemia and during clofibrate treatment (Havel 
and Gordon, 1960; Strisower et al , 1968; Nichols, 1969; Wilson a nd Lees, 
1972), and between VLDL and HDL during carbohydrate induction (Levy et al , 
1966) and clofib rate treatment (Strisower et al, 1968). 
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The Role of Hormones . It is like ly that the hyperlipidaemia of pregnancy 
is related to hormonal changes. 
Insulin The similarity in lipoprotein patterns between pregnancy and the 
insulin-deficien t diabetic and the growth hormone-deficient dwarf may 
seem almost paradoxical. The level of insulin is elevated in both the 
fasting state and in response to glucose during the third trimester of 
pregnancy (Spellacy et al , 1963; Bleicher et al, 1964). It has been 
suggested that this increase is secondary to the raised free fatty acid 
levels leading to relative insulin resistance (Spellacy et al, 1963; 
Bleicher et al , 1964; Freinkel, 1964). 
HPL and HGH Human placental lactogen (HPL or human chorionic 
sornrnatotrophin), which was identified in the early 1960's by several 
workers including Josimovich and MacLaren (1962) has chemical, 
immunological and biological similarities to human growth hormone (HGH), 
whilst also having lactogenic activity (Liggins, 1972). Its presence in 
the maternal circulation may be detected from the sixth week of pregnancy, 
and it steadily increases to become maximal at about 34 weeks (Beck and 
Daughaday , 1967), remaining high until delivery. Its secretion throughout 
pregnancy is thought to be a direct function of placental weight 
(Josimovich, 1971). Similar to its counterpart, HGH, it has diabetogenic 
effects, being glucose-sparing and resulting in mobilization of free fatty 
acid (Grumbach et al , 1968). Enhancement of in vitro lipolysis in adipose 
tissue has been demonstrated (Turtle and Kipnis, 1967) as has synergistic 
action with HGH (Turtle and Kipnis, 1967; Murakawa and Raben, 1968), the 
latter having 10 to 1000 times the activity of HPL. HPL has been 
demonstrated to have an insulogenic activity, increasing circulating 
insulin levels whe n infused into normal subjects (Beck and Daughaday, 
1967) and producing in animals changes in S cells similar to those seen 
during pregnancy (Malaisse et al , 1969). 
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Oestro_g__ens Oestrogens may also be implicated although some of the effects 
of oestrogens could result from the interaction with other hormones. The 
use of oral contraceptive preparations has been accompanied by changes in 
insulin levels and reactivity (Spellacy et al, 1967, 1968; Yen and Vela, 
1968; Hazzard et al , 1969; Wynn and Doar, 1969), and in growth hormone 
levels (Spellacy , 1967a,b). Beck and Wells (1969) have suggested that 
oestrogens themselves may induce end-organ resistance to glucose transport 
in the peripheral tissues . The progestogenic components of oral 
contraceptives have also been implicated in changes in carbohydrate 
metabolism in monkeys (Beck , 1969). 
Corticosteroids Plasma corticosteroids increase progressively throughout 
pregnancy (Bayliss et al , 1955). The level of free cortisol in plasma 
is either normal or elevated and the transcortin concentration is increased 
(Doe et al, 1969; O'Connell and Walsh, 1969). Clinically the pregnant 
woman shows several features of Cushing's syndrome; resistance to 
insulin, lymphopenia, eosinopenia, amino aciduria and glucosuria (Steinbeck, 
1972). Glucocorticoids decrease glucose utilization in muscle and adipose · 
tissue, accelerate gluconeogenesis and increase circulating free fatty 
acids. Increases in all lipids and lipoproteins have been observed in 
subjects treated with cortisone (Adlersberg et al , 1950, 1951). 
Thyroid Function Plasma protein-bound iodine and total thyroxine increase 
during the first trimester and remain elevated until 6 weeks post parturn 
(Ibbe rtson, 1972) . Free thyroxine may be increased during the first 11-
18 weeks (Fisher et al , 1970). Other functions of thyroid activity also 
alter, with the BMR increasing 20-30% by the third trimester (Freedberg 
et al, 1970). The addition of increased circulating thyroxine may 
furthe r aggravate the insulin resistance of the pregnant woman. This may 
tend to negate the effect of increasing thyroxine, which frequentl y r esults 
in low levels of LDL and choles t e rol (Fredrickson et al, 1967). 
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Rena.l Physiology and Disease . The hyperlipidaemia of pregnancy and that 
seen in some cases of the nephrotic syndrome show other similarities . 
Renal function is altered in normal pregnancies, with an increase in 
glome rular filtration rate and renal blood flow (Nanra and Kincaid-Smith, 
1972), the former secondary to increased plasma volume. Aldosterone 
production is increased, as isrenin-angiotensin activity . Urinary 
catecholamine excretion is not altered during normal pregnancy (Zuspan, 
1970) but a reported sensitivity to catecholamines occurs in complications 
such as oedema, proteinuria and hypertension, i.e., pre-eclampsia (Raab 
et al, 1956; Talledo et al, 1968). 
The syndrome of nephrosis is defined as hyperlipidaemia, 
hypoalbuminaemia, proteinuria and generalized oedema. It is then a 
quartet of symptoms, representative of a group of renal diseases and 
pathologies. Comparison of the symptoms with those that might occur 
during the third trimester reveal a shared hypoalbuminaemia (in pregnancy 
secondary to an increase in plasma volume), generalized oedema, which 
occurs in 30% of normal pregnancies (Thomson et al, 1967) and of course, 
hyperlipidaemia . Proteinuria in pregnancy occurs in pre-eclampsia. 
Hypertriglyceridaernia was more severe among the women who had hypertension 
at term, and who by Baird's criteria would be considered to have 
pre-eclampsia at delivery. Pathological renal lesions accompanying 
pre-eclampsia have been described (Robbins, 1967), and on occasion may 
be extremely difficult to differentiate from changes which occur in many 
of the renal dise ases which produce the nephrotic syndrome. Experimental 
nephrosis produced in rats by anti-kidney serum is accompanied by 
hypoalbuminaemia, hepatic hyperplasia and marked increases in VLDL and LDL 
synthes is in the perfused liver (Marsh and Drabkin, 1960) or liver slices 
(Radding and Steinberg, 1960), as well as lipid accumulation within the 
liver (Hoak et al , 1968). The turnover of plasma esterified cholesterol 
and triglyceride has been reported to be increased in subjects with 
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nephrosis (McKenzie and Nestel , 1968; Kekki and Nikkila , 1971b) . 
Lipoprotein and Lipid Metabolism . The hyperlipidaemia of pregnancy may 
be discussed in terms of alterations in synthesis and catabolism of 
lipoproteins and their lipid constituents. 
Free fatty acids stimulate the hepatic secretion of triglycerides 
by increasing both the number and the size of the VLDL molecules. Nestel 
and Steinberg (1963) and Heimberg et al (1965) reported this 
relationship with liver perfusion studies. In pregnancy, increased 
lipolytic activity could occur as the result of HPL and increased 
corticosteroids. 
Endogenous cholesterol synthesis increases with body weight (Nestel 
et al, 1969). The weight accumulated during a normal pregnancy is greater 
than that due to the increased size of the uterus and its contents and the 
increase in plasma volume. There is also increased deposition of body 
fat (Hytten and Leitch, 1972). Plasma cholesterol concentration need not 
be related to the rate of production or the amount of cholesterol in the 
two exchangeable pools in normal subjects or in individuals with 
established hyperlipoproteinaemia (Nestel et al, 1969). This does not 
exclude such a relationship when the plasma cholesterol is rising 
progressively as in pregnancy. 
With respect to the protein components of the plasma lipoproteins, 
the half-life of LDL protein in normal women (Walton et al, 1963, 1965) 
may be shorter than in men (Gitlin et al, 1958; Langer et al, 1969), a 
comparison similar to that reported by Scott and Hurley (1969) who undertook 
longer studies. However, Langer et al (1972) were unable to demonstrate 
any sex difference. Among pathological conditions which may have some 
comparable features to changes during pregnancy, the turnover of LDL is 
apparently increased among nephrotic children (Gitlin et al, 1958) and 
in some patients with hyperlipaemia (Walton et al, 1965; Scott and 
Winterbourn, 1967). This area is clouded by the study of patients with 
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different forms of hyperlipidaemia. The catabolic rate of LDL has been 
reported to be decreased in subjects with Type IIa hyperlipoproteinaemia 
(Langer et al, 1969a,b, 1972), though Scott and Winterbourn (1967) have 
shown that the absolute turnover may be increased. Recent reports by 
Simons et al (1973) show an increased turnover of LDL protein in 
homozygous hypercholesterolaemia. Reinjected HDL-protein clearance is 
increased in patients with endogenous hypertriglyceridaemia, but this may 
be due to their diminished HDL pool (Furman et al, 1964). The labelled 
small molecular weight polypeptides of human VLDL transfer to HDL both 
in vitro and in vivo, while the apolipoprotein of LDL (apoLDL) found in 
VLDL moves unidirectionally from VLDL (d <1.006) to LDL (d 1.019-1.063) 
via an intermediate density range (1.006-1.019) (Bilheimer et al, 1972; 
Eisenberg et al, 1973). The small polypeptide transfer also occurs 
following infusion of human VLDL into the squirrel monkey (Schonfeld et al, 
1972). Infusion of heparin affects the in vivo distribution of the 
radioactivity associated with the small polypeptides and their movements 
between VLDL and HDL, as well as in the subfractions of VLDL (Eisenberg 
et al, 1973). 
Some interrelationships between lipoproteins have been briefly 
demonstrated in the results section. Some of these are functionally 
important: the catabolism of VLDL probably requires activity of the 
enzyme lecithin:cholesterol acyl transferase (LCAT), which initially 
esterifies cholesterol in HDL (Glomset, 1968). In these current studies, 
the ratio of free:esterified cholesterol in LDL decreased slightly from 
0.42 in the non-pregnant population to 0.34 during labour. The ratios 
in VLDL and HDL were unchanged. Svanborg and Vikrot (1965c) were unable 
to demonstrate any difference in the percentage of cholesterol esterified 
in vitro in the plasma of pregnant patients. Whilst this was not a direct 
measure of LCAT activity, they interpreted this as showing that enzyme 
activity was unchanged during the third trimester. In rats, administration 
of a mixed steroid contraceptive increases the rate of plasma 
cholesterol esterification (Aftergood et al , 1968). 
The reason for the fr equently observed reciprocal relationship 
between VLDL and other lipoproteins in some hyperlipaemias is unknown, 
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but may reflect diminished catabolism of VLDL since some and possibly all 
LDL protein is derived from VLDL. LDL and HDL are also reciprocally 
related and this can be shown by treatment with oestrogens and androgens 
(Oliver and Boyd, 1954, 1956a,b; Hood, 1959; Robinson and Le Beau, 1965). 
The forme r results in a decreased LDL and an increased HDL concentration, 
VLDL also increasing, whilst the latter gives rise to the reverse. 
Combine d preparations result in intermediate responses that depend on the 
relative proportions of the component steroids (Stokes and Wynn, 1971). 
Triglyceride kinetics are altered by the steroids, synthesis being 
increased by the oestrogenic component and clearance by the progestogenic 
drug (Kekki and Nikkila, 1971a; Kissebah et al, 1973). By extrapolation 
it may be considered that a similar state exists during pregnancy. The 
maintenance of a constant cholesterol to triglyceride ratio in VLDL in 
this study would support the theory of increased VLDL synthesis secondary 
to increased triglyceride synthesis. Increased synthesis of triglyceride 
in response to oestrogen treatment occurs in the absence of elevated free 
fatty acid levels or an increase in free fatty acid turnover (Kissebah 
et al, 1973). Plasma free fatty acid levels are raised in pregnancy 
(Nelson et al , 1966; Fioretti et al, 1970; Becker et al, 1971) and 
may provide an additional stimulus for greater triglyceride production. 
Post-heparin lipolytic activity (PHLA), the key enzyme responsible for 
triglyceride clearance, has been found to be depressed during pregnancy 
(Meng and McGanity, 1958; Fabian et al, 1968). If this were the case, 
then the basis of the hypertriglyceridaemia of pregnancy might involve 
reduced clearance as well as increased production. However, in the current 
studies, the absolute amount of LDL-cholesterol and triglyceride increased 
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markedly, which , togethe r with the evidence from oral contraceptive 
studies, would suggest that a decrease in the rate of catabolism of VLDL 
was not the major cause of the hypertriglyceridaemia, although the rate 
of clearance was obviously not sufficient to prevent the rise in 
triglyceride . The reportedly low levels of PHLA did not take into account 
the expanded plasma volume (Hytten and Leitch, 1972). While PHLA may 
therefore not be low in normal pregnancy it is reduced in pregnancy 
complicated by diabetes (Knopp and Arky, 1972). In this latter situation 
there is an exaggeration of the increased triglyceride concentration of 
pregnancy. 
B. PLASMA LIPID AND LIPOPROTEIN CHANGES DURING THE PUERPERIUM 
Plasma cholesterol and triglyceride concentrations fall during the 
first 24 hours after delivery. The plasma triglyceride continued to 
decrease, but was still higher than in the non-pregnant population 6-7 
weeks postpartum. By comparison the plasma cholesterol concentration 
underwent a further increase, the LDL-cholesterol content being the same 
on day 5 postpartum as at delivery. It subsequently decreased slowly, 
but was still significantly higher than in the controls at 6-7 weeks 
after delivery. 
Previous reports have also indicated that the levels of cholesterol 
and triglyceride decrease in the puerperium, the cholesterol more slowly 
than the triglyceride (Watson, 1957; De Alvarez et al, 1959; Konttinen 
et al , 1964; Svanborg and Vikrot, 1965b) . One report however showed 
some variance with the generally reported pattern of cholesterol change. 
Oliver and Boyd (1955) found the level to decrease after delivery, but 
subsequently to rise so that at the end of the first week, the plasma 
level was the same as, or slightly higher than, the concentration at 
delivery . This is similar to the findings in the present study. Since 
the secondary increase occurred in the LDL fraction, it probably resulted 
from the rapid catabolism of VLDL and conversion to LDL. The fall in VLDL 
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and triglyceride concentrations may have partly reflected the fall in 
free fatty acid concentration, which occurs after delivery of the 
placenta (Fairweather, 1965), and resembles the rapid fall seen after 
commencing nicotinic acid (Carlson et al, 1968) . The kinetics of free 
fatty acid and triglyceride in VLDL are much more rapid than that of 
cholesterol, and the more rapid fall in triglyceride than in cholesterol 
would be expected. The turnover of free fatty acid is measured in minutes, 
that of triglyceride in hours, but that of cholesterol in weeks. 
Both cholesterol and triglyceride were significantly higher than in 
the control women 6-7 weeks postpartum. This finding was similar to 
that of other workers , who have found lipid levels to remain elevated 
for weeks or months after cessation of pregnancy (Peters et al, 1951; 
Oliver and Boyd, 1955; De Alvarez et al, 1959). Lactation did not 
apparently influence lipid levels. The post-partum hyperlipidaemia was 
found to be very sensitive to dietary manipulation, responding quickly to 
changes in dietary cholesterol and fatty acid composition (Chapter 6). This 
is in contradistinction to findings during pregnancy, when diet does not 
readily influence the hyperlipidaemia (Moses et al, 1952; Hansen et al, 
1964; Mullick et al , 1964; Green, 1966). The persistent post-partum 
hyperlipidaemia might therefore reflect dietary factors. The possibility 
that it may be hormonally mediated is supported by the findings that 
hyperlipidaemia may persist after use of sex steroid preparations, e .g. 
oral contraceptives . The altered triglyceride kinetics may be detected 
up to 6 weeks after stoppingtheiruse(Kekki and Nikkila, 1971a). Many 
physiological parameters apparently return to normal very quickly after 
removal of the foetus and placenta; for instance there is an immediate 
improvement in the hypertension of pre-eclampsia and eclampsia, though 
no difference was found in the rate of lipid change among this group of 
women as compared with the others. Patients suffering from cholestasis 
of pregnancy or that due to the use of oral contraceptives rapidly lose 
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symptoms such as pruritis caused by the retention of bile salts 
(Adlercreutz et al , 1968) . Hepatic excretory function which may be 
diminished during pregnancy as measured by bromsulphthalein excretion 
(e.g. Combes et al , 1963) improves rapidly post-partum as sho..m by the 
increased biliary concentration of cholesterol and bile acids in the 
first week after delivery (Large et al , 1960). However , the restoration 
of other metabolic functions and the return of hormonal equilibrium to 
the non-pregnant state might conceivably take much longer. 
CHAPTER 3 
STEROL AND BILE ACID EXCRETION DURING PREGNANCY 
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INTRODUCTION 
The hyperlipaemia of pregnancy conforms most closely to the 
phenotype of combined hyperlipoprote inaemia. The plasma cholesterol 
concentration increases significantly and maximally during the second 
trimeste r, while the increase in plasma triglyceride is maximal in the 
third trimes ter. Possible differences in the handling of cholesterol and 
bile acids may b e partly responsible for, or related to, the 
hyperlipidaemia. 
The incidence of gall-bladder disease is higher among women of 
childbearing age than among men of the same age (Kaye and Kern, 1971). 
The secretion of biliary cholesterol is similar among men and women, but 
bile acid secretion may be reduced in some women (Grundy et al, 1972). 
The incidence of gall-bladder disease is increased two-fold amongst users 
of oral contraceptives and is two and a half times higher amongst post-
menopausal women taking oestrogen (Boston Collaborative Drug Surveillance 
Program, 1973, 1974). Both cholesterol and bile salt concentrations are 
increased in bile with oral contraceptives (Davis and Preston, 1972). The 
oestrogen-induced increase in biliary cholesterol concentration and 
reduction in the pool size and synthesis rate of bile acids has been 
confirmed by Pertsemlidis et al (1973a). During pregnancy in the human, 
the bile acid concentrations in plasma are unchanged from the non-pregnant 
situation (Sjovall and Sjovall, 1966). However, a single report noted a 
decrease in biliary cholesterol and bile acid concentrations in the second 
half of pregnancy (Large et al, 1960). 
Sterol balance studies have been carried out on 7 women at 3 stages 
during normal pregnancies in order to further elucidate possible 
mechanisms associated with the hyperlipaemia of pregnancy . 
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METHODS 
A. EXPERIMENTAL DESIGN 
Suhjects . Sterol balance was studied during each of the three trimesters 
of pregnancy in 7 women . The group had a mean age of 26 . 9 years (range 
25-29 years), and included both nulliparous and multiparous women. 
Table 3.1 gives the details of each subject. The study was conducted 
with subjects remaining in a free-living situation. 
Diet . A diet of approximately constant cholesterol composition was designed 
for each woman for use in the study periods, with the aim of making it as 
similar to her usual diet as possible . Each woman was instructed in the 
weighing and preparation of the cholesterol-containing foods and the need 
for rigid adherence to the diet. The prescribed diet was conunenced -10 
days prior to a faecal collection period , and continued throughout the 8 
days of collection . 
Collections . It was decided not to use an inert fae cal marker , although 
it seemed most unlikely that chromium sesquioxide would be te r atogenic. 
Corrections for faecal flow could therefore not be made , but it was hoped 
that sterol excretion would be averaged in an 8 day collection of faeces. 
Faeces were collected directly into plastic bags, and deep frozen . 
Fasting blood samples were collected at 4 to 5 week intervals during 
pregnancy, at least one lipid estimation being carried out during each 
study period . 
B . LABORATORY METHODS 
Plasma Lipids. Plasma cholesterol and triglyceride were estimated in a 
Technicon Auto Analyser Mark II Colorimeter. Plasma lipoproteins were 
separated by preparative ultracentrifugation and precipitation (Chapter 2). 
1easUY1ement of Faecal eutral Sterols and Bile Acids. The method used 
was that of Miettinen et al (1965) and Grundy et al (1965). 
Extraction The faeces were collected into two 4-day pools and each pool was 
homogenized with water . Duplicate aliquots of about 2 gm were taken for 
Name 
N.B. 
R.B. 
R.C. 
H.M. 
R.S. 
c.v.d.s. 
c.w. 
Age 
(years) 
29 
27 
25 
27 
25 
28 
27 
TABLE 3.1 
Women in the Sterol Balance Studies: Personal and Dietary Details 
Parity 
2 
0 
1 
1 
0 
1 
1 
Gestation 
(weeks) 
10 
11 
8 
9 
10 
10 
12 
First Trimester 
Weight 
(kg) 
63.6 
55.8 
60.4 
45.4 
60.4 
63.6 
55.4 
Plasma 
Cholesterol 
(mg/100 ml) 
227 
226 
229 
182 
221 
149 
233 
Plasma 
Triglyceride 
(mg/100 ml) 
166 
103 
87 
86 
117 
53 
98 
Dietary 
Chole sterol 
(mg ) 
454 
443 
213 
420 
450 
426 
420 
I--' 
rv 
0 
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neutral sterol and bile acid extraction and analysis . Internal standards 
of 5-10,000 dpm of labelled cholesterol and bile acid were carried 
through the procedure. The aliquots were saponified with 2 mls of 10 N 
sodium hydroxide and 18 mls of 95% ethanol and r efluxed for 1 hour over 
a steam bath. Ten mls of water were added to the cooled samples and the 
neutral sterols were extracted into petroleum ether (B.P. 60-80°C), 
(3x50 mls, lx25 mls). The neutral sterols were separated into choleste rol, 
coprostanol and coprostanone bands by thin layer chromatography using a 
heptane:ether; 45:55 solvent system. Each band was eluted separately. 
An aliquot of the cholesterol band was taken for counting to calculate 
recovery, which averaged 90%. A known aliquot of 5-a cholestane was 
added to each band to act as internal standard during gas liquid 
chromatography. 
The ethanolic solution containing the bile acids was evaporated 
almost to dryness. Following the addition of 5 mls of 2 N sodium hydroxide 
1 it was further saponified at high pressure (2 atmospheres) for 2 /2 hours. 
After cooling to room temperature, the bile acids were extracted at pH 2 
into chloroform:methanol; 2:1 (v:v) (60 ml) and chloroform (2x40 ml). 
The large volume was reduced to dryness in a rotary evaporator, and the 
extract redissolved in 10 ml of chloroforrn:methanol; 2:1. A one ml 
aliquot was taken for measurement of radioactivity to calculate bile acid 
recovery. The remaining 9 ml were evaporated to dryness, and the bile 
acids methylated at room temperature overnight, using 4 ml of 5% HCl in 
dry methanol. Following methylation, the mixture was evaporated to 
dryness and redissolved in 9 ml of chloroform:methanol; 2:1. The 
methylated bile acids were separated by thin layer chromatography of a 4 
ml aliquot using first a benzene solvent to separate the fatty acid methyl 
esters. The plates were then run in a second solvent, iso-octane: 
isopropanol:acetic acid; 60:20:0.5. The bile acids were eluted with 
methanol, evaporated to dryness and redissolved in 4 ml of ethyl acetate, 
from which 1 ml was taken to check for losses . To the remaining 3 ml, 
130 µg of 5-a cholestane was added . 
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Gas Chromato_g_r~hic Analysis The aliquots containing the sterols plus 
5-a cholestane were evaporated to dryness . Fifty µl of silylating agent 
(Tri-Sil , Pierce Chemical Co ., Illinois, U.S.A.) was added 30 minutes 
prior to injection. Standards of cholesterol and methyl chelate were 
similarly silylated and analyzed repeatedly. The gas chromatograph 
(Packard Series 7800) contained a 6 foot, coiled, glass column , packed 
with 1% DC-560, 100/120 mesh on Gas-Chrom Q (applied Science Lab ., State 
Park, Pennsylvania , U.S.A.). The following conditions were ope rative: 
Inlet temperature 260°C 
Column t emperature 240°C 
Flame ionization de tector temperature 250°C 
Outlet temperature 250°C 
Carrier gas (N 2 ) flow rate 60 ml/min 
Hydrogen flow rate 40 ml/min 
Air flow rate 375 ml/min 
Column inlet pressure 28 psi 
RESULTS 
A. PLASMA LIPIDS 
The plasma cholesterol and triglyceride concentrations during 
pregnancy are shown in Table 3.2. They are very similar to the changes 
previously described amongst the larger group of subjects (Chapter 2) . 
B. STEROL BALANCE DURING PREGNANCY 
1 . Bile Acid Excretion There was some variation between individuals 
which was of the order found in non-pregnant women . The mean bile acid 
Gestation 
(weeks) 
9-11 
12-14 
15-18 
19-22 
23-26 
27-30 
31-34 
TABLE 3. 2 
Plasma Lipid Changes During Pregnancy 
n 
Plasma Lipid Concentration 
(mg/100 ml) 
Cholesterol Trigylceride 
6 206 + 13.4* 102 ± 15.5 
6 211 ± 17.0 85 + 8.7 
6 225 + 13.4 119 + 19.0 
7 262 + 13.6 143 + 22.2 
5 282 + 18.4 166 + 15.3 
4 295 ± 12.2 180 + 8.9 
7 300 + 15.3 251 + 40.4 
*concentration: mean+ S.E.M. 
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excretion was 155 mg/day (2.75 ± 0 . 96 mq/kg/day) during the first 
trimester (Table 3.3). Due to inter-subject variation, the mean of 197 
mg/day found in the second trimester was not statistically different . 
However, the lower value of 152 mg/day in the third trimester was 
significantly different from the excretion in the second trimester 
(p <0.01). Therefore, there may be an increase in bile acid excretion 
during the second trimester of pregnancy which returns during the third 
trimester to first trimester values. 
2. Neutral Sterol Excretion The amount of total neutral sterol 
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excreted in the faeces also varied between individuals to the degree found 
in published studies in men and non-pregnant women. The neutral sterol 
excretion within the group remained unchanged throughout pregnancy, as did 
the net sterol excretion, which is the sum of bile acid and neutral sterol 
excreted minus the dietary cholesterol. 
3. Plasma Lipids and Sterol Excretion During the second trimester 
there was a positive correlation of 0.761 (p <0.05, n=7) between the 
plasma cholesterol concentration and bile acid excretion. From only 5 
samples in the second trimester, a correlation of 0.739 (not significant) 
was found between VLDL-cholesterol and bile acid output, and of -0.859 
between HDL-cholesterol and bile acid excretion (p <0.1). 
There was a similar relationship between total plasma triglyceride 
concentration and bile acid excretion (r=0.865, p <0.02, n=7), which was 
probably linked to VLDL-triglyceride (r=0.685), though this was not 
significant with only 5 measurements. 
4. The Effect of Weight The rate of increase in body weight was 
normal in all 7 women. The individual weights during each collection 
period are shown in Table 3.4. There was no relationship between the 
increase in weight during pregnancy and change in sterol excretion 
(r=0 .019). However, there was a negative relationship between the increase 
in body weight and the increase in plasma cholesterol in the first half of 
TABLE 3. 3 
Excretion of Bile Acids and Ne utral Ste rol s During Pregnancy 
Subject Gesta tion (weeks) 
First Trime ste r 
N . B . 10 
R. B . 13 
R. C . 11 
H. M. 10 
R. S . 15 
C . v . d.S . 12 
c .w. 14 
Mean ± S .D. 
Second Trimeste r 
N. B . 23 
R . B . 22 
R . C . 22 
H. M. 22 
R . S . 26 
C . v . d . S . 22 
c .w. 22 
Mean + s.o. 
Third Trimes ter 
N.B . 34 
R. B . 31 
R. C . 32 
H. M. 32 
R. S . 34 
C . v . d . S . 38 
c .w. 32 
Mean + S . D. 
Ne utral 
Ste rol s 
(mg/ d a y) 
842 
599 
440 
478 
403 
692 
850 
615 + 186 
672 
592 
286 
396 
981 
874 
469 
610 + 255 
660 
827 
417 
522 
716 
1074 
475 
670 + 229 
Bile 
Aci ds 
(mg/day) 
192 
172 
142 
179 
70 
132 
201 
155 + 45 
296 
222 
253 
122 
247 
66 
171 
197 + 81 
186 
175 
155 
105 
187 
122 
134 
152 + 33 
Total 
Sterols 
(mg/day) 
1034 
771 
582 
657 
473 
824 
1051 
770 + 219 
968 
814 
539 
518 
1228 
939 
640 
807 + 259 
846 
1002 
572 
628 
903 
1195 
609 
822 + 232 
Dieta ry 
Choleste rol 
(mg/ da y) 
454 
440 
212 
420 
450 
426 
420 
400 ± 85 
454 
380 
212 
420 
450 
426 
420 
395 + 84 
454 
380 
212 
420 
450 
426 
420 
395 + 8 4 
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Ne t 
Ste r ol 
Ba l a n ce 
(mg/day ) 
580 
331 
370 
237 
23 
398 
631 
368 + 206 
514 
434 
327 
98 
778 
513 
220 
411 + 222 
392 
622 
360 
20 8 
453 
769 
1 89 
4 27 ± 211 
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pregnancy (-0 . 744 , p ~ 0.05, n=7). 
Subject 
c.w. 
c.v.d.s. 
R.B. 
R.C. 
N.B. 
R.S. 
H.M. 
DISCUSSION 
TABLE 3. 4 
Changes in Weight During Pregnancy: 
The Relationship to Plasma Cholesterol Changes 
in the First Half of Pregnancy 
Weight (kg) during collection 
Increase Between 
Collections 1 & 2 
1 2 3 
55.4 58.6 66.3 
63 . 6 66.7 73.1 
55.8 60.4 63.6 
60.4 63 . 6 72.2 
63 .6 66.3 69.0 
60.4 63.l 66.1 
45.4 46.7 50.9 
Weight 
(kg) 
3.2 
3.1 
4.6 
3.2 
2.7 
2.7 
1.3 
Plasma 
Cholesterol 
(mg/100 ml) 
33 
37 
40 
48 
74 
98 
103 
Neutral sterol and total sterol excretion remained unchanged 
throughout pregnancy, whilst there may have been an overall increase in 
bile acid excretion during the second trimester , which then returned to 
first trimester values during the third trimester . During the second 
trimester, bile acid excretion was directly related to the plasma 
cholesterol and plasma triglyceride concentrations. Whilst the increase 
in weight during pregnancy had no apparent effect upon sterol excretion, 
during the first half of pregnancy the increase in weight bore an inverse 
relationship to the increase in plasma cholesterol . 
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Ideal sterol balance studies demand maintenance of a steady- state 
in the subject, particularly with regard to constant sterol ingestion, 
steady body weight and unchanging plasma lipid concentrations. The l atter 
two criteria could not be strictly upheld in studies carried out during 
pregnancy . The average weight gain per week during pregnancy varies 
with the time of gestation; up to the 16-lBth week weight is gained at 
about 0.36 kg/week, between the 19th to 28th weeks 0.45 kg/week and then 
until term, 0.36-0.41 kg/week (Thomson and Billewicz, 1957). For practical 
purposes then, during any one collection period, the weight of the women 
in this study could be considered stationary. Plasma lipids change 
markedly during pregnancy, but once again, the increment which generally 
occurred over one collection period was small. One exception to this 
was during the first trimester collection in subject R.S., when the 
plasma cholesterol concentration increased from 221 to 254 mg/100 ml, 
while the net sterol excretion was only 23 mg/day. 
Plasma cholesterol concentration need not be related to the rate of 
cholesterol production or to the amount of cholesterol in the two 
exchangeable pools either in normal subjects or in those with established 
hyperlipoproteinaemia (Nestel et al, 1969). Endogenous cholesterol 
synthesis (Nestel et al , 1969) and bile acid excretion (Miettinen, 1973; 
Nestel and Hunter, 1974) increase with body weight. The weight 
accumulated during pregnancy includes increased deposition of body fat 
(Hytten and Leitch, 1972) . However, the sterol balance studies do not 
show a direct r elationship between body weight or increase in body 
weight and excretion of sterols or bile acids. A relationship between 
plasma lipids and weight was demonstrable with a negative correlation 
between the increase in body weight and plasma cholesterol in the period 
of the first to second trimester . This may be an indication of movement 
of choleste rol between body pools and plasma as a function of altered 
synthesis , since changes in body mass alter the flux of cholesterol between 
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plasma and tissues (Nestel et al , 1973). The positive correlation 
between plasma cholesterol, plasma triglyceride and bile acid excretion 
is in accord with an increase in lipid synthesis during the second 
trimester and catabolism of cholesterol as bile acid. 
Studies in women taking oral contraceptives have shown that the 
biliary bile salt and cholesterol concentrations are increased (Davis and 
Freston, 1972). In conjunction with this, pool size and synthesis rate 
of cholic acid are decreased (Pertsemlidis et al, 1973a). The oral 
contraceptive studies may simulate early pregnancy. A single study by 
Large et al (1960), in which samples of bile were taken from an indwelling 
T-tube following cholecystectomy showed that the biliary cholesterol, bile 
acid and phospholipid concentrations were high during the first trimester 
of pregnancy and maximal at about 3 months of gestation. In this woman 
biliary lipid concentrations subsequently decreased and rose again during 
the first week of the puerpuriurn. When ethinyl oestradiol was administered 
to male rats, there was an increase in biliary cholesterol concentration 
but with decreasing bile flow (Davis et al , 1973, 1974); low doses 
increased the degradation of cholesterol while a high dose reduced 
degradation. If the effects of oestrogens on cholesterol metabolism vary 
with the dosage, then the variable blood levels during pregnancy may 
explain the increase in bile acid excretion in some subjects during mid-
pregnancy with a decrease in others. A recent study of bile salt kinetics 
in the pregnant baboon (Dietrick et al , 1973) may not be directly comparable 
to the situation in the human, the baboon undergoing a fall in serum 
cholesterol during pregnancy (van Zyl , 1957). Percutaneous aspiration of 
gall bladder bile was used in 4 animals prior to and during pregnancy . 
In all animals pregnancy resulted in a decrease in the chenodeoxycholate, 
but not in the cholate , pool size . However , there was a marked decrease 
in the synthesis rate of both bile acids and an increase in their 
half-lives during pregnancy . 
CHAPTER 4 
PLASMA LIPID CHANGES IN THE NEONATE 
AND DURING INFANCY 
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INTRODUCTI ON 
The human infant has a very low plas ma cholesterol level at birth 
(Whyte and Yee , 1958; Sweeney et al, 1961; Mortimer, 1964 ; Glueck et al , 
1971; Barnes et al , 1972; Darmady et al , 1972), and in this r espec t is 
no differe nt from othe r mammals (Shope , 1929; Friedman and Byers, 196 1; 
Carroll et al , 1973). The cholesterol concentration has been found to be 
independent of maternal regulation, samples taken from different 
socioeconomic and ethnic backgrounds being similar despite differences in 
the maternal levels (Whyte and Yee, 1958; Mendez et al, 1959; Glueck 
et al , 1971). However, infants of diabetic mothers may have a higher 
umbilical cord cholesterol level than infants born to normal mothers 
(Mortimer , 1964; Pantelakis et al, 1964a). The sex of infants does 
contribute to some degree, females having a higher cholesterol level at 
birth than males (Barnes et al, 1972; Darmady et al, 1972). 
The average plasma triglyceride level at birth is also low (e.g. 
Sweeney et al, 1961; Brody and Carlson, 1962; Kwiterovich et al , 1973). 
It is subject to environmental influence such as foetomaternal stress 
during parturition (Tsang et al, 1974a). 
The lipoproteins in cord plasma differ from those in the normal 
adult both in absolute concentrations and in distribution (Glueck et al , 
1971, 1973; Wille and Phillips, 1971; Kwiterovich et al, 1973). 
Plasma lipid changes following birth have been monitored, with 
cholesterol increasing approximately 2-fold by the end of the first week 
(Darmady et al , 1972) and more slowly thereafter during the first year 
(Darmady et al , 1972; Friedman and Goldberg, 1973a; Greten/Schettler, 
1973). An increase in free fatty acid concentration is seen within 1-2 
hours of birth, becoming maximal between 4-24 hours (Chen et al, 1965; 
Laron et al , 1967) and preceeding an increase in plasma triglyceride or 
VLDL concentration (Zee, 1968). The LDL concentration also rises on the 
first day, with HDL increasing about 25 % during the first week (Abrams 
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and Freeman, 1969). 
The plasma cholesterol concentration during infancy responds readily 
to dietary changes. Short term dietary studies using substituted 
vegetable oil-milk formulas, the addition of corn oil to diets, or the 
use of soya bean products all lead to a decrease in plasma cholesterol 
accompanying the ingestion of increased amounts of linoleic acid {Fomon 
and Bartels, 1960; Sweeney et al , 1961, 1962; Gyorgy et al, 1963; 
Darmady et al , 1972; Tsang et al, 1974b). 
The study of the incidence of hyperlipaemias within families has 
defined the mode of inheritance of some of the hyperlipoproteinaemias. 
Familial Type II hypercholesterolaemia (Type IIa) has an inheritance 
consistent with an autosomal dominant pattern {Fredrickson and Levy, 1972) 
as has combined hyperlipoproteinaemia {Type IIb) {Goldstein et al, 1973a). 
The recognition of the association of abnormalities of lipid metabolism 
and raised plasma lipids with arteriosclerotic disease (e.g. 2nd 
International Symposium on Arteriosclerosis, 1970) and an increasing 
belief that the high incidence of premature cardiovascular disease in 
Western Society need not be inevitable, has led to greater emphasis on 
early identification of individuals at risk. 
Clinical identification of infants with hyperlipoproteinaemia has 
been largely limited to marked examples, such as primary or genetic 
disease among those homozygous for Type IIa, or Type I and secondary 
hyperlipoproteinaemia in children with congenital biliary atresia. 
However, clinical manifestations of other primary hyperlipoproteinaemias 
{e.g. heterozygous Type IIa) are rare, and therefore the diagnosis is 
rarely made without blood tests (Fredrickson and Breslow, 1973). Several 
studies have explored the possibility of diagnosing familial 
hyperlipidaemia randomly at birth (Glueck et al, 1971; Darmady et al , 
1972; Greten/Schettler, 1973; Goldstein et al, 1973b), or more 
specifically in infants of parents known to be heterozygous for a Type II 
131 
hyperlipoproteinaemia (Kwiterovich et al, 1973; Goldstein et al, 1973b). 
Children found to be hypercholesterolaemic at birth have been followed 
up in order to evaluate the usefulness of neonatal lipid measurement. 
Glueck et al (1971) (Tsang et al , 1974b) have found the cord blood 
cholesterol to be a useful index of future hypercholesterolaemia, and a 
collaborative study in Germany reached a similar conclusion regarding 
genetic hypercholesterolaemia, especially when the cholesterol was 
measured in LDL rather than whole plasma (Greten/Schettler , 1973) . 
However , Darmady et al (1972) in London concluded that genetic 
hypercholesterolaemia could not be reliably diagnosed on the basis of 
umbilical cord values . There was nevertheless a significant relationship 
between the cord cholesterol level and the concentration at 12-24 months 
(Darmady et al , 1972 ; Tsang et al , 1974b) . Studies o f umbilical cord 
measurements have been confined to the problem of hypercholesterolaemia 
since the other hyperlipoproteinaemias are rare in childhood (Fredrickson 
and Levy , 1972) . 
This chapter describes the follow- up of a lar ge number of infants 
in whom plasma cholesterol and triglyceride concentrations were measured 
at birth . 
METHODS 
A . MEASUREMENT OF PLASMA LIPIDS IN SMALL BLOOD SAMPLES 
DURING INFANCY 
Of two possible methods for collecting blood, the heel prick method 
was used rather than venepuncture . Following cleaning of the heel area, 
a small stab was made using a guarded lancette (Medipoint Inc., Mineola, 
N. Y., U. S . A . ) and no further pressure was applied to minimize 
contamination with tissue fluid . The drops of blood which collected at 
the site were drawn into a heparinized capillary tube(s) (Chase Instruments 
Corp . , Lindenhurst , N. Y., U. S.A ., Cat. No. 501) by capillary action, until 
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Comparison of Plasma Triglyceride Concentration 
Derived from Large and Small Plasma Volumes 
The plasma triglyceride concentration of 14 samples was measured 
on a Technicon Auto Analyser II Colorimeter following extraction 
of 20-50 µland 0 . 5 ml plasma in isopropanol as described in the 
text . The straight line represents the expected values if there 
i s perfect agreement between the 2 extracts . 
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Comparison of Plasma Cholesterol Concentration 
Derived from Large and Small Plasma Volumes 
The plasma cholesterol concentration of 20 samples was measured 
on a Technicon Auto Analyser II Colorimeter following extraction 
of 20-50 µland 0.5 ml plasma in isopropanol as described in the . 
text. The straight line represents the expected values if there 
is perfect agreement between the 2 extracts. 
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TABLE 4.1 
Comparison of Plasma Analyse s of Chole sterol Conc entration 
on Blood Obtained by Finger Prick and Ve nepuncture 
Plasma Concentration 
(mg/100 ml) 
(n=8) 
Cholesterol 
Triglyceride 
RESULTS 
Finger Prick 
(Small sample) 
171.1 + 35.2* 
110 . 9 + 69.9 
*Mean+ S . D. 
Venepuncture 
(Large samp le) 
183.1 + 31.9 
114.5 + 74.7 
A . PLASMA CHOLESTEROL AND TRIGLYCERIDE CONCENTRATIONS AT BIRTH 
1 . Plasma Lipids and Lipoorotein Distribution A summary of whole 
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plasma lipid levels and the lipoprotein distribution of cholesterol and 
triglyceride is shown in Table 4 . 2 . The distribution of plasma cholesterol 
and triglyceride concentrations within a group of 230 infants is shown 
in Figure 4 . 3 . Although the cholesterol concentration was not significantly 
different between male and female infants, there was a significant 
difference in LDL-cholesterol content (Table 4 . 2) . The distribution of 
cholesterol and triglyceride between the lipoproteins was quite different 
to that in the adult. HDL carried some 45% of the plasma cholesterol, 
and only 50% was associated with LDL . The comparable adult distribution 
is 31% and 64% respectively . The major carrier of triglyceride in the 
newborn infant is LDL (47%), with 31% and 22% associated with VLDL and 
HDL respectively . The ratio of cholesterol to triglyceride was 0.29:1 
in VLDL in the infant compared to 0.2:l in the female adult, 1.47:l in 
LDL in the infant versus 4 . 2:l in the adult (1.76:1 in the delivering 
mother), and 2 . 7:l in HDL in the infant and 3.1:l in the adult. The 
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TABLE 4.2 
Plasma Cholesterol and Triglyce ride Concentrations 
and Their Lipoprotein Distribution at Birth 
Plasma Concentration 
(mg/100 ml) 
ALL INFANTS 
Cholesterol 
Triglyceride 
MALES 
Cholesterol 
Triglyceride 
FEMALES 
Cholesterol 
Triglyceride 
NORMAL DELIVERIES 
Cholesterol 
Triglyceride 
No. of 
Infants 
29 
12 
11 
16 
Total 
94 + 32* 
68 + 30 
86 + 23 
60 + 15 
113 ± 40 
79 ± 39 
89 ± 23 
57 ± 15 
VLDL 
6 + 3 
21 + 10 
6 + 2 
20 + 7 
6 ± 3 
24 + 15 
6 + 2 
17 + 6 
COMPLICATED DELIVERIES 9 
Cholesterol 
Triglyceride 
Significant differences: 
LDL-cholesterol: 
Plasma triglyceride: 
VLDL-triglyceride: 
LDL-triglyceride: 
HDL-triglyceride : 
106 + 46 
81 + 32 
6 + 3 
27 ± 10 
Males vs females 
Normal vs complicated 
Normal VS complicated 
Normal vs complicated 
Normal vs complicated 
*Mean+ S.D. 
p 
p 
p 
p 
p 
LDL 
47 + 18 
32 + 12 
39 + 8 
27 + 10 
59 + 24 
37 + 16 
43 + 14 
28 + 9 
HDL 
42 + 18 
15 + 7 
42 + 18 
13 + 4 
48 + 21 
19 + 10 
41 + 17 
13 + 4 
55 + 26 45 + 22 
37 + 16 18 + 10 
<0.02 
<0.02 
<0.01 
>0.05 
>0.05 
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Distribution of Plasma Cholesterol and Triglyceride 
Concentrations in Umbilical Cord Plasma 
The cholesterol and triglyce ride concentrations were measured in the 
umbilical cord plasma collected from a group of 230 infants . They 
were a subgroup of 747 babies sampled in Canberra (Barnes et al , 
1972), in whom plasma lipids were remeasured at 12- 22 months of age . 
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distribution of lipids among the lip oprote ins r esembl e d that s een in 
pregnancy, though the absolute values were v e ry much lower . 
Several significant inter- and intra-lipoprotein relations hip s were 
found in the newly born infant (Table 4.3). The total triglyceride 
concentration was correlated with the VLDL-triglyceride concentra tion; 
the triglyceride contents of fraction d 1.006-1.019 and of d <1 . 006 
(VLDL) were also correlated . HDL and LDL cholesterol were significantly 
correlated. 
Plasma 
TABLE 4. 3 
Inter- and Intra-Lipoprotein Relationships in 
the Newly Born Infant 
(The lipoproteins of umbilical cord plasma) 
triglyceride - VLDL-triglyceride 
n=29 
Correlation 
Coefficient 
(r) 
0.862 
VLDL-triglyceride - LDL1 *-trigly
ceride 
n=l2 0.814 
VLDL-triglyceride - VLDL-cholesterol 
n=29 0.425 
HDL-cholesterol - LDL-cholesterol 
n=29 0.599 
HDL-cholesterol - VLDL-cholesterol 
n=29 -0.256 
*LDL - lipoprotein density d 1.006-1.019 1 
Significance 
(p) 
<0.001 
<0.01 
<0.05 
<0.001 
n.s. 
2. Maternal-Infant Lipid Relationships There was no significant 
correlation between maternal plasma cholesterol concentration at delivery 
and infant plasma cholesterol concentration (Table 4 .4). 
TABLE 4.4 
Plasma Lipid Concentrations: Infant-Maternal Relationships 
AT DELIVERY 
Who le Plasma 
Maternal cholesterol - infant cholesterol 
n=l22 
Maternal triglyceride - infant triglyceride 
n=l22 
Lipoproteins 
Maternal LDL-cholesterol - infant cholesterol 
n=38 
Maternal HDL-cholesterol - infant cholesterol 
n=39 
Maternal HDL-cholesterol - infant HDL-cholesterol 
n=l7 
AT 6-7 WEEKS POSTPARTUM 
Whole Plasma 
Maternal cholesterol (6 wks) - infant cholesterol (birth) 
n=78 
Maternal triglyceride (6 wks) - infant triglyceride (birth) 
n=79 
Lipoproteins 
Maternal LDL-cholesterol (6 wks) - infant cholesterol (birth) 
n=25 
Correlation 
Coefficient 
(r) 
0.188 
0.243 
0.428 
-0.100 
0.497 
0.159 
0.031 
0.003 
Significance 
(p) 
n.s. 
<0.02 
<0.01 
n.s. 
<0.05 
n.s. 
n.s. 
n.s. 
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Howe v e r, among t he indi vidua l lipopr ote in fractio ns s ome r e l ationships 
we re demonstrable . Amo ng a group of 38 i nfants , a significan t positiv e 
correlation wa s found b etween the choles tero l concen t r a tions in mate rnal 
LDL and in the infant whole plasma (F igure 4.4). A significan t 
relati ons h i p was also found b e tween the choleste rol conce ntration in 
maternal and infant HDL in a small group of 17. 
There was a weak, but positive correlation be tween maternal and 
infant triglyce ride levels. Since the maternal triglyceride conce ntration 
was increase d in wome n suffering from pre-eclampsia, hypertension and 
renal disease, the effect of these conditions on the infant's lipids was 
examined separate ly as will be discussed later. 
The maternal lipoproteins at the time of delivery reflect hormonal 
rather than genetic factors, so that a possible relationship between 
mother and child might be more realistically examined several weeks after 
delivery . This was attempted 6-7 weeks postpartum , but as shown in 
Table 4 . 4 , a significant relationship was not found . 
3 . Environmental Factors: The Effect on Umbilical Cord Trigly c e ride 
The cord triglyce ride concentration may partially reflect environmental 
factors ope rating on the mother and the foetus during parturition . The 
obste tric r e cords and labour histories of 88 mothers and 89 babies 
(including one pair of twins) were examined retrospectively . Criteria 
regarding duration of labour a nd maternal hypertension are those of 
accep t e d obstetric p r a ctice . A summary of results is shown in Table 4 .5. 
(a) Mate r na l Fa ctors The normal group consists of infants from 
normote nsive labours, of norma l duration and the result of vaginal 
deliveries, in whom no evidence of foetal distress was found. Hypertension 
is define d as blood pressure greater than 140/90 on more than one 
occasion during labour . Duration of delivery is normal if the first 
stage is less than 24 hours , and a normal s e cond stage is less t h a n 30 
minutes . Foetal distre ss was diagnos ed by a marked acceleratio n or 
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Relationship Between the Cholesterol Concentrations 
of Maternal LDL and Infant Whole Plasma 
The LDL content of cholesterol in maternal plasma at delivery and 
in the babies whole plasma was measured in 38 pairs . The means and 
standard deviations of both groups are also shown . 
(a) 
TABLE 4.5 
Plasma Lipid Concentrations: The Effect of Labour and Foetal Maturity 
No. of 
Infants 
Cord Plasma Concentration 
(mg/100 ml. Mean± S.D.) 
Cholesterol 
MATERNAL 
No known complication (control) 41 79 ± 20.5 
Parity: Nul liparous 38 81 ± 20.7 
Multiparous 51 78 ± 20.6 
Hypertension during labour (~140/90) 25 81 ± 25.2 
Prolonged labour: First stage >24 hr 5 87 ± 36.5 
Second stage >30 min 37 82 ± 21.8 
>45 min 22 79 ± 17.3 
Significant differences: 
(triglyceride) 
Parity: Nulliparous versus multiparous 
Maternal hypertension versus normal B.P. 
Prolonged second stage of labour versus control 
P <0.001 
P <0.01 
P <0.01 
Triglyceride 
53 ± 14.0 
70 ± 20.8 
56 ± 14.5 
68 ± 20.0 
63 ± 20.2 
65 ± 19.8 
71 ± 21.3 
Continued 
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(b) FOETAL 
TABLE 4 .5 
(Continued) 
No. of 
Infants 
No known complication (control) 30 
Foetal distress 
Low apgar (~7) 
Dysmaturi ty 
Rhesus incompatability 
Significant differences: 
(triglyceride) 
11 
21 
3 
6 
Foetal distress versus control 
Low apgar versus control 
Dysmaturity versus control 
Cord Plasma Concentration 
(mg/100 ml. Mean± S.D.) 
Cholesterol 
78 ± 18.9 
83 ± 24.1 
81 ± 28.9 
86 ± 16.8 
73 ± 9.2 
P <0.01 
P <0.05 
P <0.001 
Triglyceride 
52 ± 13.4 
69 ± 24.9 
61 ± 16.4 
90 ± 9.5 
66 ± 22.5 
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deceleration of foetal heart rate. 
In general, factors related to duration and severity of labour 
were reflected in the cord triglyceride level (Table 4.5). This was 
seen in nulliparous as compared to multiparous women, the former usually 
having longer labours and a higher incidence of pre-eclampsia. The 
occurrence of hypertension alone and prolongation of the second stage of 
labour also resulted in an elevation of cord triglyceride levels. 
(b) Foetal Factors The normal group consisted of infants who were 
delivered vaginally and whose mothers had normal labours, the infants 
having Apgar scores of 9 and 10 at delivery. The Apgar score is a simple 
assessment of the infant's cardiovascular, respiratory and neuromuscular 
status following birth. In the group in whom foetal distress or an Apgar 
score of 7 or less was noted the cord triglyceride levels were 
statistically higher than normal. Dysmaturity was also associated with 
high cord triglyceride values. The small group of infants with Rhesus 
factor incompatibility did not have statistically abnormal triglyceride 
levels. 
While these environmental factors did appear to influence the 
neonatal plasma triglyceride concentration, the cholesterol concentration 
was not affected. 
B. CHANGES IN PLASMA CHOLESTEROL AND TRIGLYCERIDE DURING 
THE FIRST WEEK OF LIFE 
The changes in plasma cholesterol and triglyceride over the first 
week of life were followed in 10 infants in whom cord lipid measurements 
were available. Blood samples were collected periodically during the 
first week. The mean values are shown in Table 4.6. All infants had 
been fed either glucose solution or diluted milk formula routinely in the 
nursery prior to the first sample. No attempt was made to fast the 
infants prior to sample collection; however, the last feed was always 
3 hours previously. This contributed to the fluctuations in plasma 
TABLE 4.6 
Plasma Lipid Concentrations: Changes During the First Week of Life 
Age Birth 0-24 hr 25-48 hr 49-72 hr 
Plasma concentration 
(mg/100 ml) (n) 
Cho les tero l mean 85 73 98 145 
S.D. 15.3 (10) 28.5 (6) 38.9 (4) 54.2 (6) 
Triglyceride mean 51 89 120 65 
S.D. 35.9 4 7,. 9 35.2 33.6 
• 
Weight mean 3.638 3.445 
(kg) S.D. 0.484 0.447 
Packed cell volume mean 54.4 50.5 
(%) S.D. 7.8 6.5 
Significant differences: Cholesterol concentration: Birth vs 49-72 hours p <0.01 
Birth vs 94-120 hours p <0.001 
Triglyceride concentration: Birth vs 49-72 hours p <0.05 
Birth vs 94-120 hours p <0.01 
Weight: Birth vs 49-72 hours p <0.001 
Packed cell volume: Birth vs 49-72 hours p <0.001 
94-120 hr 
140 
40.8 (9) 
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triglyceride levels. 
Plasma cholesterol concentrations were measured during the first 
24 hours in 6 of the 10 infants , and in 5 out of 6 there was a decrease 
(Figure 4.5). In the remaining infant , a marked increase occurred within 
8 hours of delivery, which in this infant was accompanied by a slight 
decrease in plasma triglyceride. In only one other infant was there a 
decrease in plasma triglyceride in the first 24 hours, and this occurred 
in a dysmature infant, whose plasma triglyceride at birth was 126 mg/100 
ml. 
Measurements made during the third day showed both plasma cholesterol 
and triglyceride to be generally higher than at birth (Table 4.6, Figure 
4.5). Measurements carried out in 5 of the children on day 10 suggest 
that there may have been a slight reduction in plasma cholesterol and 
triglyceride , which still remained above the umbilical cord level. 
The newborn infant is highly unstable in metabolic terms. Table 
4 .6 also shows the change in weight and packed cell volume during the 
first 3 days postpartum. There is a strong negative correlation between 
the decrease in infant body weight during the first 3-4 days of life and 
the increase in plasma triglyceride which has occurred over the same 
period of time (expressing both a s a percentage of the birth value): 
r = -0.755, p <0.05 (Figure 4.6). 
The type of milk fed to the infant, whether human milk or milk 
formula did not significantly affect the p a ttern of plasma lipid change 
during the first 10 days. This was also the case in the larger group 
of infants in whom measurements were made at b irth and on day 5 (Table 
4 .7). There was a highly significant correlation between the cord plasma 
and day 5 plasma cholesterol concentrations (r = 0.548 , n=34, p <0.01). 
C . PROSPECTIVE STUDY OF CHANGES IN PLASMA LIPIDS DURING INFANCY 
1 . Design During the months August 1971 to February 1972 blood 
samples were collected from all babies born at the Canberra Hospital . 
FIGURE 4.5 Plasma Cholesterol Concentration: Changes During 
the First Week of Life 
The plasma cholesterol concentrations of 10 infants in whom the cord 
cholesterol had been measured was sampled intermittantly during the 
first 7-10 days of life. The results are expressed in terms of a 
percentage change compared with the umbilical cord concentration (0%). 
All infants show an increase during the first 96-98 hours. 
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Male infants 
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FIGURE 4.6 Relationship Between Plasma Lipid and Weight Changes 
During the First Week of Life 
The plasma triglyceride and cholesterol concentration of 7 infants 
during the first 3-4 days of life were inversely related to the loss 
o f bo dy \•.1e i ght of the infants following birth. Both plasma lipid 
concentration and body weight are expressed as t~e percentage change 
from the time of birth. 
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TABLE 4. 7 
Plasma Lipid Concentrations: The Effect of Milk Formulae During Infancy 
Human 
Cow's milk products 
P/S ratio <0.05 
P/S ratio ::::o.40 
Soya bean 
P/S ratio >4.0 
Birth 
87 ± 27.0 {21)* 
70 ± 19.1 {8) 
86 ± 29. 5 (5) 
65 ± 20.1 {4) 
Plasma Cholesterol Concentration 
(mg/100 ml) 
Day 5 
145 ± 42.1 {21) 
147 ± 52.5 (8) 
173 ± 37.8 {5) 
*Mean± S.D. 
6.:...8 weeks 
185 ± 34. 5 ( 8) 
139 ± 32.4 (3) 
109 ± 12.4 {4) 
1--' 
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The sample was collected at birth by the delivering obstetrician by 
venepuncture of the umbilical cord vein after the cord had been clamped 
prior to delivery of the placenta. The results obtained from 747 children 
have been previously reported (Barnes et al, 1972) . Some of the children 
were retested at 12-22 months of age . 
The parents of all children (with the exception of those who had 
been placed for adoption) were sent a brief letter, reminding them that 
a sample of blood had been collected at the time of birth and inviting 
them to have the child retested . Two hundred and thirty children were 
subsequently retested over a period of twelve months . Blood was collected 
early in the morning, with the child fasted for about 12 hours . The 
blood sample was collected from a heel prick as described earlier and 
the child was weighed . A short questionnaire regar ding the infant's 
current dietary intake of milk and eggs and the family history of 
arteriosclerotic disease was completed by the mother . 
The aims of the questionnaire wer e two fold : f irstly to obtain 
information about the intake of cholesterol from milk and eggs and the 
approximate unsaturated fatty acid content of the diet , based on use of 
polyunsaturated margarine or oil and the use of milk infant formulae 
containing linoleic acid. The second aim was to gather information 
regarding the incidence of arteriosclerotic disease within the irmnediate 
family . Questions were directed towards the occurrence of heart attacks, 
strokes and angina and the age of occurrence , and the knowledge of 
hypercholesterolaemia or hypertension in the family. The inunediate 
family was defined as including the infant's great-grand.parents and 
their children, i.e . , a 4-generation span . 
2 . Plasma Cholesterol and Triglyceride Concentrations at 12-22 
Months of Age The group was subdivided into those infants eating a 
highly saturated diet and those eating a more unsaturated diet. Several 
children were excluded because of intercurrent illness. The results from 
the two groups are compared in the accomp anying tables . Tabl e s 4.8 and 
4.9 show the mean plasma concentrations in both groups at birth and at 
the time of follow-up. Figure 4.7 shows the distribution of the plasma 
concentrations within the group. As can be seen, the plasma levels at 
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12-22 months are significantly lower in the group on the more unsaturated 
diet. There is no difference in the mean age, weight or dietary cholesterol 
intake between the two groups (Table 4.10). Subdividing the groups 
according to sex shows that the female infants generally have a lower level 
of cholesterol and triglyceride than the males during infancy, the reverse 
of the findings at birth. Table 4.8 also shows the groups subdivided 
according to blood groups. There is no apparent relationship between blood 
group and plasma cholesterol at birth or at the time of follow-up. 
The correlation matrix (single correlation coefficients) for the 
group of infants eating the more saturated diet is shown in Table 4.11. 
Only three of the pairs had correlations which achieve significance, 
namely cord cholesterol and current plasma cholesterol (r = 0.215), 
current plasma triglyceride and plasma cholesterol (r = 0.192) and 
current weight and age (0.520). 
The range of dietary cholesterol derived from milk and eggs was 
extremely wide, as demonstrated by the standard deviation in Table 4.10. 
The intake varied from virtually zero cholesterol from these products 
per week to over 3000 mg/week among a small group of children. The 
average consumption of milk was 20-22 ounces per day and eggs 2-3/day, 
irrespective of age . No estimate was made of additional intake from meat 
or other dairy products . No correlation was found between the dietary 
intake and the plasma cholesterol levels within the total population 
(Table 4 . 11) . No difference in plasma levels could be found by taking 
the extreme ranges of the dietary intake of cholesterol (Table 4.12). 
However, among infants ~18 months of age, the increase in plasma 
cholesterol from birth (expressed as a percentage of the birth level) 
TABLE 4.8 
Plasma Cholesterol Concentration at 12-22 Months: 
The Effect of Diet, Sex and Blood Group 
No. of 
Infants 
Plasma Cholesterol Concentration 
(mg/100 ml) 
1. Saturated diet 
Males 
Females 
2. Unsaturated diet 
Males 
Females 
3 • B load group 
Group O 
Group A 
Group B 
175 
86 
89 
26 
13 
13 
76 
66 
12 
Birth 
77 + 21.2* 
74 + 17.7 
80 + 23.8 
79 + 21.3 
80 + 24.9 
77 ± 18. 0 
77 ± 18.0 
76 + 19.7 
74 + 18.0 
4. Original sample (Barnes et al , 1972) 
All infants 
Males 
Females 
Significant differences: 
747 
368 
379 
76 + 19.5 
74 + 18.2 
79 + 20.4 
1. vs 2. All infants. 
1. Males vs females - birth 
4. Males vs females - birth 
*Mean + S .D. 
12-22 months 
194 + 44.4 
199 + 48.8 
189 + 39.4 
176 + 40.6 
181 + 39.8 
170 + 42.l 
194 + 42.1 
190 + 43.8 
185 + 35.6 
p <0.05 
p = 0.051 
p <0.001 
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TABLE 4.9 
Plasma Triglyceride Concentration at 12-22 Months: 
The Effect of Diet and Sex 
1. Saturated diet 
Males 
Females 
2. Unsaturated diet 
Males 
Females 
No. 
180 
82 
98 
26 
11 
13 
Plasma Triglyceride Concentration 
(mg/100 ml) 
Birth 
56 + 20.9* 
53 + 19.0 
56 ± 20.4 
55 + 18.4 
53 + 18.7 
57 + 19.3 
No. 
138 
65 
73 
26 
11 
13 
12-22 months 
101 + 56.0 
108 ± 61.0 
94 + 53.l 
70 ± 40.6 
74 + 42.0 
66 ± 40.9 
3. Original sample (Barnes et al, 1972) 
All infants 747 
368 
379 
Males 
Females 
Significant differences: 1. 
1. 
1. 
52 
52 
52 
vs 2 . All infants. 12-22 mths. 
p 
vs 2. Males. 12-22 mths. p 
vs 2 . Females. 12-22 mths. p 
*Mean± S.D. 
<0.01 
= 0.08 
= 0.08 
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Plasma cholesterol and triglyceride concentrations in plasma obtained 
by heel prick were measured in 230 infants between the ages of 12-22 
months . These infants had p r eviously been sampled at birth (Figure 4 . 3) . 
TABLE 4 .10 
Infants 12-22 Months: Comparison of Mean Ages, 
Weights and Cholesterol Intakes 
1. Saturated diet 
Males 
Females 
2. Unsaturated diet 
Males 
Females 
No. of 
Infants 
175 
86 
89 
26 
13 
13 
Age 
(months) 
Dietary 
Cholesterol 
(g/week) 
16.5 + 2.6* 1.184 + 0.635 
16.5 + 2.4 
16.4 + 2.7 
17.9 + 2.2 
17.8 + 2.3 
18.0 + 2.1 
*Mean+ S.D. 
1.197 ± 0.609 
1.172 + 0.662 
1.078 + 0.670 
0.902 + 0.678 
1.255 + 0.638 
Weight 
(kg) 
11.4 + 1.39 
11.8 + 1.29 
11.1 + 1.39 
11.4 + 1.21 
11.6 + 0.68 
11.3 + 1.6 
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TABLE 4.11 
Plasma Lipid Concentrations at 12-22 Months: Correlation Matrix 
Cord Cholesterol 
Birth Weight 
Current Cholesterol 
Current Weight 
Age 
Dietary Cholesterol 
Current Triglyceride 
Cord 
Cholesterol 
1.000 
0.077 
0.215** 
-0.178 
Birth 
Weight 
1.000 
-0.056 
0.175 
Current 
Cholesterol 
1.000 
0.049 
Current 
Weight 
1.000 
Age 
-0.037 -0.005 -0.004 0.520*** 1.000 
-0.130 0.051 0.081 0.180 
0.139 -0.009 0.192* 0.068 
n=l74 (infants on saturated diet only) 
*p ~ 0.05 
**p <0.05 
***p <0.001 
0.142 
0.072 
Dietary 
Cholesterol 
1.000 
-0.046 
Current 
Triglyceride 
1.000 
I--' 
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TABLE 4 .12 
Plasma Cholesterol Concentration at 12-22 Months: 
The Effect of Dietary Choleste rol and Age 
(a) Comparing low and high intake of cholesterol 
Dietary Cholesterol** from Milk and Eggs 
(<500 mg/wk) (>200 0 mg/wk) 
Plasma cholesterol cone. 198 + 49.3 (19)* 
*Mean ± S . D . (no . ) 
**Estimated from questionnaire 
190 + 48.0 (24) 
(b) Relationship between dietary cholesterol intake and plasma 
cholesterol expressed as percentage increase over the birth 
level 
1. Saturated diet 
Age 12-14 months 
Age 15-17 months 
Age )18 months 
2. Unsaturated diet 
No. of 
Infants 
175 
61 
42 
72 
25 
Correlation 
Coefficient 
(r) 
0.169 
0.145 
-0.059 
0.309 
-0.065 
Significance 
(p) 
<0.1 
n.s. 
n.s. 
<0.01 
n.s. 
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correlated with dietary cholesterol intake (Table 4.12). 
A positive correlation exists between body weight and plasma 
cholesterol concentration among the younger infants (aged 12-14 months) 
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(Table 4.13) and between body weight and plasma triglyceride concentration 
among the older infants (aged ~18 months). In the overall group, no 
relationship exists apart from age correlated with body weight (Table 
4. 11) . 
TABLE 4.13 
Plasma Lipid Concentrations at 12-22 Months: 
The Effect of Body Weight 
1. PLASMA CHOLESTEROL 
Saturated diet 
Aged 12-14 months 
Aged ~15 months 
2. PLASMA TRIGLYCERIDE 
Saturated diet 
Aged 
Aged 
~17 months 
~18 months 
No. of 
Infants 
164 
50 
113 
124 
62 
62 
Correlation 
Coefficient 
(r) 
-0.052 
0.291 
0.024 
0.068 
-0.025 
0.253 
Significance 
(p) 
n.s. 
<0.05 
n.s. 
n. s. 
n.s. 
<0.05 
Table 4.14 shows the distribution of infants according to their 
plasma cholesterol concentrations at birth and at 12-22 months. At 
birth, 7 children had plasma cholesterol concentrations greater than the 
mean plus 2 standard deviations (116 mg/100 ml) and 30 greater than 1 
Total 230/747* 
Plas ma Choles t e rol Conc. 2 
at Age 12-22 mths. 
Norrnocholes t e rolaemic 
( <x + 1 S .D.) 
(~2 38 mg/100 ml) 
Hype rcholes t e rolaemic 
(a) >x + 1 S.D. 
(>23 8 mg/100 ml) 
(b) >x + 2 S.D. 
(>28 2 mg/100 ml) 
TABLE 4.14 
Plasma Cholesterol Concentration at 12-22 Months: 
Relationship to Umbilical Cord Cholesterol 
Cord Plasma Cholesterol 1 
Norrnocholesterolaemic 
( ~96 mg/ 100 ml) 
Hyperchole sterolaemic 
( <x + 1 S .D.) 
200 
203 172 
27 21 
7 7 
(>96 mg/100 ml) 
a. 
>x + 1 S.D. 
30 
24 
6 
0 
*All infants, saturated and polyunsaturate d diets 
1 < 
Cord plasma: 76 ± 20 mg/100 ml (mean ± S.D.) 
2 Pla sma cholesterol at 12-22 mths.: 194 ± 44 mg/100 ml 
(mean ± S.D.) 
(>116 mg/100 ml) 
b. 
>x + 2 S.D. 
7 
5 
2 
0 
t-' 
u, 
I..O 
standard deviation. Of the former, at follow-up, 2 out of 7 infants 
had a cholesterol concentration greater than 1 standard deviation above 
the mean, while among the latter, 6 out of 30 showed a cholesterol level 
atfollow-upthat exceeded the mean by 1 standard deviation. Altogether 
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3 of these 6 mildly hypercholesterolaemic children at follow-up had a 
family history of ·hypercholesterolaemia. Of those infants that were 
normocholesterolaemic at birth, 21 (10.5%) were hypercholesterolaemic at 
follow up, 7 (3.5%) outside the 95th percentile. Therefore, many infants 
found to be hypercholesterolaemic at follow-up on the basis of the 
present statistical definition (greater than 1 standard deviation above 
the mean) were normocholesterolaemic at birth. The relative proportions 
of male and female children in the hypercholesterolaemic groups at birth 
and follow-up were different. At birth, among those with plasma 
cholesterol concentration greater than 96 mg/100 ml, the M:F ratio was 
12:18; if greater than 116 mg/100 ml, the M:F ratio was 3:4. At follow-
up, the ratios were reversed, with the M:F ratio being 17:10 at 
cholesterol levels above 238 mg/100 ml, and 4:3 at levels above 282 
mg/100 ml. This means that a male baby who is hypercholesterolaemic at 
birth had a greater chance of remaining hypercholesterolaemic than a 
female infant. 
3. The Relevance of Family History and Plasma Lipid Studies 
During Infancy The family history of each child has been analyzed for 
each of 3 events; the occurrence of either a heart attack or a stroke, 
which may or may not have resulted in death, before 50 years of age, the 
same occurrence in a family member older than 50 years, and the existence 
of a raised plasma cholesterol level in any member of the family. In a 
simple scoring system, a child could be positive for any one of these 
events only mce, that is the history was either positive or negative 
for that classification. 
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The data for infants in whom plasma cholesterol and triglyce ride 
concentrations at 12-22 months were available are shown in Table 4 .15. 
The ntnnber of infants in each of the hyperlipidaemic groups is compared 
with the normolipidaemic infants , i . e . those whose cholesterol and 
triglyceride concentrations are less than 1 standard deviation above the 
mean. The number of children in whom familial hypercholesterolaemia 
has been identified is more than twice as high in the hyperlipidaemic 
groups as among the normolipidaemic infants . The number of early deaths 
in the hyperlipidaemic group is about 50% more than in the normal controls, 
whilst the prevalence of later death and disease is the same in all 
groups. 
DISCUSSION 
A. PLASMA LIPID CONCENTRATIONS AT BIRTH 
1. Cholesterol The low plasma concentrations that were found at 
birth in Canberra were similar to those in many other countries; in the 
majority of studies the mean level lies between 60 and 79 mg/100 ml 
(e.g. Glueck et al, 1971; Darmady et al , 1972; Mortimer, 1964; 
Pantelakis et al , 1964a; Sweeney et al , 1961; Whyte and Yee, 1958; 
Zee , 1968). The 230 infants studied at follow-up did not vary 
significantly in their birth cholesterol and triglyceride concentrations 
from the larger population of 747 children from which they were drawn 
(Barnes et al , 1972). In that group , the maternal and infant plasma 
lipid concentrations were not significantly correlated. However, more 
detailed analysis of data in the smaller group showed several important 
interrelationships. 
The relationship between whole plasma cholesterol concentrations 
in mother and infant was not significant (r = 0.188), in agreement with 
the findings in the larger population . However , study of the lipoprotein 
fractions was more fruitful. Among a subgroup of 38 maternal-infant 
TABLE 4.15 
Plasma Lipid Levels During Infancy: The Relationship to Family History 
A 
Normal 
Lipids 
B 
tcholesterol 
Total Number of Infants 116 23 
History of: Early death or disease 17 6 
(<50 years) (14.7%) (26.1%) 
Late death or disease 75 17 
(>50 years) (64.6%) (74.0%) 
Hypercholesterolaemia 11 5 
(9.5%) (21.8%) 
A. Plasma cholesterol concentration 
and Plasma triglyceride concentration 
B. Plasma cholesterol concentration 
and Plasma triglyceride concentration 
C. Plasma triglyceride concentration 
and Plas ma cholesterol concentration 
D. Plas ma cholesterol concentration 
and Plasma triglyceride concentration 
C 
iTriglyceride 
19 
4 
(21.0%) 
14 
(73.6%) 
4 
(21.0%) 
<238 mg/100 ml 
<156 mg/100 ml 
>238 mg/100 ml 
<156 mg/100 ml 
>156 mg/100 ml 
<238 mg/100 ml 
>238 mg/100 ml 
>156 mg/100 ml 
D 
Combined 
Hyperlipidaemia 
6 
1 
(16.7%) 
3 
(50.0%) 
3 
(50.0%) 
B+C+D 
48 
11 
(22.9%) 
34 
(70.8%) 
12 
(25 .0%) 
1--' 
(;) 
[\J 
pairs in whom the plas ma lipoprote ins h a d b een s eparate d, t he r e was a 
positive correlation between the materna l LDL-choles t e rol at de livery 
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and the infant's whole plas ma chole s t e rol. The chole sterol in HDL in the 
moth e r and the infant (n=l7) we re also correlated, possibly r e fl e cting 
the intercorrelation between LDL and HDL cholesterol that was found in 
the infants. 
Foetal tissues are capable of chole sterogenesis from early in 
gestation; this is particularly so in the liver where the in vitro and 
in vivo incorporation of ace t ate into cholesterol has been demonstrated 
(Popjak and Be eckman, 1950; Chevallier, 1964; Givner and Jaffe, 1971). 
There is also in vivo transfer of cholesterol from the maternal 
circulation across the placenta (Chevallier, 1964; Connor and Lin, 1967; 
Hellig et al , 1970; Pitkin et al, 1972). In the human, the physical 
gradient is in favour of the foetus, but foetomaternal transfer probably 
also occurs to a small extent, as shown in the monkey (Pitkin et al, 
1972). The proportion of cholesterol in the rat foetus which is derived 
from the maternal circulation is dependent upon the stage of gestation, 
decreasing with increasing maturity of the foetus (Chevallier, 1964). 
It has been estimated that at term 18-20% of the cholesterol in a human 
foetus is maternal in origin (Plotz et al , 1968; Hellig et al, 1970). 
If pregnant guinea-pigs are fed an hypercholesterolaemic diet during 
pregnancy, their foetuses have the same average plasma cholesterol 
concentrations at birth as those whose mothers did not receive cholesterol, 
but the proportion of foetal cholesterol derived from the mother is 
increased (Connor and Lin, 1967). The transfer of cholesterol across 
the placenta is increased under these conditions , resulting in a decrease 
in foetal cholesterogenesis. In the rabbit foetus, the plasma cholesterol 
is increased slightly if the mother is fed cholesterol (Popjak, 1946), 
and the placenta shows marked morphological changes, with increased fat 
deposition on the foetal side (Popjak, 1946; Zilversmit et al, 1972). 
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A positive correlation between maternal LDL-cholesterol at delivery 
and the infant plasma cholester o l has been found in the present study. 
This may reflect the known transfer of cholesterol across the placenta, 
although if this were the reason, one might expect the infant's 
cholesterol to rise even further. The other possibility, that of a 
genetic inte r-re lationship , may have been seen with mate rnal LDL rathe r 
than with whole plasma cholesterol, because the LDL concentration at 
delive ry may more closely r esemble the non-pregnant choleste rol l e vel 
than does total cholesterol. It is also likely that the genetic 
expression of hypercholesterolaemia in the infant is better seen in the 
LDL-cholesterol rather than in the whole plasma cholesterol concentration 
(Greten/Schettler, 1973; Kwiterovich et al , 1973). 
2. Triglyceride There was a weak positive relationship between 
the maternal plasma triglyceride concentration at delivery and the infant's 
cord plasma concentration (r = 0.243). 
Maternal plasma glyceride does - not cross the placenta to any 
significant extent (McBride and Korn, 1964). However, lipoprotein lipase-
like activity has been demonstrated in the placenta in vitro (Mallov and 
Alousi, 1965). 
The triglyceride concentration in the umbilical cord plasma was 
influenced by foetal and maternal factors. A similar observation has 
been made by Tsang et al (1974a). Maternal factors such as parity, the 
presence of hypertension, pre-eclampsia , prolongation of the second stage 
of labour, all resulted in an increase in the infant plasma triglyceride 
concentration. Foetal factors included dysmaturity , foetal distress and 
low Apgar scoring. Some of these factors were probably inter-related. 
For instance, the nulliparous woman tends to have a longer labour than 
the multiparous, and is prone to a greater incidence of pre-eclampsia . 
The foetus is more likely to suffer "foe tal distress" when hypertension 
develops during labour, and a dysmature infant is particularly at risk. 
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As dis cussed previously (Chapter 2), the plasma triglyceride 
concentration is also higher in women who are hyperte nsive during the 
third trimester or at delivery. 
The factor common to all these conditions is "stress ", in utero , 
in the birth canal , or immediately post-natal. The plasma catecholamine 
concen tration is raised in umbilical cord samples from infants born to 
mothers suffering from pre-eclampsia and in infants suffering from 
asphyxia neonatorum. The level of plasma presser activity is 
significantly related to umbilical arterial P co2 and pH, an
d to the 
a a 
1 minute and 5 minute Apgar scores (Holden et al , 1972). The catecholamines 
are derived from the fo e tus, there being little transfer from the maternal 
circulation (Adams et al, 1961). Catecholamine levels are 10 times 
higher in the dysmature infant with placental insufficiency than in a 
normal full term infant during the first 10-28 hours of life (Cheek et al, 
196 3) . 
Any relationship between high triglyceride levels and catecholamines 
is likely to be mediated through raised free fatty acid turnover. The 
plasma free fatty acid concentration of women at term is significantly 
higher than in non-pregnant women (Nelson et al, 1966; Becker et al, 
1971; Fairweather, 1971) but is not demonstrably higher in women with 
pre-eclamps ia than in women with normal pregnancies (Keele and Kay, 1966; 
Holden et al , 1972) . There is transfer of free fatty acid across the 
placenta (van Duyne et al , 1962; McBride and Korn , 1964; Szabo et al , 
1969) even against a smal l concentration gradient (van Duyne et al , 1962; 
Szabo et al , 1 969 ). The rate of transfer and retention by the foetus is 
relate d to the maternal plasma concentration (Sabata et al, 1968). The 
low circulating l e v e ls of free fatty acid in the foetus have b een offered 
as an indication of the low rate of transfer from the maternal circulation 
(van Duyne and Havel , 1959), but an alternative suggestion is of a high 
rate of utili zation by the foetus (Nelson, 1965), since maternal free 
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fatty acid p robably con tributes to the laying dovm of foetal adipase 
tissue (Schwartz , 1968). Retention of free fatty acid by the foetus can 
b e demonstrated by umbilical arterio-venous differen ces (Holden et al , 
1972). 
In vivo measurements of oxygen saturation during labour and at 
delive ry indicate a marked relative hypoxia in the neonate during 
parturition, with saturations of only 50.8% (± 16.9, n=18) during the 
first stage of labour and 37.3% (± 14.2) during the second stage (mean 
± S.D.) (Beard, 1974). Hypoxia stimulates catecholamine secretion 
(Greenberg et al , 1961; Cheek et al, 1963; Holden et al, 1972). 
The plasma free fatty acid concentrations of infants born to mothers 
suffering from pre-eclampsia are lower than in normal infants at birth 
(Keele and Kay, 1966). This may be due to the elevated ketone concentration 
(Paterson et al, 1967), since infusions of ketones result in a depression 
of circulating free fatty acid in normal human adults (Fajans et al, 1964; 
Senior and Loridan, 1968) and children (Loridan and Senior, 1970; 
Binkiewicz et al , 1974). 
In the presence of normal (Harris, 1974) or low (Keele and Kay, 1966) 
plasma free fatty acid concentrations in pre-eclamptic and dysmature 
infants respectively, the increased triglyceride concentration of the 
stressed neonate is not clearly related to free fatty acid metabolism, 
though the only available data is on free fatty acid concentration. This 
does not exclude an increased incorporation of free fatty acid into 
triglyceride , such as occurs in adults given ethanol, which also lowers 
plasma free fatty ceid levels (Nestel and Hirsch, 1965). 
B. PLASMA LIPID CHANGES DURING THE FIRST WEEK OF LIFE 
1. Cholesterol During the first 24 hours there was a decrease in 
plasma concentration in 5 out of 6 of the infants, coupled with an 
increase in plasma triglyceride. In one infant in whom this early decrease 
in cholesterol was not observed, the plasma triglyceride decreased. The 
plasma cholesterol level then increas ed in all infants during the n e xt 
3 days and then decreased slightly over the following week. At 6-8 
weeks of age , breast-fed infants had significantly higher plasma 
cholesterol levels than infants fed on evaporated cow's milk. 
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Others have noted this increase in the plasma cholesterol towards 
the end of the first week (Kaplan and Lee, 1965; Darmady et al, 1972), 
both in LDL (during the first 24 hours) and in HDL (Abrams and Freeman, 
1969; Studd et al , 1970). Close to term, the foetus is responsible for 
the synthesis of most of its cholesterol, though about 18-20% has 
probably been derived from the mother (Hellig et al, 1970). Following 
birth, any control exerted on foetal cholesterol metabolism by the mother 
or the placenta will be removed and synthesis of cholesterol might · 
increase. In fact, cholesterogenesis in the neonate is depressed (e.g. 
Carroll, 1964; McNamara et al, 1972) and may reflect the operation of 
new controlling factors. 
The suckling young of all species develop hypercholesterolaemia 
and significant increases in plasma cholesterol are seen during the first 
week (Carroll et al, 1973). Shope (1929) considered dietary cholesterol, 
particularly that in colostrum, to be responsible. Hypercholesterolaemia 
in calves is aggravated by cholesterol supplementation of milk (Wiggers 
et al , 1971). The high fat content of milk is also important, being 
itself sufficient to produce hypercholesterolaemia in the suckling rat 
(Harris e t al , 1966). The combination of cholesterol and fat is necessary 
to produce hypercholesterolaemia in the suckling rabbit (Friedman and 
Byers, 1961) and calf (Carroll et al, 1973). 
The incorporation of acetate (Carroll, 1964; Ballard and Hanson, 
1967) and glucose (Ballard and Hanson , 1967) into cholesterol is depressed 
in the liver of the suckling rat, increasing to adult levels only upon 
weaning. The activity of HMG-CoA reductase declines rapidly in the 
post-natal period from the high value irrunediately prior to birth and 
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declines to very low levels b e fore wean ing (McNamara et al , 1972). Shah 
(1973) has shown that the incorporation of mevalonate into both 
non-saponifiable and digitonin-precipitable lipids was low in the 
suckling rat. 
The question arises as to the nature of the inhibitor of HMG-CoA 
reductase activity during suckling. Incubation with eithe r a supernatant 
fraction of a suckling rat liver homogenate or pre-incubation with rat 
milk decreases the activity of adult liver HMG-CoA reductase (McNamara 
et al, 1972). Cow and human milk have a similar inhibitory property 
demonstrated in vivo and in vitro (Boguslawski and Wrobel, 1974). Lastly 
of course, cholesterol itself is capable of feedback inhibition (Shah, 
1973). 
2. The Effect of Milk Composition in Later Infancy The infants who 
were being breast-fed at 6-8 weeks of age had higher plasma cholesterol 
levels than those infants on evaporated milk. Some studies have produced 
similar results (Fomon and Bartels, 1960; Darrnady et al, 1972), while 
others have not (Gyorgy et al, 1963; Woodruff et al, 1964). The linoleate 
content of human milk is higher than cow's (or evaporated) milk, and on 
this basis alone, the plasma cholesterol levels of children being breast-
fed would be expected to be lower. However, among younger children, the 
absorption of fat is relatively inefficient (Fomon et al, 1970) and 
absorption of fat from cow's milk is less efficient than from human milk. 
This raises the possibility that any advantage which may be gained 
through higher linoleate content is outweighed by the greater absorption 
of fat. 
3. Triglyceride The plasma triglyceride concentrations measured 
during the first week of life shows a general increase during the first 
5 days, with a slight decrease over the next 4-5 days. Since measurements 
were made at the same time in relation to feeding, this fall may indicate 
an improvement in the clearance of triglyceride. The plasma triglyceride 
concentration at 48-72 hours of age was negatively related to the change 
in body weiqht of the infant expressed as a percentage of the birth 
weight (r = -0.755 , p <0.01). This may reflect the utilization of fat 
stores for energy . In the normal infant, fat accounts for 16% of the 
total body weight at birth (Widdowson , 1950) as in the adult (Widdowson 
et al, 1951). It serves as the largest store of energy within the body 
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(Dawes , 1968). Carbohydrate stores, concentrated as glycogen within the 
liver and ske letal and heart muscle (She lley , 1964), are rapidly depleted 
following delivery. Live r carbohydrate falls to less than 10% of its 
birth leve l within 24 hours in a normal infant and within 12 hours in 
premature infants (She lley and Neligan , 1966). There is therefore 
convers ion from the utilization of carbohydrate in utero and at birth to 
that of fat. This leads to a rapid post-natal increase in plasma free 
fatty acid, glycerol and ketone concentrations, which is maximal at about 
2 hours after birth (van Duyne and Havel, 1959; Chen et al, 1965; Keele 
and Kay, 1966; Harris, 1974). An inverse relationship between plasma 
free fatty acid and glucose is seen initially, the latter decreasing 
during the first 2 hours after delivery but then increasing, even in the 
presence of raised free fatty acid and the absence of food (Chen et al, 
1965; Keele and Kay, 1966; Harris, 1974). The infant plasma triglyceride 
and VLDL concentrations increase significantly during the first 9 hours 
of life (Zee , 1968) probably secondarily to increased hepatic esterification 
of circulating free fatty acid (Havel, 1963). 
C. PLASMA LIPIDS DURING INFANCY 
1. Cholesterol The mean plasma cholesterol of the infants aged 12-22 
months was 194 ± 44 mg/100 ml on the saturated diet, significantly higher 
than in the smaller group of infants who were eating a diet riche r in 
polyunsaturated f atty acids (176 mg/100 ml). The male infants had higher 
plasma l evels, but not significantly so. Blood groups were not a 
determinant of cord plasma cholesterol concentration, nor did they affect 
the cholesterol level during infancy, though it must be noted that much 
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larger samples might be required to demonstrate a relationshio. 
There was a significant correlation between the plasma cholesterol 
concentration in umbilical cord blood and the level during infancy 
among the children on the saturated fat diet (r = 0.215). Among the 
fewer children on the unsaturated fat diet the coefficient did not reach 
significance . At 5 days of age a highly significant relationship existed 
between cord and current plasma cholesterol concentrations (r = 0.548). 
At the age of 12-22 months, there were two environmental factors, 
other than the fatty acid content of the diet, which showed important 
relationships with the plasma cholesterol concentration. The first was 
the infant's weight among the younger infants (12-14 months) and the 
second the dietary intake of cholesterol among the older infants (~18 
months of age). 
Estimates of the mean plasma cholesterol level among an infant 
population aged 12 months vary from 150 mg/100 ml (Friedman and Gold.be rg, 
1973) to 191 ± 36 mg/100 ml (Darmady et al, 1972). Other results are 
biased by the choice of children according to their likelihood or 
otherwise of inheriting hypercholesterolaemia (e.g. Glueck and Tsang, 
1972; Tsang et al, 1974). Neither of the 2 former studies (Friedman 
and Goldberg, 1973; Darmady et al , 1972) detecte d any siqnificant 
difference in plasma cholesterol concentration between males and females, 
and neither study took any account of dietary factors. 
In this current study , the fatty acid comp osition of the diet, 
whilst judged only on the u se of milk formulae and polyunsaturated 
margarines and oils , had a significant impact on the plasma choleste rol 
levels during infancy. The cholesterol intake was approximately similar 
in the two groups of infants who were eating different kinds of fat. The 
response of the infant to the use of polyunsaturated fatty acids has been 
demonstrated many times, both close to birth (e.g. Sweeney et al , 1961; 
Gyorgy et al , 1963; Darmady et al , 1972) and at several months of age 
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(Glue ck and Tsang , 1972; Glueck et al , 1972; Tsang et al , 1974b). 
Other surveys have also established a direct relationship between 
the umbilica l cord cholesterol concentration and the plasma concentration 
during infancy . Darrnady et al (19 72) found a correlation coefficient of 
0.27 (n=273) and Tsang et al (1974b) of 0.47, both for children on 
saturated and on unsaturated diets . No account was taken of the degree 
of saturation in the forme r study , even though the authors had previously 
shown differences in plasma cholesterol concentration according to the 
milk formula being used . 
The relationship between the infants' weight and plasma cholesterol 
concentration was only demonstrable in this study among infants 12-14 
months of age. The early increase in plasma cholesterol from birth_ to 
6 weeks of age may be related to the infant's increase in weight 
(McKerrow , 1961). A significant correlation between the fat intake per 
day and the plasma cholesterol level is demonstrable in babies up to 4 
months of age whether they are being breast-fed or formula-fed (McKerrow, 
1962). Hames and Greenberg (1961) showed a correlation between plasma 
cholesterol and weight, which had been adjusted for height and age, 
amongst girls 6-11 years, but not amongst boys. Court et al (1974) in 
children 2-17 years and Hickie et al (1974) in males 11-18 years were 
unable to demonstrate any relationship between obesity (skin-fold thickness) 
and plasma cholesterol levels. In adults, body weight is related to 
choleste rol turnover , production being significantly correlated with 
excess weight (Nestel et al , 1969), but plasma cholesterol concentration 
and exchangeable cholesterol pool size are generally independent of 
turnover. Plasma cholesterol concentration has been directly, but weakly, 
correlated with body weight or fatness (Tanner, 1951; Gofman et al , 1952; 
Montoye et al (1966) but many studies have failed to demonstrate such 
a relationship (Lewis et al , 1957; Miller et al , 1958). 
The epidemiological evidence implicating individuals with blood 
group A as being at high ri sk from thrornbo-ernbolic and coronary heart 
disease (Nefzger et al, 1969; Kingsbury , 1971; Jick et al, 1969) has 
prompted other epidemiological investigations of risk factors within 
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this group. Plasma cholesterol has been found to be higher among males 
having blood group A in some studies (Oliver et al, 1969; Langman, 1969). 
No difference in plasma cholesterol concentrations were found in either 
male or female infants at birth or at follow-up when they were examined 
according to their blood group. Saha and Banerjee (1971) also failed to 
find any difference at birth attributable to blood group. 
2. Triglyceride The mean plasma triglyceride found in all infants 
was higher than anticipated, with wide standard deviations. Such 
variation is extremely suggestive of testing in the non-fasting state, 
particularly since the mean and standard deviation decreased with the 
age of the children. It may be that it is easier to fast an eighteen 
month infant than one of 12 months, and possibly the request not to feed 
the child may not have been sufficiently stressed. However, plasma 
triglyceride concentration was significantly lower among infants on the 
more polyunsaturated diet, and the females had significantly lower levels 
than the males . In infants 18 months and older, there was a positive 
but weak correlation relating body weight and plasma triglyceride 
concentration. 
The plasma triglyceride concentration during childhood is 60-80 
mg/100 ml among children 1-20 years (Hodges and Krehl , 1965; Glueck et 
al , 1973c; Kwiterovich et al , 1974; Court et al , 1974; Hickie et al, 
1974; Wilmore and McNamara , 1974). Concentration is positively 
correlated with age amongst boys 11-18 years (r = 0.22, n=613) (Hickie 
et al , 1974) . A relationship also exists between plasma triglyceride 
and subscapular skin-fold thickness (all children, including the obese, 
r = 0.42, aged 2-17 years [Court et al, 1974); boys aged 11-18 years, 
r = 0 . 18 [Hickie et al , 1974]). Among children diagnosed as having 
familial hypertriglyceridaernia approximately one-third are overweight 
(Glueck et al , 1973c) . Weight r eduction and a low fat diet result in a 
173 
significant decrease of plasma triglyceride in the majority of children. 
D. THE VALUE OF MEASURI NG PLAS:MA LIPID CONCENTRATIONS AT 
BIRTH AND AT 1-2 YEARS OF AGE 
Of the original 747 babies sampled at birth, 230 infants we re 
resampled at 12-22 months . For the purpose of analysis, hypercholesterolaemia 
was defined at birth as a cholesterol level greater than either 1 or 2 
standard deviations (S.D.) above the mean (96 and 116 mg/100 ml 
respectively). The number of infants so classified was 30 and 7 
respectively. At 12-22 months, hypercholesterolaemia was defined as 
greater than 1 S.D. above the mean (238 mg/100 ml). Out of 30 such 
infants, only 6 had had cord cholesterol levels greater than 96 mg/100 ml 
at birth and 2 greater than 116 mg/100 ml. The yield in terms of 
hypercholesterolaemia at 1.2-22 months was therefore 6 out of 30 (20 %) and 
2 out of 7 (28.5%) respectively (in terms of hypercholes terolaemia 
diagnosed at birth). The majority of children with hypercholesterolaemia 
at follow-up were normocholesterolaemic at birth. 
Table 4.16 summarises the results from several trials which have 
been conducted to evaluate the efficacy of cord cholesterol measurements 
as an index of inheritence of hypercholesterolaemia. The majority have 
been designed to follow only those children defined as hypercholesterolaemic 
at birth and have not studied the fate of the normocholesterolaemic 
children. 
In the study publishe d by Darmady et al (1972), 274 out of 302 
children were re-examined. Hypercholeste rolaemia at birth was defined 
as 100 mg/100 ml (mean± 1 S.D. = 78 ± 23 mg/100 ml) and 34 children 
fell into this category. Of these, 30 were retested as 12 months of age, 
at which time the mean plasma cholesterol was 191 mg/100 ml (S.D. = 36 
mg/100 ml). Hypercholesterolaemia, arbitrarily defined as being greater 
TABLE 4.16 
The Predictive Value of the Diagnosis of Hypercholesterolaemia 
Study/Author 
1 
American: 
Glueck et al (1971) 
Tsang et al (1974b) 
German: 
1,2 
Greten et al (1973) 
Schettler (1973) 
English: 
2 
Darmady et al (1972) 
Kwi terovich et al 
(1973) l 
Goldstein et al 
(1973b)3 
Canberra (1972-73) 2 
~.O • 
of 
Infants 
1800 
1323 
302 
29 
2000 
230 
(74 7) 
I 
I 
I 
I 
I 
I 
Umbilical Cord Cholesterol 
Cholesterol 
(mg/100 ml) No. of Infants 
Mean S.D. Normal >x + 1 S.D. >x + 2 S.D. 
64 
60 
35 
(LDL} 
78 
100 
73 
76 
19 
20 
13 
23 
15 
13 
19 
81 
268 
13 
134 
1 LDL-cholesterol 
2 Whole Plasma 
65 
92 
34 
16 
71 (Chol.) 
125 (Chol. 
and 
T .G. ) 
' 7/40 
30 
3Whole plasma cholesterol and triglyceride 
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Based on Umbilical Cord Plasma Measurements 
Infants with 
Family History 
17/56 
( 8/56: 3 generation) 
10/73 
? 
16/16 
13/13 
37/125 
(9/125: 3 generation) 
20 
/134 
Cholesterol 
(mg/100 ml) 
Mean S.D. 
Follow-up Cholesterol 
No. of Infants 
-
>x + 1 S. D. 
>x + 1 S.D. >x + 2 S.D. with Family 
History 
. . . . . . . . . . . . Dietary de pendent ................. . 
113 33 
(LDL) 
191 36 
>170 (LDL) 
<170 (LDL) 
194 44 
5/30 0/5 
1 /274 
11/12 11/12 
0/7 
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than 240 mg/100 ml a point mid-wa y betwe en the first and s e cond s t a ndard 
deviations, was found at follow-up in 24. Howe v er, only 5 of the 24 h a d 
also been hypercholesterolaemic at birth, i.e. 5 of the 30 initia lly 
hypercholesterolaemic infants. Family studies on all 5 were negative, 
and the only infant found to have familial hypercholesterolaemia was 
norrnocholesterolaemic at birth. 
In the German study (Greten/Schettler, 1973) of 1323 unselected 
births a diagnosis of hypercholesterolaemia was made on the basis of both 
plasma cholesterol and LDL-cholesterol concentrations. A total of 92 
infants had either plasma or LDL levels (or both) greater than 2 S.D. 
above the mean . Both parents were tested in 73 of these and in 10 cases 
type II hypercholesterolaemia was found. A control group of 81 
norrnocholesterolaemic infants was randomly selected for follow-up, and 
among these, 3 parents were found to be hypercholesterolaemic. At 12 
months of age, 61 initially hypercholesterolaernic and 65 initially 
norrnocholesterolaemic infants were resampled. LDL-cholesterol was used 
to define hypercholesterolaemia (greater than 1 S.D. being probable and 
greater than 2 S.D. definite type II hypercholesterolaemia). Where both 
the infant and a parent had been diagnosed as having hypercholesterolaemia 
(10 cases), 4 out of 10 infants had definite and a further 5 out of 10 
probable hypercholesterolaemia at follow-up. In the control group, the 
corresponding proportion was 1 out of 3 (Table 4.16). 
The large American series (Glueck et al , 1971; Tsang e t a l , 1974b) 
also provides follow-up data. The mean cord cholesterol level from 1800 
unselected, consecutive births was 64 ± 19 mg/100 ml. The definition 
of hypercholesterolaemia was greater than 100 mg/100 ml and 65 infants 
were so diagnosed. Of the 65 , 56 were followed for 12 months: one of the 
parents was found to be hypercholesterolaemic in 17 of the 56 (30.3%), a 
figure very similar to that reported by Goldstein et al (1973b) (Table 4.16). 
A diagnosis of familial hyperchole s terolaemia was made in 8 of the 
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children , on the evidence of 3 generation vertical transmission and/or 
tendinous xanthomatos is. A control group was selected from the original 
1800 infants, (normocholesterolaemic at birth and neither par en t 
hyperlipidaemic ). Both normocho l esterolaemi c and hypercholesterolaemic 
infants participated in dietary studies involving changes in dietary P/S 
ratio and choleste rol content (Glueck et al, 1972; Tsang et al , 1974b). 
At follow-up, the mean plasma cholesterol values on a low P/S ra tio , high 
cholesterol diet were: normocholesterolaemic children with 
normolipidaemi c parents, 135 mg/100 ml; hypercholesterolaemic children 
with normal parents, 164 ± 17 mg/100 ml (n=30); hypercholesterolaemic 
children of probable familial origin, 233 ± 59 mg/100 ml (n=12). On a 
diet with a high P/S ratio and low in cholesterol, this latter group of 
infants had a plasma level of 161 ± 27 mg/100 ml, i.e., the diet disguised 
the genetic trait. The normocholesterolaemic children had a mean of 131 
mg/100 ml . The study also showed that children who are 
hypercholesterolaemic at birth and who have a family history of 
hypercholesterolaemia are most likely to remain hypercholesterolaemic 
during infancy . 
A further study which emphasized the significance of genetic 
transmission in determining persistent hypercholesterolaemia is that of 
Kwiterovich et al (1973) . Twenty nine children of a known 
hypercholesterolaemic parent were examined at birth and 19 were retested 
1 between the ages of 1-2 /2 years. Classifying the children on the basis 
of LDL-cholesterol levels, 16 (55%) fell outside the 95th percentile at 
birth; 12 of the 19 were retes ted, and 11 of these 12 remained 
hypercholesterolaemic . The twelfth child had been placed on a cholesterol-
lowe ring diet and was normocholesterolaemic. Similarly, the infants 
who were normocholesterolaemic at birth r emained so at follow-up (7/7) 
despite having a hypercholesterolaemic parent. 
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Goldstein et al (1973b) studied2000consecutive births and 
determined the incidence of hyperlipoproteinaemia in the families (parents 
and grandpar ents ) of 134 infants born with normal plasma lipids and of 125 
in whom plasma triglyceride and/or cholesterol were outside the 95th 
perce ntile. Evidence of 3 generation transmission was obtained in 9 of 
the 125 hyperlipidaemic infants; in 5 the defect was familial 
hypercholesterol aemia ; in 4, combined hyperlipidaemia (CHL). This gave 
a minimal estimate of heterozygote frequency for hyperlipidaemia of 
9/2000 or 0.45%, 0.25% for hypercholesterolaemia and 0.20% for CHL. This 
compares with 1/274 or 0.37% (Darmady et al , 1972), 8/1800 or 0.44% 
(Tsang et al , 1974b) and 10/1323 or 0.75% (Greten/Schettler , 1973) for 
hypercholes terolaemia. Goldstein and his colleagues found that among the 
babes with high cord lipids 37 (26.4%) had one parent who was 
hyperlipidaemic , compared with 20 (14.9%) in the normolipidaemic group. 
A similar figure was found in this current study regarding the prevalence 
of probable familial hyperlipidaemia. 
Infants who have been found to b e normocholesterolaemic at birth 
have received little attention, and yet it appears that these children 
will form the majority of future hyperlipidaemic subjects. For instance, 
in this current study 24 of the hypercholesterolaemic infants at 12 months 
had been normocholesterolaemic at birth (80%). A similar figure was 
derived by Darmady et al (1972): 19 out of 24 or 79%. However , it would 
seem that this group of infants may have a higher percentage of famili es 
with known hypercholes terolaemia (20.8%) and a history of early 
arterioscle rotic disease (33.3 %) compared to the normolipidaemic infants 
(9.5 % and 14.7% respectively) . 
It has been shown that the cord plasma triglyceride may be related 
as much to environmental as to genetic factors. The plasma concentrations 
at 12-22 months were higher than anticipated and higher than levels 
generally quoted for children 1-20 years of age (Section C.2) . Taking 
this into consideration, a diagnosis of hypertriglyceridaemia was made 
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if the child ' s plasma triglyceride , assumed to be fasting, was greater 
than 150 mg/100 ml (> mean + 1 S . D.). Among these infants the family 
history contained a reference to hypercholesterolaemia or early 
arteriosclerotic disease more often than among the normocholesterolaemic 
infants. 
There have been some studies in children concerned with the 
diagnosis of familial hypertriglyceridaemia in childhood, either as Type 
IV or combined hyperlipidaemia (CHL). Among 77 children born into 
families where one parent had CHL, only 39% were found to have 
hyperlipidaemia (Glueck et al , 1973d). 'lwenty three of these had a 
raised cholesterol (6 with raised triglyceride), whilst only 9 had an 
elevation of triglyceride alone. In a study of familial 
hypertriglyceridaemia (Type IV), 113 children, 1-20 years, from 36 
propositi, were examined by Glueck et al (1973c): only 20% were found 
to be hypertriglyceridaemic, though among offspring older than 21 years 
of age, 10 out of 17 (58%) were involved. During childhood there seems 
to be incomplete penetrance of the hypertriglyceridaernic trait. That age 
may alter the penetrance of an hyperlipidaemic gene was also concluded 
by Kwiterovich et al (1974) in a study of 236 children r esulting from 
90 matings of parents with Type II hyperlipoproteinaemia . Between the 
ages of 1-19 years , 45% of the children were involved, but if this were 
further subdivided according to age , the prevalence was 52% if younger 
than 10 years and only 39% between 10 and 19 years . 
In this current study being reported , the infants who were 
hypercholesterolaemic (n=23), hypertriglyceridaemic (n=l9) or both (n=6) 
at 12-22 months had family histories of higher prevalence of early 
arteriosclerotic disease and a greater likelihood of a family history of 
hypercholesterolaemia . Goldstein et al (1973b) found the overall 
prevalence of measured lipid abnormality and death from coronary heart 
disease to be the same in the relatives of the normolipidaemic and 
hyperlipidaemic infants defined at birth . 
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In summary it would appear that infants found to be 
hypercholesterolaernic at birth are more likely than norrnocholesterolaemic 
infants to be hyperlipidaemic at 12-22 months, and to come from families 
with a history of lipid abnormality, which may be expressed as early 
arteriosclerotic disease. Nevertheless, the majority of infants who 
are hypercholesterolaemic or hypertriglyceridaemic at 12-22 months were 
norrnocholesterolaemic at birth, though they appear to show a higher 
prevalence of familial involvement than infants who remain 
norrnolipidaemic . Environmental factors such as dietary cholesterol, 
the saturation of fat and infant weight are important determinants of 
hyperlipidaemia and may disguise the true incidence of familial 
hyperlipidaemia . 
CHAPTER 5 
STEROL EXCRETION IN THE NEONATE AND YOUNG INFANT: 
THE INFLUENCE OF AGE AND DIET 
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INTRODUCTION 
The human infant, like all mammalian young, is born with a low 
plasma cholesterol level, which rapidly increases over the first week of 
life (Pomeranze et al, 1958; Kaplan and Lee, 1965; Darmady et al , 1972). 
The "hypercholesterolaemia of suckling" regresses upon weaning in several 
animal species (Carroll et al, 1973), but not in the human infant. 
Several studies in children of European origin have shown a slow steady 
increase in plasma cholesterol levels through childhood and adolescence 
to values found in the adult population (Whyte and Yee, 1958; Hames 
and Greenberg, 1961; Godfrey et al, 1972; Friedman and Goldberg, 1973a). 
The origin of foetal cholesterol is two-fold, from de novo 
synthesis within the foeto-placental unit and from the maternal circulation. 
The human foetus is capable of cholesterogenesis from early in gestation, 
the highest rate of synthesis being within the liver (Solomon et al, 1967; 
Telegdy et al, 1970a; Mathur et al, 1970; Givner and Jaffe, 1971). The 
placenta, which is an important site for the synthesis of steroid hormone 
derived from cholesterol (Talegdy et al, 1970b) is capable of synthesizing 
only minor amounts of cholesterol itself (van Leusden and Villee, 1965; 
Zelewski and Villee, 1966). The relative amount of cholesterol derived 
from the maternal circulation varies according to the age of the foetus, 
decreasing with maturity in the rat (Chevallier, 1964), and according to 
the species of animal (Chevallier, 1964; Connor and Lin, 1967; Pitkin 
et al, 1972). It seems likely that 18-20% of the cholesterol in a hurnan 
infant may be derived from the maternal circulation (Hellig et al, 1970). 
The same basic pathway of cholesterol synthesis probably operates 
in the foetus as in the adult, with intermediates such as squalene and 
lanosterol having been identified (van Leusden et al, 1971). However, 
additional pathways may operate in the placenta (Zelewski and Villee, 
1966). It is known that in the rat HMG-CoA reductase is the major rate 
controlling enzyme of cholesterol synthesis in the foetus at term and in the 
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suckling animal (Harris et al , 1967; Mc amara et al , 1972). Other rate 
controlling points have been sought, Shah (1973) demonstrating low rates 
of incorporation of mevalonate into non-saponifiable lipids and digitonin-
precipitable sterols in the suckling, but not in the weanling rat. 
7-dehydrocholesterol reductase activity is low in the liver of the foetal 
and newborn rat, reflecting the low rates of sterol synthesis, but 
increases rapidly during weaning (Wrobel, 1972). However, since 
7-dehydrocholesterol does not accumulate, the reductase is unlikely to be 
a rate-limiting enzyme. 
Bile acids are present in the gall bladder (Bongiovanni, 1965), 
meconium (Sharp et al, 1971; Back and Ross, 1973) and duodenum (Poley 
et al, 1964) of the human neonate. Any secondary bile acid present- in 
the infant at birth is due to placental transfer from the maternal 
circulation (Lester et al, 1972). As well as cholic, chenodeoxycholic, 
lithocholic, ursocholic and deoxycholic acids being present in human 
meconium, 3S-hydroxy-5-cholenoic acid has been found in premature and 
mature neonates, in decreasing quantities with increasing maturity (Back 
and Ross, 1973). Two pathways for bile acid synthesis may exist side by 
side in the foetal liver. The first is the sequence operating in the 
adult liver, the rate limiting enzyme being cholesterol-7a-hydroxylase 
(Danielsson et al, 1967; Shefer et al, 1970), resulting in cholic and 
chenodeoxycholic acids. The alternative pathway is via 3S-hydroxy-5-
cholenoic acid, lithocholic acid and chenodeoxycholic acid, involving 
cholesterol-26-hydroxylase in the first step (Mitropoulos and Myant, 1967). 
The foetal dog has been used as a model to investigate the enterohepatic 
circulation of bile acids. Near term, the liver will take up, conjugate 
and secrete tracer doses of cholic acid (Jackson et al, 1971) with 
reabsorption of bile acid in the intestinal tract (Smallwood et al , 1972). 
Cholesterol is the precursor of bile acids, the latter serving also 
as the major route of excretion of cholesterol. In the adult, disruption 
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of bile acid metabolis m affe cts chole ste roge nesis direc tly, without the 
complicating factor of altered chole sterol abs orption (Ha mp recht e t a l , 
1971). In the suckling rat, surgical seve rance of the bile duct leads 
to a 2-3 fold increase in cholesterol synthe sis within 24 hours (Harris 
et al , 1967) with an increase in HMG-CoA reductase activity (McNamara 
et al , 1972). Cholic acid infusion inunediately suppresses this increase 
in cholesterol synthesis (Harris et al, 1967). In the foetal dog, 
biliary drainage results in an increase in the conversion of cholesterol 
to bile acid (Lester et al , 1972). 
Cholesterol turnover reflects the balance between the input of 
cholesterol from endogenous synthesis in tissues and from dietary 
cholesterol and the loss of cholesterol, which occurs mainly in the faeces 
in the form of cholesterol, bile acids and their degradation products 
(Nestel , 1970). Cholesterol turnover may be described in terms of a 
two-pool model (Nestel et al , 1969); pool A, the more rapidly turning 
over the the two pools, probably consists of the plasma, erythrocytes 
and viscera such as the liver and intestine, whilst pool B relates to 
adipose, skin and skeletal tissues (Chobanian and Hollander, 1962). Ideal 
studies of sterol balance demand steady state conditions including 
constant sterol intake, constant body weight and steady plasma cholesterol 
concentration. Cholesterol absorption increases proportionately to the 
increase in dietary cholesterol (Connor and Lin, 1974). Cholesterol and 
the fatty acid composition of the diet are both important determinants 
of plasma cholesterol concentration (Mattson et al, 1972; Keys et al, 
1965a,b). However , plasma cholesterol concentration is not related to the 
synthetic rate of cholesterol , but rather to the fractional clearance 
from pool A (Nestel et al, 1969). In studies lasting 3-4 weeks, 
polyunsaturated fatty acids have been shown to increase the catabolism 
and excretion of cholesterol in adults (Moore et al, 1968; Nestel et al, 
1973) . 
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The aim of this study was to measure cholesterol and bile acid 
synthesis in the human neonate and during infancy, and in particular the 
response to dietary changes in fat ty acid composition and cholesterol 
content. 
METHODS 
The aims of the study were 2-fold. The first was to measure the 
excretion of cholesterol, bile acids and their degradation products 
periodically during infancy. The second was to determine the effect of 
cholesterol-free soy milk and cholesterol containing cow's milk on 
choles terol metabolism during infancy. 
A. EXPERIMENTAL DESIGN 
Four infants were studied till up to 5 months of age. All infants 
were carried through a normal pregnancy and delivery. They were being 
bottle-fed from birth by choice. A summary of the experimental design 
with the relationship in time between diet and sample collections is 
shown in Table 5.1. Infants were weighed regularly from the time of 
birth. Their weights are shown in Figure 5.1. The individual details 
of infants are given in Table 5.2. 
Three infants (J.C,, S.F. and A.S.) were studied from birth to 56 
days of age. Studies were commenced prior to the discharge of mother 
and baby from hospital on the sixth day post-partum . The infants were 
fed an evaporated cow ' s milk mixture for the first 25 days, then changed 
to a soy bean (cholesterol free) milk until 40 days of age . For the 
final 16 days they rever t ed to the initial cholesterol-containing 
evaporated milk . Collections of faeces were made on days 5-10, 19-25, 35-40 
and 50-56 inclusive . 
A fourth infant (L .K .) was maintained on the soy milk for two months 
from 25 days of age. At this stage cholesterol, in the form of egg yolk 
TABLE 5.1 
Experimental Design of Diet and Sample Collections During Sterol Balance Studies in Infancy 
Age of infants (weeks) 
Infants 
J.C. 
J.F. 
A. S . 
Infant 
L.K. 
Samples 
Sa!Ilples 
[ 
Milk 
Formula 
Faeces 
Blood 
Milk 
Formula 
[ 
Faeces 
Blood 
Birth 2 
I I 
Evaporated 
cow's 
// / V r./; 
+ + + + 
Evaporated 
(S .26) 
l% ~ 
+ + + + 
-
4 6 8 10 12 14 16 18 
I I I I I I I 
Soy Evaporated 
bean cow's 
:/,/ '/ 1// 
+ + + + 
Soy bean 
Soy bean + 
Egg yolk 
~ . ~ rn 
+ + + + + + 
20 
' 
~I 
+ + 
I 
I-' 
O'.) 
J:::, 
FIGURE 5.1 Growth of Infants During Sterol Balance Studies 
Infants were weighed regularly from the time of b irth. Their rate 
of growth is shrn-.-.:n compared with figures recently compiled for an 
Australian population (NHMRC, 1974). 
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TABLE 5.2 
Infants in the Sterol Balance Studies: Personal and Dietary Details 
Cord lipids 
(mg/100 ml) 
Evaporated milk 
Birth 
Weight 
(kg) 
3.13 
3 .03 
3.25 
3.35 
Cholesterol Triglyceride 
58 
48 
58 
94 
47 
33 
47 
34 
Brand 
. 1 Carnation 
. 1 Carnation 
t . 1 Carna ion 
S.262 
Milk formula. Manufactured by 1. Carnation Milk Co. 
2. Wyeth and Sons 
P/S Ratio. From Table 5.3 
Cholesterol content: following dilution 
P/S Cholesterol 
Ratio Content 
0.04 
0.04 
0.04 
0.40 
(mg/100 ml) 
8 
8 
8 
7 
1--' 
0) 
°' 
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powder* was added to the soy milk. The quantity was calculate d to 
approximate that in the evaporate d milk b e ing drunk by the 3 othe r 
infants at the same age. The purpose of this study was to determine the 
effect of dietary cholesterol in the presence of a high P/S ratio. 
Faeces were collected on days 5-10, 19-25, 41-47, 64-69, 115-120 and 127-133 
inclusive. 
B. DIETARY INTAKE 
Both in hospital and at home, the mother kept a record of all milk 
drunk by the infant during each collection period. The amount of 
cholesterol ingested by the infant during the collection period was 
calculated from the total volume of milk drunk and the cholesterol 
concentration of the milk . The latter was ascertained by random sampling 
and measurement during the collection periods (Table 5.2). The only 
supplementation of diet of the first 3 infants was with small quantities 
of cereal and "fruit gel".** In the latter part of the studies, baby L.K. 
received daily supplements of 2.00 g egg yolk powder, containing 57.4 mg 
of cholesterol which was suspended in one-half of the soy milk ration. 
The bottle was then washed out with the other half. 
C. SAMPLE COLLECTION 
1. Blood Cord blood was collected at delivery for cholesterol 
measurements. Subsequent samples were collected from a heel prick on 
day 5 and at the beginning and end of each collection period. The infant 
was not necessarily fasting . 
2. Faeces Faeces were collected from the infants using inert nappy 
liners (Johnson & Johnson, Pty. Ltd.) throughout the collection periods. 
Soiled liners were placed immediately into plastic bags and the faeces 
*Egg yolk powder: spray dried egg yolk, manufactured by The Egg Marketing 
Board for the State of New South Wales. Code YS-52, Batch No. 152/208. 
Grade A. Cholesterol content 2735 my per 100 g powder. 
**Comme rcial product consisting of fruit jelly, marketed by baby food 
manufacturers. 
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deep frozen. 
D. LABORATORY METHODS 
1. Measureme nt of Plasma and Milk Cholesterol The plasma cholesterol 
was extracted directly into redistilled isopropanol. The method for 
measurement for small plasma samples has been described in Chapter 4. 
Milk cholesterol was extracted by saponification of a 2 ml aliquot 
with 2 mls of 10 N sodium hydroxide and 18 mls of 95% ethanol, refluxing 
for 1 hour over a steam bath. On cooling, 10 mls of water was added, 
and the cholesterol extracted with petroleum ether (B.P. 60-80°C). An 
aliquot of this was dried down and redissolved in redistilled isopropanol. 
Cholesterol was measured colorimetrically in a Technicon Auto 
Analyser II (Chapter 2). 
2. Neutral Sterol and Bile Acid Extraction and Analysis A marker 
was not used in these studies . To minimize any irregularity in faecal 
flow collections were carried out continuously for 6-7 days. The totality 
of faecal collection was checked by measuring the plant sterol content 
of the faeces during the soy milk periods: recovery was found to be 101% 
and 115% in 2 children. This finding also excludes significant 
degradation of neutral sterols as described with liquid formulae diets 
in adults (Grundy et al, 1968). 
The nappy liners were removed from the frozen faeces. Seven day 
pools were homogenized with water, and duplicate aliquots of about 2 mls 
were taken for neutral sterol and bile acid extraction and analysis. The 
method used was that of Miettinen et al (1965) and Grundy et al (1965), 
as described in Chapter 3 . 
3. Milk Fatty Acid Profile and P/S Ratio Samples of milk were 
analyzed for their total fatty acid composition according to the method 
described in Chapter 6, following extraction of 0.2 ml into chloroform: 
methanol (v:v); 2 : 1. The polyunsaturated to saturated (P/S) ratio was 
calculated from the sum of Cl8:2 plus Cl8:3 divided by the sum of 
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saturated Cl2 to Cl6 inclusive. Stearic acid (Cl8:0) was exclude d b e caus e 
it has little effect on plasma cholesterol concentration in man (Keys 
et al , 1965c). The fatty acid profiles of commonly used infant milk 
formulae are shown in Table 5.3. 
Milk 
Formula 
TABLE 5. 3 
Fatty Acid Composition of Milk Formulae 
Commonly Used During Infancy 
Fatty Acid Composition 
(% Total fatty acids) 
ClO:O 12:0 14:0 16:0 16:1 18:0 18:1 18:2 18:3 
Cow's milk 1 2 9 27 4 10 32 4 
Carnation 1 0.2 9.9 36.2 2.4 17.4 32.0 1.9 
S.26 2 1 19.5 9.4 14.9 1.1 8.3 27.7 17.7 
2 1.4 19.3 9.8 17.3 1.8 9.5 30.8 19.4 S.M.A. 
3 0.7 10.1 34.4 2.6 16.4 33.3 2.4 Lactogen 
Pro Sobee 4 14.4 5.9 25.1 51.8 
Milk formulae: Evaporated cow 's milk manufactured by; 
1. Carnation Milk Company 
3. The Nestle Company (Aust.) Ltd. 
8.7 
P/S 
Ratio 
0.08 
0.04 
0.40 
0.40 
0.04 
4.2 
Evaporated cow's milk with vegetable oil additives; 
2. Wyeth and Sons 
Soy bean extract; 
4. Mead Johnson 
RESULTS 
A. PLASMA CHOLESTEROL 
The plasma cholesterol level of the infants doubled during the first 
5 days, and thereafter responded to changes in the diet as shown in Table 
5.4. The high P/S ratio, chole ste rol-free milk (Pro Sobee ) r edu ced the 
plasma cholesterol level of all infants and this was reversed whe n the 
original formula was reintroduced. 
TABLE 5. 4 
Plasma Cholesterol Concentration With Dietary Change: 
Milk 
Formula 
Carnation 
S26 
Carnation 
S26 
Pro Sobee 
Carnation 
Age of 
Infants 
Birth 
5 days 
3 weeks 
5 weeks 
8 weeks 
Pro Sobee 16 weeks 
+ egg yolk 
Individual and Mean Results 
Infant M.C. 
58 
133 
133 
106 
153 
Plasma Cholesterol 
(mg/ 10 0 ml ) 
S.F. A.S. L.K. 
48 58 94 
100 122 
169 
200 122 
131 
100 118 111 
140 125 
120 
Mean 
(± S.E.M.) 
65 + ro.1 
131 + 14.4 
147 + 18.0 
109 + 3.8 
139 + 8.1 
In the single infant, L.K., who was maintained on Pro Sobee, the 
190 
plasma cholesterol level remained low on the high P/S, cholesterol-free 
formula. Addition of egg-yolk cholesterol increased the plasma cholesterol, 
though not to the level seen with the choleste rol-containing formula, S26, 
the latter having a P/S ratio of 0.40 and a cholesterol content 
equivalent to the amount added as egg yolk. 
B. NEUTRAL STEROL AND BILE ACID EXCRETION 
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All results have been expressed in terms of mg/kg/day in an attempt 
to make the data comparable from one infant to another, and to take into 
account changes with growth. 
1. Sterol Excretion During Infancy During the first 6-10 days of 
life, the infants excreted 1.7 mg/kg/day of bile acid and had a net sterol 
output of 6.3 mg/kg/day (Table 5.5). The output of both doubled over 
the next 2 weeks (bile acids P <0.001; net sterol excretion, p <0.01), 
so that by 3 weeks of age bile acid excretion was comparable to that 
published for adults (cf Miettinen, 1973). Bile acid and net sterol 
excretion did not change significantly thereafter on comparable diets 
at 8 weeks of age. 
Throughout the studies, most of the neutral sterol recovered in the 
faeces was in the form of cholesterol. Only one infant (A.S.) excreted 
significant amounts of coprostanol, which amounted to one-quarter of the 
total neutral sterols measured whilst on the soy bean milk. This is in 
contrast to the adult, in whom most excreted cholesterol has undergone 
microbiological transformation, most commonly to coprostanol. 
2. The Effect of Changing the P/S Ratio and the Cholesterol Content 
of Milk Three infants took part in a cross-over study of evaporate d 
milk (P/S, 0.04; cholesterol content, 7 mg/100 ml), and soy bean milk 
(P/S, 4.20; cholesterol free). A fourth infant was fed the soy bean 
milk for 2 months, in order to study the longer term effects of high P/S 
ratio on sterol excretion, and cholesterol was also later added to the 
formula to examine the interaction of high P/S ratio and cholesterol 
intake. 
The combined effect of withdrawing cholesterol and increasing the 
P/S ratio resulted in a 2 to 5 fold increase in net sterol output in 3 
TABLE 5. 5 
Faecal Sterol and Bile Acid Excretion in the Neonate and Young Infant: 
The Effect of Age and Dietary Change 
Sterol Excretion Cholesterol 
Milk Weight (mg/kg/day) Intake Infant Formula (kg) Neutral Bile Total (mg/kg/day) 
Sterols Acids Sterols 
Neonatal Period (6-10 days of age ) 
M.C. Carnation 3.13 15.3 1.1 16.4 15.0 
S.F. Carnation 3. 03 24.0 2.2 26.2 15.2 
A. S. Carnation 3.25 17.4 1.6 19.0 12.6 
L.K. S.26 3.35 13.4 1.8 15.2 6.7 
Mean± S.E.M. 17.5 ± 2.3 1.7 ± 0.2 19.2 ± 2.5 
Three Weeks of Age 
M.C. Carnation 3.62 16.6 2.5 19.3 16.6 
S.F. Carnation 3.48 28.7 3.6 32.2 13.5 
A.S. Carnation 3.67 16.9 4.6 21.5 14.0 
L.K. S.26 3. 67 26.2 3.4 29.7 9.7 
Me an ± S . E . M . 22.1 ± 3.1 3.5 ± 0.4 25.7 ± 3.1 
Net 
Sterol 
Output 
(mg/kg/day ) 
1.4 
9.0 
6.4 
8.5 
6.3 ± 1.7 
4.1 
18.7 
8.2 
20.2 
12.8 ± 3.9 
Continued 
f-' 
\.0 
N 
Milk Weight 
Infant Formula (kg) Neutral 
Sterols 
Five Weeks of Age 
M.C. Pro Sobee 4. 30 18.4 
S.F. Pro Sobee 3.85 26.2 
A.S. Pro Sobee 4.03 19.4 
L.K. Pro Sobee 3.91 12.8 
Mean± S .E. M. 19.2 ± 2.7 
Eight Weeks of Age 
M.C. Carnation 5.02 21.5 
S.F. Carnation 3.98 23.1 
A.S. Carnation 4.14 20.5 
Mean± S.E.M. 21.7 ± 0.8 
TABLE 5 .5 
(Continued) 
S terol Exe re tion 
(mg/kg/day) 
Bile Total 
Acids Sterols 
3.4 21.9 
23.2 49.4 
10.8 30.0 
4.3 17.1 
10.4 ± 4.6 29.6 ± 7.1 
1.0 22.5 
1.7 24.9 
5.6 26.1 
2.8 ± 1.4 24.5 ± 1.1 
Cholesterol 
Intake 
(mg/kg/day) 
17.0 
14.4 
14.0 
Net 
Sterol 
Output 
(mg/kg/day) 
21.9 
49.4 
30 .0 
17.1 
29 . 6 ± 7.1 
5.4 
7.5 
12.1 
8.3 ± 2.0 
f-' 
'° w
Milk Formula 
Name P/S 
Ratio 
S.26 0.40 
Pro Sobee 4.2 
Pro Sobee 4.2 
Pro Sobee 4.2 
plus 
egg yolk 
Pro Sobee 4.2 
plus 
egg yolk 
TABLE 5.6 
Faecal Sterol and Bile Acid Excretion in One Young Infant: 
The Effect of Prolonged Feeding of a High P/S Diet and of Cholesterol 
Plasma sterol Excretion Dietary 
Cholesterol (mg/kg/day) Duration Age Weight Cholesterol 
(wks) (wks) (kg) Concentration Neutral Bile Total (mg/kg/day) (mg/100 ml) Sterols Acids Sterols 
3 3 3.7 131 26.2 3.4 29.7 9.7 
2 5 3.9 111 12.2 4.3 17.1 
7 10 4.8 98 13.6 4.6 18.2 
2 16 5.2 120 30.4 9.1 39.5 10.5 
4 18 5.6 113 35.6 5.0 40.6 9.8 
Net 
Sterol 
Excretion 
(mg/kg/day) 
20.2 
17.1 
18.2 
29.0 
30.8 
I--' 
'° ~
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of the infants (Table 5.5). Tnis was statistically significantly higher 
for the group compared to the preceding diet (p <0.02) (Figure 5.2). The 
infant who did not respond (L.K.) had already been r eceiving S26 formula 
milk , which has a P/S ratio of 0.40 compared with 0.04 for the evaporated 
cow's milk (Table 5.3). A further decrease in plasma cholesterol did 
occur however (Table 5.4). The bile acid excretion increased in all 
infants (Table 5.5, Figure 5.2). There was wide variation in response, 
from 26% (L.K.) to 550% (S.F.). 
When the soy bean milk was replaced by the initial evaporated milk, 
all 3 infants demonstrated a decrease in net sterol excretion (p <0.01) 
and bile acid excretion (Table 5.5, Figure 5.2). 
Both bile acid and neutral sterol excretion remained elevated in 
baby L.K., in whom the soy bean formula was continued for 2 months 
{Table 5.6, Figure 5.3). The addition of cholesterol to the diet resulted 
in a doubling of the bile acid excretion and a 60% increase in net sterol 
output during the first 2 weeks. The plasma cholesterol level increased 
approximately 20%. over the next 2 weeks, the bile acid excretion returned 
towards previous levels, but net sterol excretion remained elevated, 
indicating that the additional sterol was beingre-excretedin the neutral 
sterol fraction. 
DISCUSSION 
A. THE DIETARY P/S RATIO AND PLASMA CHOLESTEROL DURING INFANCY 
Substitution of the high P/S ratio, cholesterol-free milk for the 
cow's milk based formulae reduced the plasma cholesterol level in all 4 
infants. This was reversed when the original formula (lower P/S ratio 
and containing cholesterol) was reintroduced. Addition of an equivalent 
amount of cholesterol to the soy bean formula increased the plasma 
cholesterol leve l in the one infant, but not to the level seen previously 
on the lower P/S ratio formula. 
FIGURE 5 . 2 Fae ca l S t e rol and Bile Acid Excretion in the Neonate 
and Young Infant: The Effect of Age and 
Dietary Change 
The faecal excretion of neutral sterols and bile acids was measured 
at 6-10 and 19-25 days of age in 4 infants and in 3 infants at 50-56 
days of age , whilst on -a cholesterol-containing, low P/S ratio milk. 
All 4 infants wer e s witche d to a cholesterol-free, high P/S ratio 
formula at 26 days o f age. 
The plasma cholesterol concentration of the group (mean± S.E.M.) 
during each study i s shown above the histograms designed to represent 
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FIGURE 5.3 Faecal Sterol and Bile Acid Excretion in One Young 
Infant: The Effect of Prolonged Feeding of a High 
P/S diet and of Cholesterol 
Faecal neutral sterol and bile acid excretion was measured at 6-10, 
and 19-25 days of age whilst the infant was on a cholesterol-
containing, low P/S ratio diet. A cholesterol-free, high P/S ratio 
formula was substituted, and faecal excretion re-measured at 41-47 
and 64-69 days of age . When the infant was 15 weeks of age, 
cholesterol (in the form of egg-yolk powder) was added to the soy 
milk, a n d 2 further measurements of faecal bile acid and neutral 
sterol excretion made . 
The mean plasma cholesterol concentration dur ing each study period 
is shown, with histograms to represent 
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Numerous short-term studies in the young infant have demon s trate d 
the effect of different "milk" formulae on the plasma cholesterol l e vel. 
The most conunon comparison has b e en made between infants consuming 
evaporated cow ' s milk products and milk products to which vegetable oils 
have been added (Fomon and Bartels, 1960; Sweeney et al, 1961, 1962; 
Gyorgy et al , 1963; Darmady et al , 1972). The filled milk products 
resulted in lower plasma cholesterol levels than with cow's milk. The 
linoleate content of the formulae has been increased further by using 
soy bean with other vegetable oils added . The plasma cholesterol level of 
• 
infants on these formulae are further reduced in comparison with those fed 
evaporated milk (Fomon and Bartels, 1960; Sweeney et al, 1961, 1962; 
Gyorgy et al , 1963). The age of the infants has been from 1 week to 6 
months, and studies have generally been conducted as comparisons between 
groups of infants on different formulae, rather than as a cross-over 
design as in this current work. In one cross-over design, Pomeranze et al 
(19 58) fed 3 infants alternately on evaporated cow's milk formula with 
and without a daily supplement of 50 g of corn oil. The plasma cholesterol 
levels fell and rose accordingly. 
In general, the plasma cholesterol level of the infant can be 
influenced by the linoleate content of the "milk" formula, and the higher 
the ratio of the polyunsaturated to saturated fatty acids of the product, 
the lower will be the plasma cholesterol level. 
Comparative studies of the effect of human milk and cow's milk have 
also been carried out. It might be anticipated that breast-fed infants 
would have lower plasma cholesterol levels than those fed cow's milk, 
since the linoleate content of human milk (Insull and Ahrens, 1959) is 
approximately twice that of evaporated milk (Table 5.3). However, among 
infants 6 weeks of age and older, breast-fed infants either had higher 
(Fomon and Bartels , 1960; McKerrow, 1961; Darmady et al, 1972) or similar 
(Woodruff et al , 1964) plasma conce ntrations to those being fed cow's milk. 
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At one week of age no difference was apparent (Darrnady et al , 1972). One 
exception has been published (Gyorgy et al , 1963); premature infants up 
to 13 weeks of age being fed pooled human milk had lower plasma cholesterol 
levels than those fed evaporated milk. However, the former infants were 
hypoproteinaemic and showed poor weight gain and the difference in plasma 
cholesterol might have been due to deficient calories. In a second group 
of premature infants supplementation of the breast milk with casein 
resulted in plasma cholesterol and protein levels comparable to those on 
cow's milk. 
During the perinatal period, lipid absorption is much less 
efficient than in the adult (Fomon et al, 1970). The percentage of fat 
absorbed from cow's milk is smaller than from human milk in both full 
term neonates (Fomon et al, 1970) and premature infants (Signer et al, 
1974). Absorption of lipid particularly palmitic and stearic acids by 
the neonate is highest when palmitate is predominantly present in the 
S-position of the triglyceride molecule (Filer et al, 1969). This is the 
case with human milk fat, while in butter fat palmitate is equally 
distributed among the 3 positions (Freeman et al, 1965). Long chain 
polyunsaturated fatty acids and short chain saturated fatty acids seem 
equally well absorbed under most circumstances (Fomon et al, 1970). The 
linoleate absorbed is proportional to the content of the milk formula 
(Barness et al , 1974). If the plasma cholesterol concentration in an 
infant is dependent upon the relative caloric contributions of saturated 
and unsaturated fatty acids, as in the adult (Keys et al , 1965a), then the 
better absorption of palmitate from human milk may discount any advantage 
gained from the increased linoleic acid content of human relative to 
cow's milk. 
B. STEROL METABOLISM 
1. Excretion of Bile Acid by the Neonate The faecal excretion of 
bile acid in the neonates at 6-10 days of age was 1.7 mg/kg/day, 
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increasing to 3.5 mg/kg/day during the first 3 weeks of life. Few values 
of bile acid excretion in childhood have been reported. Measurements 
using an enzymatic method have yielded values of 7.3 mg/kg/day for 
premature infants (n=16) and 6.1 mg/kg/day for children aged 4 months to 
5 years (n=18) (Weber et al, 1972). Using a similar enzymatic method, 
but fluorometric rather than colorimetric assay, Signer et al (1974) 
obtained values of 21.0 mg/kg/day and 36.2 mg/kg/day in 2 groups of 
premature infants being fed human milk and cow ' s milk respectively. These 
latter values are considerably higher than those obtained in the current 
work , which compare more favourably with other studies in which the daily 
bile acid excretion was 10-85 mg/day in 16 children, aged 2 months to 14 
years of age (Leyland , 1970). This latter study utilized gas 
chromatographic techniques, and excretion was found to correlate with 
body weight . Bile acid excretion is reduced in young girls with anorexia 
nervosa, and may reflect diminished food intake and decreased body 
weight (Nestel, 1974) . Values obtained in adults have been 3 . 8 mg/kg/day 
(Miettinen , 1973) and 3 . 7 mg/kg/day in normolipidaemic subjects (Nestel 
and Hunter , 1974) . 
2 . Sterol Balance and Metabolism in the Neonate and Infant Net sterol 
excretion was low in the first 6-10 days of life and doubled over the next 
2 weeks while the infants were being fed the same milk formula. It did 
not change further, provided the diet was not changed . 
Ideal studies of cholesterol turnover demand maintenance of a 
steady state , particularly with regard to constant sterol ingestion and 
body weight . Obviously the latter requirement cannot apply in studies 
of growing infants . The average increase in body weight per week was 
about 0 . 15 kg or 5%. In a true steady state, cholesterol synthesi s equals 
the excretion of bile acids plus neutral sterols when the diet is 
cholesterol free . When cholesterol is present in the diet, synthesis 
equals total sterol excretion minus dietary cholesterol. Since in the 
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present studies a steady state cannot be assumed in view of the continuing 
growth of the infant and its expanding cholesterol pool, the difference 
between total sterol excretion and cholesterol intake is simply the net 
sterol output. This represents newly synthesized cholesterol and 
re-excreted dietary cholesterol in those infants consuming cholesterol. 
A change in net sterol output may therefore reflect changes in synthesis, 
in re-excretion or in both. Although one cannot distinguish between these, 
certain assumptions can and will be made on the basis of findings in adults 
studied under steady state conditions . 
The rate of synthesis of cholic acid in the mature newborn is 
2 
22.7 ± 4.lmg/day (mean± S.E.M.) or 110 ± 20 mg/m /day (Watkins et al, 
1973a). Expression of data in the literature has often been in terms of 
surface area, since comparison of metabolic data between small and large 
animals and infants and adults correlates better with body surface area 
than body weight (Kleiber, 1947). The data of Watkins et al (1973a) was 
obtained by measurement of the dilution in bile of orally administered 
deuterium labelled cholic acid. This also requires steady state conditions 
and therefore the validity of the data is in doubt. In premature infants 
of 34-36 weeks ' gestation , cholate synthesis was reported as 6.3 ± 1.2 
mg/day, and that of chenodeoxycholate 1.6 ± 0 .1 mg/day (Watkins et al, 
1973b). The cholate pool sizes were estimated to be 41.7 ± 7.4 mg and 
15 ± 1.6 mg in the mature and premature infants respectively, with that 
of chenodeoxycholate being 3.8 ± 0.7 mg in the premature infant. The rate 
of synthesis was therefore very high compared to the total pool size . 
From the current study then , although the values for the newborn are less 
than in the adult, this difference tends to disappear within 3 weeks of 
birth (Table 5 . 5) . 
Studies in the foetal dog have demonstrated that a well-developed 
enterohepatic circulation exists in utero (Lester et al, 1972), but the 
pattern of bile acid absorption is different to that in fully-grown 
animals (Smallwood et al , 1970) . Absorption of taurocholate from the 
jejunum is nearly as efficient as from the ileum. The suckling rat has 
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an efficient conservation of bile acids , with very slow rates of faecal 
excretion (Harri s et al, 1967) . This is coupled with low rates of 
mevalonate synthesis , which in association with the in vitro inhibition of 
mevalonate synthesis by addition of taurocholate, has been interpreted as 
feed-back inhibition of cholesterol synthesis by bile acids (Harris et al, 
1967). Weaning leads to an increase in bile acid excretion, together with 
an increase in cholesterol synthesis (Harris et al , 1967; McNamara et al , 
1972), which has been attributed to changes in the propertions of either 
fat, protein or carbohydrate in the diet (Harris et al, 1966; Carroll et 
al, 1973). Similar changes in synthesis are produced by interruption of 
the enterohepatic circulation, either surgically (Harris et al, 1967; 
McNamara et al , 1972) or with bile acid binding resins (Harris et al, 
1967) in the suckling or in the adult animal (Huff et al, 1963; Shefer 
et al , 1968), as well as in man (Grundy et al, 1971). The mechanism of 
sequestration of bile acids appears to be important in the increased bile 
acid loss in fibrocystic disease (Weber et al, 1973). Greater excretion 
of bile acid has been demonstrated in premature infants fed a cow's milk 
substitute in comparison with human milk (Signer et al, 1974). This may 
have been due to the sequestration of bile salts by calcium soaps and 
glyce rides which were less well absorbed in the premature than in the 
normal infa nts (Fomon et al , 1970; Watkins et al , 1974). 
It seems then, that in the mature neonate during the first week of 
life , the size of the total bile acid pool and the faecal loss of total 
bile acids are about half that found in the adult, though the rate of 
cholate synthesis alone is very similar to the adult values. The 
premature infant has a lesse r capacity to synthesize bile acids. 
For reasons already discussed, the excretion of neutral sterols cannot 
be equated with cholesterol synthesis even during the periods of 
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cholesterol-free die ts. In fact, the present studies do not include 
measurements in the absence of die tary choleste rol until the second month 
of life. Net sterol excretion then averaged 30 mg/kg/day , which is more 
than twice as high as in adults studied under steady state conditions on 
very low cholesterol diets (Connor et al , 1969; Quintao et al , 1971; 
Nestel and Hunter, 1974). 
3. The Effects of Changing the Dietary P/S Ratio and Cholesterol on 
Sterol Metabolism in the Young Infant When cholesterol was removed from 
the diet and the P/S ratio of the formula increased, bile acid excretion 
increased in all subjects (Table 5.5). The net sterol excretion increased 
markedly in 3 out of the 4 infants (Table 5.5). The fourth infant (L.K.) 
had been on an artificial milk having a P/S ratio of 0.40 and may have 
already been responding to the stimulus of polyunsaturated fat, although 
her plasma cholesterol level did fall further with Pro Sobee and removal 
of dietary cholesterol (Table 5.6). 
Two dietary factors must be considered, namely the effect of 
increasing the P/S ratio and the effect of reducing the cholesterol 
content. The actions of these two factors in lowering plasma cholesterol 
levelshavebeen considered to be both independent and interdependent. 
Keys et al (1965b) , Hegsted et al (1965) and Mattson et al (1972) support 
the significance and independence of the two. However, to obtain an 
adequate reduction in plasma cholesterol, the proportion of polyunsaturated 
fatty acids within the diet must be increased as the dietary cholesterol 
content is increased and Brown and Page (1965) and Brown (1970) have 
suggested an interdependence between the two. This is supported by studies 
of Connor et al (1961, 1964) and Erickson et al (1964), who showed that 
with cholesterol-free diets , even a 10-fold increase in P/S ratio (from 
0.2 to 2.6) did not further lower the plasma cholesterol concentration. 
On the other hand, when in later studies the P/S ratio was raised to 4.7 
the plasma cholesterol level was reduced even though the diet contained 
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no cholesterol (Connor et al , 1969). 
The effect of dietary fat upon cholesterol and bile acid synthesis , 
and the basis for the reduction of plasma cholesterol which accompanies 
the use of polyunsaturated fatty acids, are not clear. Normal men eating 
no cholesterol increase their bile acid and neutral sterol excretion 
in response to an increase in the P/A ratio from <0.05 to 4.7, at least 
over a period of three weeks (Connor e t al, 1969) . Moore et al (196 8 ), 
using experimental dietary periods of 16 days were also able to demonstrate 
an increase in faecal steroid excretion when the P/S ratio was increased. 
In the studies by Nestel et al (1973) the substitution of polyunsaturate d 
for conventional ruminant products in the diet enhanced bile acid and 
neutral sterol excretion in normal subjects during the first 3 to 4 weeks. 
When the studies were carried on for 6 weeks , when the plasma cholesterol 
concentration had reached its new steady level , sterol excretion returned 
to control values (Nestel et al , 1974) . This may explain the failure 
of other studies, notably those of Grundy and Ahrens (1970) to demonstrate 
a consistent increase in sterol excretion with polyunsaturated dietary 
fat . No difference in bile acid excretion could be shown in a comparison 
of corn oil and butter fat when the faecal collect ion was made only 4 
days after the change of diet (Ali et al , 1966) . The type of subject 
chosen for comparison of sterol excretion with polyunsaturated and more 
saturated fat diets may also be important . Most of the subjects studied 
by Grundy and Ahrens (1970) were g enetically hypercholesterolaemic . It 
would seem that the response in terms of change in sterol excretion is 
better seen in normolipidaemic (Moore et al , 1968 ; Connor et al, 1969; 
Nestel et al, 1973) and hypertriglyceridaemic (Grundy and Ahrens, 1970; 
Grundy , 1974) rather than in hypercholesterolaemic subjects (Avignan 
and Steinberg, 1965; Spritz et al , 1965 ; Grundy and Ahre ns, 1970). It 
should be noted that Grundy and Ahrens (1970) did find bile acid excretion 
to be increased in 5 out of 11 subjects "at some portion of the 
unsaturated fat period" , but they concluded that "changes in bile acid 
excretion may occur in association with decreasing plasma cholesterol 
on unsaturated fat diets , but such changes need not occur". 
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The increase in the infants ' net sterol output during the cholesterol-
free, high P/S formula milk feeding probably reflects 3 important changes. 
Firstly , the withdrawal of dietary cholestero l removes the suppression 
of cholesterol synthesis . Hepatic cholesterogenesis in man is under the 
control of direct feedback inhibition of dietary cholesterol 
(Bhattathiry and Siperstein, 1963; Fujiwara et al , 1965; Pawliger and 
Shipp , 1968) , although this may not apply to all tissues. For instance 
cholesterol feeding did not produce suppression of the rate of acetate 
incor_IX)ration into digitonin- precipitable sterols in the human small 
intestine (Gamel and Dietschy , 1970). The activity of HMG-CoA reductase 
in cultured fibroblasts from normal human skin is regulated by the content 
of LDLandVLDL in the culture medium (Brown et al , 1973). The suppression 
is proportional to the amount of LDL which is bound to the cells and 
degraded (Brown and Goldstein , 1974). In cells derived from subjects 
homozygous for familial hypercholesterolaemia , HMG-CoA reductase was not 
similarly suppressed (Goldstein and Brown, 1973) probably because LDL 
binding to the cells was deficient (Brown and Goldstein , 1974) . 
Increasing dietary cholesterol usually decreases cholesterol synthesis 
in man , as measured by sterol balance techniques (Grundy et al, 1969; 
Quintao et al , 1971), but exceptions have been reported (Quintao et al , 
1971) . The increased absorption of cholesterol with increased ingestion 
is also accompanied by increased re-excretion of cholesterol, and any 
accumulation of cholesterol within the body need not be reflected in 
plasma cholesterol levels (Quintao et al , 1971) . 
The second major factor to be considered as a cause for the increase 
in net sterol output is the re-excretion of endogenous cholesterol. In 
the infants on the soya bean formula, the presence of increased 
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quantities of plant sterol might have decreased the r eabsorption of 
endogenous cholesterol as described by Grundy et al (1969) and Shefer 
et al (1973). Shefer et al (1973) noted that feeding sitosterol to rats 
not only markedly increased the specific activity of hepatic HMG-CoA 
reductase , but also raised that of cholesterol 7a-hydroxylase by 40%. 
Thus both cholesterol and bile acid synthesis were stimulated. This is 
analogous to partial interruption of the enterolymphatic circulation of 
cholesterol. 
The third factor, namely a direct stimulation of biliary cholesterol 
and bile acid excretion by polyunsaturated fatty acids has already been 
discussed . 
There is also a fourth point which should be considered in the 
infants . Milk from the rat (Harris et al , 1967 ; McNamara et al, 1972), 
cow and human (Boguslawski and Wrobel , 1974) inhibits cholesterogenesis. 
Activity is demonstrable both in vivo and in vitro i n the rat, and the 
factor is heat stable . If such a factor were able to survive the 
processing of evaporated and other artificial milks , and if it were 
operative also in the human infant , then a change in the infant's formula 
from evaporated milk to the soya bean product might be accompanied by 
the removal of an inhibitor other than cholesterol . 
One infant (L.K . ) maintained a high sterol output throughout the 2 
months on the soya bean, cholesterol-free formula . However , in the 
presence of 2 other factors known to increase cholesterol synthesis, it 
is not possible to claim that this demonstrated the maintenance of a 
polyunsaturated fat induced increase in sterol excretion. The addition 
of cholesterol to the Pro Sobee produced a short-term increase in bile 
acid excretion and a sustained rise in net sterol output. In human 
adults dietary cholesterol stimulates the re-excretion of endogenous 
cholesterol (Grundy and Ahrens, 1969; Quintao et al, 1971), but not of 
bile acids, which is the major excretory pathway in rat (Taylor and Gould, 
I 
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1950; Wilson, 1962, 1964) and the dog (Abell et al, 1956; Pertsemlidis 
et al , 1973). Increased activity of cholesterol 7a-hydroxylase follows 
cholesterol feeding in rats (Boyd et al , 1968; Cohen et al, 1973). The 
increase in bile acid excretion was transient in baby L.K. and the 
absence of a sustained increase with continuing dietary cholesterol is 
consistent with findings in adults (Wilson and Lindsey, 1965 ). Since 
cholesterol synthesis would have been reduced due to the addition of the 
egg yolk cholesterol, the sustained increase in cholesterol excretion 
would represent enhancement of cholesterol re-excretion . In this infant, 
in contrast to the other 3 , dietary cholesterol was fed together with 
polyunsaturated fat, both of which are known to stimulate cholesterol 
excretion. These 2 factors clearly outweighed any reduction in ste~ol 
excretion due to lessened synthesis. 
CHAPTER 6 
LACTATION STUDY 
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INTRODUCTION 
Hypercholesterolaemia rarely presents as a clinical problem in 
childhood. However, the occurrence of hyperlipoproteinaemia in the 
paediatric age group of clinical practice is receiving wide attention, 
for here may lie the opportunity for prophylactic intervention in 
atherosclerosis. A proportion of children inheriting familial Type II 
hyperlipoproteinaemia may be detected at birth by measurement of 
umbilical cord plasma cholesterol (Glueck et al, 197li Tsang et al , 1974b) 
or LDL-cholesterol (Kwiterovich et al , 1970, 1973; Greten et al, 1973). 
Dietary cholesterol and the ratio between saturated and 
polyunsaturated fatty acids are important determinants of plasma 
cholesterol during infancy. Modification of these two factors may reverse 
hypercholesterolaemia to normal values (Glueck et al, 1972; Tsang et al, 
1974b). It has been clearly demonstrated that the short term use of 
evaporated milk enriched with vegetable oils, or of soya bean milk 
products, lowers plasma cholesterol levels in infants (Sweeney et al, 
1961; Gyorgy et al, 1963; Lowe et al, 1964). Other studies have shown 
that feeding infants on human breast milk may result in plasma cholesterol 
levels as high, if not higher, than with cow's milk, despite the higher 
linoleic acid content of human milk (Fomon and Bartels, 1960; Woodruff 
et al , 1964; Darmady et al, 1972). 
Two groups of children should be considered; those who have 
normal and those who have high plasma cholesterol levels. With a high 
rate of usage of commercial infant feeding formulas , estimated as being 
fed to approximately 80% of all infants in the U.S.A. (Fomon, 1971; 
Schubert, 1973), many infants are already being reared on a diet low in 
cholesterol and high in P/S ratio. It has been recommended that dietary 
modification be commenced in children at high risk during the first few 
years of life (Filer et al , 1972; Glueck et al , 1972; Mitchell et al, 
1972). For the newborn hypercholesterolaemic infant, the use of an 
artificial formula might seem pre f e rable to huma n milk. Howe v e r, the 
benefits of breast-feeding are nume rous, and since the linole ic acid 
content of human milk can be increased (Insull et al, 1959), the use of 
human milk need not be rule d out. 
This chapter describe s the effect on the composition of human 
milk resulting from changes in the maternal diet. The ultimate aim of 
altering the lipid composition of the milk was to influence the feeding 
infant's cholesterol and fatty acid metabolism in order to decrease the 
plasma cholesterol. 
METHODS 
The effect of dietary composition on the lipid constituents of 
human milk was investigated in three separate studies. Each study 
included a period that resembled an average Australian diet containing 
400-600 mg of cholesterol per day and fat that was rich in saturated 
fatty acids . This was compared with either a change in cholesterol 
content or fatty acid composition or both. All women were studied as 
out-patients in the free-living situation. The subjects were carefully 
instructed about weighing and preparation of food. They were asked to 
adhere rigidly to those items that provided the cholesterol and fat in 
their diet, as shown in Table 6 .1. The remainder of their food intake 
was not controlled. Caloric intake was monitored by regular weighing, 
except in Study I , which was carried out within 5 weeks of delivery, 
when excess weight gained during pregnancy was being lost. 
A. SUBJECTS 
The women were between 22 and 31 years of age (mean 26.4 years); 
body weights ranged from 46 to 76 kg (mean 59.1 kg) . Women taking part 
in the studies were selected on the basis of 
(1) a normal pregnancy, 
(2) an uncomplicated delivery, 
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TABLE 6.1 
Estimated Cholesterol Content of Foods Used in the 
Lactation Studies 
Lean beef 
Lean lamb 
Cooked chicken 
Fish 
Cholesterol content* 
(mg/100 g or mg/100 ml) 
94 
98 
85 
80 
DAIRY PRODUCTS Full cream milk 14 
EGG 
Skim milk 5 
Cream 100 
Yoghurt (low fat) 5 
Butter 250 
Cheddar cheese 100 
Cottage cheese 15 
One yolk 230 
*FOOTNOTE. The cholesterol content has been calculated 
from figures in Thomas and Carden (1970) and Watt and 
Merrill (1963). 
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(3) successful initiation and maintenance of lactation and 
(4) a healthy baby. 
No account was taken of parity (1-4) or previous breast-feeding experience . 
B. EXPERIMENTAL DESIGN 
Study I. A pilot study of 4 subjects consisted of 3 dietary periods of 
one week each as shown in Table 6.2, and was commenced only 10 days post 
partum. The estimated amounts of cholesterol and the foods from which 
this was derived are shown in Table 6.2. Diets A and B contained more 
cholesterol than did Diet C (approximately 575 mg and 110 mg respectively); 
Diet A was rich in saturated fatty acids, whilst Diets Band Chad an 
increased content of polyunsaturated fatty acids.* All subjects received 
Diets A, Band C in that order. 
Study II. This group consisted of 7 women who undertook the study for a 
total of 7 weeks. The effect of 2 diets was compared, one having an 
estimated cholesterol content of 575 mg and a high saturated fatty acid 
composition (Diet D), and the other (Diet E) having a much lower 
cholesterol content and a higher polyunsaturated fatty acid composition. 
The study was commenced 6 weeks postpartum, by which time physiological 
involution had occurred. The diets were given in random order, each for 
3 weeks, and the initial diet was retested for one week during the 
seventh week of the study. 
Study III. Alonge~ study of 3 women lasting 10-12 weeks compared the 
effects of two diets that were rich in either saturated or polyunsaturated 
fatty acids with similar intakes of cholesterol. The polyunsaturated 
diet was tested for 6 weeks and was preceded and followed by 1-3 weeks 
of the saturated diet. This study was also commenced when the infant was 
6 weeks of age. 
*Polyunsaturated margarine and oils were used in place of butter in the 
more unsaturated Diets. 
STUDY I. 
Diet 
Daily cholesterol 
STUDY II. 
Diet 
Daily cholesterol 
TABLE 6. 2 
Estimated Cholesterol Content of Diets Used in the Lactation Studies 
A. High cholesterol: 
Saturated fat 
300-360 g meat 
45 g cheese or 
cream 
600 ml milk 
60 g butter 
570 mg 
D. High cholesterol: 
Saturated fat 
100-120 g meat 
90 g cheese 
600 ml milk 
30 g butter 
1 egg 
580 mg 
B. High cholesterol: 
Polyunsaturated fat 
75-100 g 
100 g 
210 ml 
100 g 
2 
meat 
cottage cheese 
skim milk 
low fat yoghurt 
eggs 
570 1ng 
E. Low cholesterol: 
Varying saturation 
75-100 g 
100 g 
210 ml 
100 g 
meat 
cottage cheese 
skim milk 
low fat yoghurt 
110 mg 
C. Low cholesterol: 
Polyunsaturated fat 
75-,100 g 
100 g 
210 ml 
100 g 
meat 
cottage cheese 
skim milk 
low fat yoghurt 
110 mg 
Continued 
rv 
1--' 
rv 
STUDY III . 
Diet F. Moderate cholesterol : 
Saturated fat 
100-120 g meat 
45 g cheese 
600 ml milk 
60 g butter 
Daily cholesterol 380 mg 
TABLE 6 . 2 
(Continued) 
G. Moderate cholesterol: 
Polyunsaturated fat 
100-120 g 
100 g 
210 ml 
1 
meat 
low fat yoghurt 
skim milk 
egg 
345 mg 
rv 
I-' 
w 
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C. COLLECTION OF SAMPLES 
1. Mothe rs The composition of milk, especially that of its fat, 
changes both during a feed and in the course of a day (Hytten, 1954a,b). 
Obtaining representative samples of milk therefore poses difficulties, 
particularly in out-patients. In these studies, samples were collected 
at the same feed each day, either the first or second of the morning, 
and at the same point in relation to the feed, either before or after. 
The sample, 5-10 mls, was manually expressed from both breasts directly 
into a sterile container. One sample was collected on each of the last 
3 days of each week. The 3 samples were analyzed separately. The milk 
was immediately refrigerated at 4°C and the lipids extracted within 72 
hours. When longer storage periods were likely, the samples were 
immediately frozen. There was no difference between the results obtained 
from samples stored in these two ways. Lipid extracts of all milk 
samples were stored until completion of the study, then analyzed together. 
Fasting blood samples were collected at the end of each week, and 
the plasma lipids extracted within 3 hours. Venepuncture of the 
antecubital vein was used, with the subject in a sitting position 
following a 5-10 minute rest period. 
2. Infants Changes in the plasma cholesterol concentration were 
also determined in the infants of 8 of the women taking part in the 
studies, (5 out of the 7 in study II and all 3 in study III). The 
details of the frequency of blood sampling are shown in Table 6.3. The 
infants were weighed regularly and maintained normal growth rates 
(Figures 6.1 and 6.2). This was the simplest and most readily available 
way of assessing the infants' satisfactory progress and calorie intake, 
taking into account the variability in growth of individual infants week 
by week and the effect that any minor intercurrent illness may have. 
Although as shown in Table 6.3, the infants were predominantly breast 
fed throughout the studies , some supplementation was required. The 
STUDY I. 
M.B. 
B. M. 
K. M. 
J.T. 
G. W. 
STUDY II. 
J.A. 
L . R . 
C.v. d .S 
Sex 
M 
F 
M 
F 
M 
M 
F 
M 
TABLE 6 . 3 
Infants in the Lactation Studies~ Personal, Dietary and Sampling Details 
Birth 
Weight 
(Kg) 
3.04 
3.36 
3.47 
3.96 
3.75 
3.55 
3.43 
3.13 
Cord 
Cholesterol 
Concentration 
(mg/100 ml) 
50 
-
68 
58 
-
58 
156 
85 
Plasma 
Sampling 
Weekly 
1 sample each 
dietary period 
Weekly 
Weekly 
Weekly 
Weekly 
Weekly 
Weekly 
Diet 
Exclusively breast fed. 
Exclusively breast fed. 
Cereals from 4 weeks of age, 
prior to commencement of study . 
Predominantly breast fed. 
Predominantly breast fed . 
Predominantly breast fed. 
Predominantly breast fed. 
Predominantly breast fed . 
t\J 
~ 
Ln 
FIGURE 6.1 Growth of Male Infants During Lactation Studies 
Infants were weighed prior to and during the lactation studies. 
Their growth is shown contained within the pe rcentile limits 
recently obtained for an Australian population (NHMRC, 1974). 
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FIGURE 6.2 Growth of Female Infants During Lactation Studies 
Infants were weighed prior to and during the lactation studies. 
Their growth is shown contained within the percentile limits recently 
obtained for an Australian population (NHMRC, 1974). 
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cholesterol intake from the supplemental foods was minimal, since only 
cereals mixed with expressed breast milk and fruit gel products were 
allowed. 
Capillary blood was collected from the infants for cholesterol 
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estimations by means of a heel prick. The infants were not necessarily 
fasting. The blood was drawn directly into heparinized micro-capillary 
tubes, and the plasma and red cells separated as described in Chapter 4. 
Plasma lipids we re immediately extracted . 
D. LABORATORY PROCEDURES 
1 . Lipid Extraction 
Milk Cholesterol . A 2 ml aliquot was saponified with 18 mls of 95% 
ethyl alcohol and 2 mls of 10 N sodium hydroxide by refluxing over a 
steam bath for 1 hour. After cooling, 10 mls of water was added, and 
the cholesterol extracted with 3 x 50 ml and 1 x 25 ml volumes of 
petroleum ether (B.P. 60-80°C). 
Triglyceride~ Phospholipids and Tota. l Fatty Acids. These lipids were 
extracted by the method of Folch et al (1957): 0.2 ml aliquots of milk 
were extracted in 20 mls of cold chloroform:methanol, 2:1 (v:v). The 
resulting protein precipitate was removed by filtration (Whatman No.l paper), 
the filter being washed 3 times with 1 ml of solution. To the resultant 
filtrate was added 0.2 of its volume of 0.73% sodium chloride solution. 
The upper phase was discarded. The remaining lower phase was washed 3 
times with 2 ml of "pure upper phase" , chloroform:methanol:water, 
3:48:47. 
2. Lipid Analysis 
1ilk and Plasma Cholesterol and Triglyceride . These were measured in a 
Technican Auto Analyzer II Colorimeter (Ope rations manual, 1971). Plasma 
aliquots (0.5 ml) were extracted in 9.5 ml redistilled isopropanol and 
treated with zeolite as described in Chapter 2. Milk aliquots were 
taken from the lower phase of the chloroform:methanol extraction; the 
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latter was dried down under nitrogen, then made up to 10 mls with 
chloroform:methanol. A 1 ml aliquot was taken for triglyceride 
estimation, dried down under air, made up to 10 mls with isopropanol and 
treated with zeolite prior to assay. Milk cholesterol contained in 100 
ml aliquots of the petroleum ether extract was evaporated to dryness, 
redissolved in 2 ml isopropanol, treated with zeolite and assayed. 
Milk Phospholipids. The colorimetric estimation of inorganic phosphorus 
was used, according to the method of Bartlett (1959) and Morrison (1964). 
Milk inorganic phosphorus was removed during chloroform:methanol 
extraction of the lipids and subsequent washing of the lower phase. 
A 4 ml aliquot of the known extract volume (10 mls) was dried under air. 
Phospholipid in the sample was digested with concentrated sulphuric acid 
at 200°C for 30 minutes. A 30% solution of hydrogen peroxide was added 
for bleaching. Colour development was carried out with ammonium 
molybdate and Fiske-Subbarow reagent in a boiling water bath. Blanks 
consisting of concentrated sulphuric acid and standards of known 
phosphorus content (stock solution of di-potassium hydrogen or 
orthophosphate) were run simultaneously. They were read in a Beckman 
DB-G Grating Spectrophotometer, at 820 n.m. 
Milk and Plasma Total Fatty Acids. The 5 ml aliquots of the chloroform: 
methanol extraction of milk or the total plasma extract were evaporated 
to dryness under nitrogen. Methylation of fatty acids was carried out 
with 5 ml 4% sulphuric acid in dry methanol for 12-18 hours at room 
temperature. The methyl esters were extracted by phase separation using 
1 ml water and 4 ml heptane, and stored at 4°C in well sealed containers. 
Immediately prior to assay, the methyl esters were evaporated to 50-100 
µl under nitrogen. Aliquots of 2-3 µl were injected into a Packard 
Series 7800 Gas Chromatograph, containing a 6 foot, coiled, glass column, 
packed with 13% ethylene glycol adipate, 80-100 mesh, on Gas-chrom P 
(Applied Science Lab., State Park, Pennsylvania, U.S.A.). 
The following conditions operated: 
Inlet t emperature 190° C 
Column t emper ature 185-190°C 
Flame ionization de t e ctor t emperature 200° C 
Outlet temperature 195°C 
Carrier gas (N2 ) flow rate 40 cc/min 
Hydrogen flow rate 40 cc/min 
Air flow rate 400 cc/min 
Standard mixtures of known methyl esters of fatty acids (N.I.H. 
mixtures C and F) were injected at the commencement of each days run, 
and at intervals during the day. Examples of the separation obtained 
for milk and plasma are shown in Figure 6 . 3 . 
The respective weights of the methyl esters were measured by 
estimation of the peak area on the chromatograph according to the 
formula; 
Area a Peak Height x Retention time. 
Each fatty acid has been expressed as a percentage of the total fatty 
acid content of the injected sample . 
3 . Milk Protein Estimation The protein content of milk samples 
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was estimated using the colorimetric method developed by Lowry (1951). 
A 100 µl aliquot of milk was diluted 1 in 25 with distilled water, and 
0 . 2 ml taken for protein estimation. Protein standards contained 25-50 
µg of bovine serum albumin (Sigma Fraction V). Following colour 
development with Folin-Ciocalteau Phenol reagent, turbidity due to the 
presence of fat in the milk samples was cleared. This was done by 
FIGURE 6.3 Separation of the Methyl Esters of the Total Fatty 
Acids of Human Plasma and Milk 
Using Gas Chromatography 
Plasma and milk samoles were extracted, methylated and analysed as 
described in the text. 
T'ne traces show typical patterns obtained. The length of the carbon 
chain and Lhe number of unsaturated levels are indicated witi~ the 
relevant peak. 
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adding an equal volume of diethyl ether to the sample and mixing 
vigorously. Following phase separation , the lipid-containing upper ether 
layer was removed . Standards were subjected to the same treabnent. The 
optical density of the samples was read at 740 nm on a Beckman DB-G 
Grating Spectrophotometer . 
RESULTS 
A. MATERNAL PLASMA LIPIDS 
All diets designed to lower plasma cholesterol levels (namely B, 
C, E and G) resulted in a significant decrease in all groups (Table 6.4), 
regardless of whether the change was due to a decrease in dietary 
cholesterol or a higher P/S ratio. The mean cholesterol values of 
subjects in study I were higher than those in II and III, due to the 
residual effect of the hyperlipoproteinaemia of pregnancy. This latter 
effect was still operative during studies II and III, as shown by the 
higher than normal values found among a group of non-pregnant young 
. 
women, who were not taking oestrogen-containing preparations. 
There was no significant change in the triglyceride concentrations 
of the groups during the studies. The hypertriglyceridaemia of 
pregnancy does not persist in the puerperium for as long as the 
hypercholesterolaemia; already at 2 weeks post-partum plasma triglyceride 
values were substantially normal (Table 6.4). 
B . MILK LIPIDS AND PROTEIN 
1 . Milk Cholesterol Under the dietary conditions studied, i.e. 
changing cholesterol content and/or fatty acid composition, whilst 
keeping the diet isocaloric, no significant change in milk lipid 
concentration could be demonstrated (Table 6.5) . This is applicable to 
both individual subjects and to pooled group data, with only 2 exceptions. 
The change in lipid composition which accompanies the transition from 
colostrum to mature milk and which generally occurs during the first 2-3 
Study 
I 
(n=4) 
II 
(n=7) 
III 
(n=3) 
TABLE 6. 4 
Maternal Plasma Cholesterol and Triglyceride Concentrations 
During the Lactation Studies 
A 
B 
C 
D 
E 
F 
G 
Diet 
Saturation 
of fat* 
s 
p 
p 
s 
p 
s 
p 
Cholesterol 
(mg/day) 
570 
570 
110 
580 
110 
380 
345 
Plasma concentration 
(mg/100 ml) 
Cholesterol Triglyceride 
349 + 47** 
316 + 38 
276 + 41 
297 + 107 
260 + 93 
226 + 18 
206 + 15 
116 + 27 
102 + 48 
109 + 37 
97 + 25 
94 + 34 
90 + 33 
90 + 34 
Significant differences. Cholesterol. A-B p = 0.062 
<0.001 
<0.001 
<0.001 
B-C 
D-E 
F-G 
*Saturation of fat: S - rich in saturated fatty acids 
P - rich in polyunsaturated fatty acids 
**Plasma concentration: mean± S.D. 
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Study 
I 
(n=4) 
II 
(n=7) 
III 
(n=J) 
A 
B 
C 
D 
E 
F 
G 
TABLE 6.5 
Milk Lipid and Protein Concentrations 
Diet 
Saturation 
of fat* 
s 
p 
p 
s 
p 
s 
p 
Cholesterol 
(mg/day) 
570 
570 
110 
580 
110 
380 
345 
*Saturation of fat: 
**Milk concentration: 
Cholesterol 
(mg/100 ml) 
23.2 ± 5.9** 
19.4 ± 2.8 
20.4 ± 2.5 
18.1 ± 2.7 
19.3 ± 3.6 
23.3 ± 2.3 
21.3 ± 2.4 
Milk Concentration 
Triglyceride 
(g/100 ml) 
2.90 ± 0.99 
2.55 ± 0.86 
3.35" ± 0.71 
3.42 ± 0.61 
3.57 ± 0.82 
4.11 ± 0.42 
4.12 ± 0.56 
Phospholipid 
(mg P. /100 ml) 
l 
5 .72 ± 1.08 
4.74 ± 0.98 
5.81 ± 2.18 
4.04 ± 0.71 
4.18 ± 0.91 
S - rich in saturated fatty acids 
P - rich in polyunsaturated fatty acids 
mean± S.E.M. 
Protein 
(g/100 ml) 
0.89 ± 0.03 
0.91 ± 0.03 
t\J 
t\J 
~ 
weeks of lactation , has been observed previously (Macy and Kelly, 1961). 
It consists of an increase in the total fat content of the milk and a 
decrease in the proportion of cholesterol, with only minor changes in 
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the phospholipid moiety . The cholesterol content of milk from one subject 
fell from 31.8 mg/100 ml (Diet A) to 23.1 mg/100 ml (Diet B) and then 
further to 17.4 mg/100 ml when Diet C was introduced . This could be 
explained on the basis of milk maturation. However, her milk triglyceride 
values also decreased by 14% of the level with Diet A. This demonstrates 
a relationship between milk cholesterol and triglyceride which will be 
discussed in more detail below. 
In no single individual, nor in any group, was a significant 
relationship found between the plasma cholesterol concentration and the 
cholesterol content of the milk . Despite significant changes in the 
plasma cholesterol levels brought about by dietary change , the cholesterol 
content of the milk could not be varied correspondingly. It is 
relevant to point out that the one hypercholesterolaemic woman did not 
produce milk with a higher cholesterol content than was found in the 
normocholesterolaemic women . 
2 • Milk Triglyceride Whilst there was wide variation in the 
triglyceride content of milk among the women , no significant changes 
were brought about by dietary change within the groups . The triglyceride 
content of milk varied from 1.3 g/100 ml to 6 . 8 g/100 ml and averaged 
3-4 g/100 ml in the 3 studies (Table 6 . 5) . 
3 . Milk Protein The protein content of milk remained constant 
throughout the studies , and showed little variation between the women. 
4 . Relationship Between Milk Cholesterol, Triglyceride and Phospholipid 
Strongly positive correlations were found between the various lipid 
constituents of milk (Table 6.6). The correlation coefficients were 
particularly high in studies II and III, i . e . during well established 
lactation . However , in transitional milk (study I) the relationships 
Subj e ct 
STUDY I . 
B.D. 
B.M. 
E.M. 
P.V. 
STUDY II . 
M.B. 
J.C. 
E.H. 
B.M. 
K.M. 
J.T. 
G.W. 
Group 
STUDY III . 
J.A. 
L. R. 
C.v.d.S 
Group 
TABLE 6.6 
Inter-relationships Between the Concentrations of 
Milk Cholestero l, Triglyce ride and Phospholipid 
Cholesterol 
Corre lation 
coefficient 
(r) 
0.532 
0.565 
0.735 
0.277 
0.962 
0.622 
0.886 
0.860 
0.877 
0.889 
0.956 
0.971 
0.202 
0.708 
0.778 
0.694 
- Triglyceride 
Significance 
(p) 
n.s. 
0.05 
0.001 
n. s. 
0.001 
<0.01 
0.001 
0.001 
0.001 
0.001 
0.001 
<0.001 
n.s. 
<0.02 
<0.02 
0.05 
Phospholipid -
Correlation 
coe fficient 
(r) 
0.603 
0.634 
0.788 
-0.014 
0.908 
0.934 
0.870 
0.881 
0.923 
0.946 
0.815 
0.951 
0.812 
Triglyceride 
Significance 
(p) 
<0.05 
<0.05 
0.001 
n.s. 
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
<0.01 
<0.001 
<0.01 
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were weaker. 
C. FA'l'TY ACID COMPOSITION OF PLASMA AND MILK 
1. Fatty Acid Composition of Plasma Plasma fatty acids were 
analyzed to demonstrate adherence by the subject to a diet which was 
being followed in an unsupervised, free-living situation. The purpose 
of the study was to alter plasma fatty acid composition and measure the 
extent of change in the milk fatty acid composition. The fatty acids 
in plasma which were measured were the total fasting fatty acids, and 
were therefore less sensitive to dietary change than those in milk, 
which were mainly triglyceride fatty acids. Although several subjects 
did not respond to dietary change as much as had been anticipated, this 
did not prevent their inclusion in the analysis of results. 
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The mean values of the major plasma fatty acids are shown in Table 
6.7. In any one individual the change was often not statistically 
significant due to week to week variation. In the whole group, however, 
increasing the polyunsaturated fatty acid content of the diet, by using 
polyunsaturated margarine and oils, significantly increased the plasma 
linoleic acid in Studies I (p <0.001) and II (p <0.05), at the expense 
of decreased plasma myristic acid, (Study I, p <0.05; Study II, p = 0.05; 
Study III, p <O. 001) and palmi tic and palmi toleic acids in Study I 
(p <0.05 and p <0.01 respectively). 
The fatty acid composition of plasma in Study I, carried out during 
the puerperium is shifted in the direction of the shorter chain fatty 
acids. A similar pattern is seen in the fatty acid composition of milk 
(Table 6. 7) . 
2. Fatty Acid Composition of Milk In all studies the milk linoleate 
content increased rapidly in response to a dietary increase. By the 
fifth day the linoleic acid content had doubled. Table 6.7 shows that 
the significant increase in linoleate occurred at the expense of myristate 
(Study I, p <0.05; Study II, p <0.001; Study III, p <0.001) and 
Study 
I 
(n=4) 
II 
(n=7) 
III 
(n=3 ) 
A 
B 
C 
D 
E 
F 
G 
Diet 
Saturation 
TABLE 6.7 
Milk and Maternal Plasma Fatty Acid Composition 
Milk Fatty Acids 
( % of total) 
Plasma Fatty Acids 
( % of total) 
of fat** C8*:0 10:0 12:0 14:0 16:0 16:1 18:0 18:1 18:2 18:3 >20 Cl2:0 14:0 16:0 16:l 18:0 18:1 18:2 
s 
p 
p 
s 
p 
s 
p 
2.8 5.2 8.1 23.7 5.4 9.6 37 .3 8.4 
3.3 3.9 5.4 20.9 5.3 7.9 39.0 15.8 
2.8 5.0 6.0 19.5 6.4 7.6 36.6 16.4 
1.4 2.7 27 . 0 6.0 9 .6 23 . 8 30 .0 
1.0 1.7 24 .0 4.8 8 .7 22.3 37 . 8 
2.1 2.2 24 . 3 5.1 8 .7 21 . 8 35.1 
Tr*** Tr 2.6 6.6 25.0 3.7 10.4 42.2 8.7 Tr 
2.7 5.3 21.5 3.5 9.6 42.0 14.7 Tr 
1.0 20.5 3.1 9.9 27.2 38.3 
0.7 19.2 2.8 10.0 26.3 40.8 Tr Tr 
Tr 
Tr 
2.1 5.5 23.9 3.5 9.8 42.9 11.3 0.8 Tr 
2.3 4.2 20.9 2.2 9.9 40.5 19.2 0.6 Tr 
1.0 19.7 3.1 8.9 26.8 37.9 
0.5 19.4 2.8 8 .7 23.8 42 . 3 
*C8:0 = number of carbon atoms followed by number of double 
bonds 
**Saturation of fat: s - rich in saturated fatty acids 
P - rich in polyunsaturated fatty acids 
***Tr : trace - less than <0.1% 
rv 
rv 
co 
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palmitate (Study I, p <0.05; Study II, p <0 .001; Study III, p <0.01). 
Significant changes sometimes occurred in stearic , palmitoleic and oleic 
acids, but these were not constant. 
As mentioned in the previous section, the fatty acid composition 
of milk during the puerperal study is shifted in the direction of the 
shorter chain fatty acids. 
3. Relationship Between Plasma and Milk Fatty Acids The milk 
linoleate content generally followed that seen in the fasting plasma 
(Figure 6.4). A significant overall correlation of 0.721 was obtained 
for the contents of milk and plasma linoleic acid. Individual variation 
did occur, particularly when there were only small changes in the P/S 
ratio of the diet. The individual correlation coefficients are shown 
in Table 6.8. 
D. THE FEEDING INFANT 
The plasma cholesterol concentrations of the 7 children who were 
studied weekly in parallel with their mothers are shown in Table 6.9 and 
Figure 6.5. Due to t_he small number of values for any one child, both 
the means and ranges have been included in the table. A single result 
from an eighth child (B.M.) is also shown. There was a decrease in the 
average plasma · level in all infants, but this was not always of 
statistical significance. The decrease in plasma cholesterol was highly 
significant (p <0.001) for the whole group. 
Figure 6.6 shows the serial results from one mother and infant 
pair (L.R.), with a reciprocal relationship between the milk linoleate 
content and the plasma cholesterol level of the feeding infant. The 
response of the infant has a time lag, here seen to be abou~ 1 week. The 
infant was hypercholesterolaemic at birth (cord plasma concentration 156 
mg/100 ml) and at 6 weeks of age had a plasma level of 235 mg/100 ml. 
FIGURE 6.4 The Relationship Between the Linoleate Contents 
of Plasma and Milk 
The plasr:1a linoleate content (expressed as a percentage of the 
total fatty acid) and the resultant milk linoleate in any one 
subject in each week of the dietary experiments are positively 
related. The correlation coefficients of individual subjects 
are shown in Table 6.8 . 
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TABLE 6 . 8 
The Relationship Between the Linoleate Contents 
STUDY II . 
(n=6/7) 
STUDY III . 
(n=l0/12) 
Group (n=70) 
of Plasma and Milk 
Subject 
M.B. 
J.C. 
E.H. 
B.M. 
K.M. 
J.T. 
G.W. 
J.A. 
L. R. 
C.v.d.S 
Correlation 
coefficient 
(r) 
0.019 
0.331 
0.810 
0.392 
0.984 
0.619 
-0.273 
0.816 
0.854 
0.845 
0.721 
Significance 
(p) 
0.05 
<0.001 
<0.01 
<0.01 
<0.01 
<0.001 
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TABLE 6.9 
The Effect of Changes in the Linoleate Content of Human Milk 
on the Plasma Cholesterol Level of the Feeding Infant 
Subject 
STUDY II. 
(Diet Dor E) 
M.B. 
K.M. 
J.T. 
G.W. 
B.M . 
STUDY III. 
(Diet F or G) 
J.A. 
L.R. 
c.v.d.s 
Mean+ S . D. 
. More Saturated Diet More Unsaturated Diet 
Milk Plasma 
Linoleate* Cholesterol** 
8.3 
8.8 
12.7 
6.4 
5.2 
11.4 
7 .3 
15.3 
150 (150) 
162 (155-169) 
163 (156-170) 
173 (164-182) 
194 
195 (194-196) 
261 (236-314) 
185 (172-192) 
185 ± 35*** 
Milk 
Linoleate 
11.3 
17.4 
21.1 
9.3 
7.2 
17.0 
18.4 
22.1 
Plasma 
Cholesterol 
96 ( 91-100) 
128 (124-132) 
158 (144-171) 
137 (125-150) 
184 
189 (161-229) 
210 (192-253) 
151 (125-167) 
156 + 38*** 
*Milk linoleate 
- % of total fatty acid 
**Plasma cholesterol - mg/100 ml 
***Significantly different at p <0.001 
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FIGURE 6 . 5 The Effect of Changes in the Linoleate Content of 
Human Milk on the Plasma Cholesterol Level of 
the Feeding Infant 
The mean plasma cholesterol concentration of each of 8 infants is 
shown during the periods in which his or her mother was eating a 
saturated or more unsaturated diet . The milk linoleate content of 
each woman during these periods is also shown . 
300 
-
-E 
0 
0 
~ 
--~ 250 
-
-
-0 
L 
Cl) 
..-
l/) 
(1)-
-0 200 ..c 
u 
a 
E 
l/) 
a 
-Q_ 
150 0 
FIGURE 6 . 6 
234 
-
25~ 
u 
a 
/\ ...... 
~ 
I ' 20 :::; 
/ I \ I I \ I a -I \ I "+-
\ I \ ~ I 15 I I 
' I \ 
0 
\ I \ -
I 
I I \ I /\ \ (lJ e I .+-J -I \ 10 a QJ I 
-
\ 
-
\ 0 
/ \ C / 
/ 5 -~ 
-
2 
2 4 6 8 10 
Time (weeks) 
The Effect of Changes in the Linoleate Content of Human 
Milk on the Plasma Cholesterol Level of the Feeding 
Infant : The Longitudional Study of One Infant 
The plasma cholesterol concentration of infant (L . R . ) was measured 
weekly from the age of 6 weeks , as was the linoleate content of her 
mother ' s milk . During the first 3 weeks , the maternal diet was saturated, 
for which was substituted an unsaturated diet for the next 6 weeks . For a 
further 3 weeks she re-substituted the original saturated diet . There was 
a n inverse relationship , which is displaced in time , between the infant's 
plasma cholesterol concentration and the milk linoleate content . 
Plasma cholesterol concentration 
(mg/100 ml) 
Milk linoleate content 
(% total fatty acid) 
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DISCUSSION 
A. THE PRODUCTIOT OF MILK 
1. Milk Triglyceride Fatty Acids Increasing the polyunsaturated 
fatty acid content of the maternal diet was reflected by a rapid increase 
in milk linoleate. The linoleate and linolenate contents showed a 2-fold 
increase in all studies when comparing the less saturated with the more 
saturated diets. The failure of some women to achieve large increases 
in milk linoleate was due to their use of hydrogenated rather than 
polyunsaturated margarines. The increase was achieved at the expense of 
some or all of myristate (Cl4:0), palmitate (Cl6:0), palmitoleate (C16:l) 
and stearate (Cl8:0). The fatty acid composition of milk during the 
puerperium (Study I) was shifted in the direction of shorter chain fatty 
acids. 
The size of the change achieved is interesting compared with the 
data of Insull et al (1959). The diets utilized in our study were all 
designed around a basic formula with cholesterol intakes of 100-600 
mg/day and up to 40% of the calories derived from fat. In the studies 
conducted by Insull and his colleagues (1959), up to 70% of the total 
calories of the liquid diet were as fat, in the form of corn oil. They 
were able to attain a maximum linoleate plus linolenate content of 42-
44%, expressed as a percentage of the total fatty acids of milk. In a 
control diet, using the same subject, but providing 40% of the calories 
as lard, the value for linoleate was 10.3%. This value is similar to 
that reported for the composition of human milk from free-living subjects 
on ad libitwn diets (Insull and Ahrens, 1959). The profiles of milk fatty 
acid composition vary among different ethnic groups, dietary fatty acid 
and carbohydrate being important (Read et al, 1965a). 
The fatty acids of milk are derived from 2 sources; from 
circulating chylomicrons and lipoproteins of plasma and from endogenous 
synthesis within alveolar cells of the mammary gland (Linzell and Peaker, 
1971). The relative contribution from the two sources has been 
estimated in animals. Linzell (1968) showed that in the goat, all milk 
fatty acids up to and including myristate (Cl4:0), plus some 50% of 
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the palmitate (Cl6:0) were synthesized from acetate and 8-hydroxy butyrate, 
accounting for some 40% of the total milk fat. The remainder, mainly 
oleate and stearate (Cl8) was taken up directly from plasma free fatty 
acids and triglycerides. In studies with small precursor molecules, 
both ruminant and rodent mammary tissue have been shown to have the 
capacity to synthesize short chain fatty acids up to Cl4, there being 
some difference in the preferred precursor molecule between species, 
resulting in characteristic fatty acid patterns (Folley and McNaught, 
1961; Garton, 1963; Smith, 1971; Katz and Wals, 1972). In estimating 
how much of the milk fat was derived from dietary as opposed to 
endogenous sources, Glascock et al (1956) estimated that, in the goat, 
27% was obtained directly from the diet. Insull et al (1959) studied this 
by using isocaloric, hypocaloric and hypercaloric diets of varying fatty 
acid composition. With eucaloric diets, as in the present studies, the 
fatty acids of the milk reflected those in the diet, but with hypocaloric 
diets, there was an increase in milk lauric acid, reflecting increased 
synthesis within the mammary gland. With the hypercaloric diets, there 
was an increase in milk fat concentration~ the dietary fatty acids 
contributing significantly if the diet contained much fat. If the excess 
calories were derived from carbohydrate there was an increase in short 
chain fatty acids due to increased synthesis in the mammary gland. 
There may b e a functional intermediate lipid pool in the mammary 
gland which prevents large fluctuations in the fatty acid composition 
(Insull et al , 1959). Such fluctuations do occur in the milk fatty 
acid composition of women on high carbohydrate diets (Read et al , 1965b). 
In this situation, the relative contributions of short (Cl2 and C14) and 
long (Cl6 and Cl8) chain fatty acids are determined by the relative 
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availability of substrate in the plasma: 8 hours after a high 
carbohydrate meal , the levels of laurate and myristate become maximal. 
Evidence for the presence of a buffering storage pool is based upon the 
observation that 2 to 3 days are required before a change in milk fatty 
acid compos ition b ecomes maximal following dietary change (Insull et al, 
1959). Furthermore, although labelled fatty acid will appear in milk 
as soon as 4 hours after being given orally, the maximum concentration is 
not reache d for 23 hours (Glascock et al, 1956). Against this, 
fluctuations in fatty acid composition occur during each 24 hour period 
(Read et al , 1965b) and it is known that large amounts of chyle may be 
directly taken up by the lactating udder of the goat (Lascelles et al, 
1964). 
Study I, carried out during the puerperium, showed fatty acid 
profiles, in both milk and plasma, which were shifted in the direction of 
an increased percentage of shorter chain fatty acids, namely Cl0-Cl4. 
This may reflect changes in the composition of fatty acids in plasma 
during pregnancy (Taylor, 1972), but the variability in the reported 
compositions for total fatty acids (Degrelle-Cheymol, 1964; Woodruff et 
al, 1964; Renkonen, 1966) or triglyceride fatty acids (Sweeney et al, 
1963) at term, makes any conclusion difficult. Maternal adipose tissue 
biopsies at mid-gestation (Roux et al, 1971) or at delivery (Sweeney 
et al , 1963) show lower levels of Cl4:0, Cl6:l and Cl8:l and higher 
levels of Cl6:0, Cl8:0 and Cl8:2 compared with normal women (Heffernan, 
1964). 
2. Milk Choles t ero l The cholesterol content of human milk was 
independent of dietary cholesterol. This is in contradistinction to 
findings in other species such as the rat (Re iser and Sidelman, 1972) 
and the guinea-pig (Connor and Lin, 1967), in which the cholesterol 
content of milk rises with increases in dietary and plasma cholesterol. 
The source of milk cholesterol is two fold, from plasma and from endogenous 
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marrnnary synthesis . The proportion derived from plasma varies between 
species, being 70-80% in the rat (Chevallier, 1964; Clarenberg and 
Chaikoff, 1966; Easter , 1971), 35% in the guinea-pig (Connor and Lin, 
1967), 50-60% in the goat (Mills et al, 1974) and a significant 
proportion in the rabbit (Connor and Lin , 1967). In the rhesus monkey, 
approximately two-thirds of milk cholesterol is derived from plasma 
(Pitkin et al , 1972). The contribution from plasma in guinea-pig milk 
increases 2-fold with increases in dietary cholesterol, which also 
greatly raised the concentration in plasma (Connor and Lin, 1967). In 
ruminants fed a protected polyunsaturated oil supplement , there is an 
increase in the plasma cholesterol concentration (Bitman et al , 1973; 
Mills et al , 1974) , yet the milk cholesterol content remains unchanged, 
due to a decrease in the contribution from plasma cholesterol (Mills et 
al , 1974). 
In my studies, the failure of the milk cholesterol to rise in the 
face of an increase in dietary cholesterol may reflect a reduced 
contribution from plasma as in the ruminant studies, or a compensatory 
decrease in cholesterogenesis . On the other hand, the decrease in milk 
cholesterol content with the change in secretion from colostrum to mature 
milk (Macy and Kelly , 1961) parallels the decrease in post-partum plasma 
cholesterol levels. 
However , the problem may be approached from another point of view . 
In mature milk , there is a constant relationship between the cholesterol 
and triglyceride concentrations (Table 6 . 6), suggesting a functional 
interrelation . Milk fat consists of lipid globules , primarily 
triglyceride , surrounded by a hydrophobic cholesterol-phospholipid-
containing membrane (Ling et al , 1961) . The cholesterol content of the 
bovine membrane comprises some 5.2% of the lipid and the phospholipid 
20 . 4% (Brunner , 1969) . The cholesterol in milk may be fractionated into 
that associated with the fat globules and that remaining in the skim 
milk. The latter is associated with membrane particles (Patton, 1973). 
These consist of microvilli shed from the alveolar cell surface 
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(Stewart et al , 1972) and some shed from the fat globule membrane by 
vesiculation (Wooding, 1971). It has b een proposed that the 2 fractions 
and the cholesterol contained therein may have differe nt origins 
(Easter, 1973), the cholesterol of the skim milk fraction being derived 
from the plasma. The turnover of dietary cholesterol from plasma into 
milk in the rat is 17-20 hours (Easter, 1971), and is found in the 
skim milk (Easter, 1973). The secretion of milk is dependent upon 
constant regeneration of cell membranes; protein and lactose secretion 
utilize membranes in vesicle transport from the endoplasmic reticulum, 
to the Golgi apparatus and then to the cell surface, where they are 
secreted by reverse pinocytosis (Helrninen and Ericsson, 1968; Keenan 
et al, 1970); triglycerides are secreted in company with hydrophobic 
substances in globules, being enveloped by portions of the alveolar cell 
membrane and extruded into the lumen (Hollmann, 1959; Kinsella and 
McCarthy, 1968). Easter hypothesizes that plasma cholesterol is 
incorporated into the cell membrane in a regenerative capacity, and is 
thus indirectly incorporated into milk in its role as a component of the 
milk fat globule membrane, de rived from the alveolar membrane (Patton 
and Fowkes, 1967). The contribution from this source should therefore 
be proportional to the secretion of milk, particularly of triglyceride. 
The relationship found in these studies would support that contention. 
The endogenous synthesis of cholesterol within the mammary gland 
from precursors such as acetate has been demonstrated many times, both 
in vivo (e.g. Popjak and Beeckmans , 1950) and in vitro (e.g. Clarenberg 
and Chaikoff, 1966). It is not responsive to negative feedback in the 
guinea-pig, as demonstrated by Connor and Lin (1967). In the ruminant, 
choleste rogenesis in the mammary gland is stimulated by polyunsaturated 
fatty acids (Mills et al, 1974). Easter (1973), using mevalonate as 
precursor, showed the presence of labelled cholesterol within the milk 
fat globule fraction only. 
Looking at the relationship in Study I more closely, if the 
correlations are derived for the latter 3 weeks of the study, rather 
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than the entire 4 week period , then the correlation coefficients resemble 
those of the mature milk samples (Study II). The comparative correlation 
coefficients are shown in Table 6 .10 below. 
TABLE 6.10 
The Correlation Between Cholesterol and Triglyceride 
Concentrations in Transitional Milk 
Weeks 1-5 post partum Weeks 2-5 post partum 
Subject Correlation Correlation 
coefficient 
p 
coefficient 
p 
B .D. 0.532 0.657 <0.05 
B.M. 0.565 0.05 0.851 <0.01 
E.M. 0.735 0.001 0.947 <0.001 
P.V. 0.227 0.444 
3. Milk Phospholipid The question of milk phospholipid has also 
been considered in terms of 2 pools (Patton, 1973). Most, if not all, 
phospholipid is synthesized in mammary tissue de nova (Easter et al , 1971). 
The pools may relate to the milk fat globule membrane, derived from the 
plasma membrane which envelopes the globule when secreted, and to the 
droplet surface itself prior to secretion. The results in Table 6.6 
indicate a strong relationship between triglyceride and phospholipid 
levels. However, since both pools above may well be concentration-
dependent and physically determined by the surface area of the globule, 
such data does not help distinguish between these two possibilities; it 
merely denotes a possible functional interaction between the two 
components. 
B. THE CHOLESTEROL LOWE RI G EFFECT I~ THE FEEDING INFANT 
The decrease in the infants' plasma cholesterol concentration in 
response to an increasing concentration of linoleate in milk was 
variable but within the group the result was significant . There was no 
relationship however between the total fat or cholesterol content of 
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the milk and the change in infant plasma cholesterol levels. The growth 
of all infants, in terms of weight, fall within and followed population 
standards. 
Other dietary studies carried out during infancy are not strictly 
comparable . Studies utilizing changes in milk formulae have exposed all 
infants on one formula to the same P/S ratio and similar cholesterol 
intakes (Fomon and Bartels, 1960; Sweeney et al, 1961, 1962; Gyorgy 
et al , 1963; Woodruff et al , 1964; Darrnady et al, 1972). Since the 
average milk cholesterol content remained constant throughout the present 
study, the total intake per day will have increased slightly over the 
study period, though in relation to the baby's weight will have remained 
fairly constant. Any change in plasma cholesterol may therefore be 
attributed to an alteration in the P/S ratio of the diet. Only small 
amounts of cereal were introduced during the study, but it is unlikely 
that the very small amount of fibre would have affected bile acid 
secretion (Kritchevsky and Story, 1974). 
It is known that the linoleic acid content of plasma (Hansen et al , 
1964) and on adipose tissue (Sweeney et al , 1963) varies with the linoleic 
acid content of the diet. The increase in adipose linoleate is more 
rapid in infancy (Sweeney et al , 1963) than in the adult (Christakis et 
al , 1965). Plasma cholesterol concentration is lowered by increasing 
the P/S ratio of the diet (Keys et al , 1965; Grande et al , 1972; Nestel 
et al , 1973). The study by Neste l et al (1973) in adults, using 
I 
polyunsaturated ruminant fat is the most comparable , since the diet 
composition remained unchanged except for the change in fatty acids. 
The mechanism of action of polyunsaturated fats appears to be through 
increased cholesterol catabolism and excretion , at least during the 
initial 3-4 weeks while the plasma cholesterol concentration is falling 
(Moore et al , 1968; Nestel et al , 1973) , though this may not continue 
into the new steady state (Grundy and Ahrens , 1970). Infants fed on 
cholesterol-free soy milk, with a P/S ratio of 4.2 show an increase in 
bile acid synthesis which is maintained for up to 6 weeks (Chapter 5). 
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